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Recently, effort has been placed on creating biomaterials that can directly interact biologically with 
cells and tissue.  In this dissertation, mammalian cells are cultured on a variety of engineered 
microenvironments, designed to elicit a specific cellular response.   In Chapter 2, chemical vapor 
deposition is used to create multi-modal substrates that can co-immobilize two biomolecules at 
precise ratios.  The substrates were characterized, and the biological potency of each of the tethered 
biomolecules was confirmed by cell culture with the HUVEC and A431 cell lines, respectively.  We 
also demonstrated that a CVD coating created by polymerization of pyridinophane has higher rates 
of cell adhesion in comparison to traditional Parylene.  In Chapter 3, surface-initiated graft 
polymerization and atom-transfer radical polymerization were used to generate substrates coated 
with a thin film of poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] 
(PMEDSAH).  We characterized the proliferation, markers of pluripotency, and morphology of 
human mesenchymal stem cells (hMSCs) grown on these substrates and compared them to tissue 
culture polystyrene (TCPS).  We found that hMSCs grown on PMEDSAH retain their characteristic 
markers, but those on grafted PMEDSAH grow at a slower rate than those on TCPS or ATRP 
PMEDSAH.  In Chapter 4 we created bioactuators.  Flexible microcylinders spatially selective for 
cell adhesion were fabricated via electrohydrodynamic co-jetting.  Cell selectivity was subsequently 
demonstrated first with fibroblasts, then neonatal rat cardiomyocytes.  We showed that the 
cardiomyocytes selectively bound to our microcylinders could bend them with a significant amount 
of force in comparison to other reported bioactuators.  Finally, in Chapter 5 we produced 
microenvironments conducive to forming cell sheets, which will be used as building blocks for 
xv 
 
higher ordered tissues.  PLGA grid scaffolds were generated via electrohydrodynamic co-jetting.  We 
created sheets of fibroblasts and hMSCs by growing them on scaffolds in rotator culture, and 
characterized sheet development by examining the distribution of extracellular matrix proteins over 
time.  We also created keratinocyte sheets by co-culture with a feeder cell sheet of fibroblasts.    In 











Introduction, Motivation, and Themes 
Introduction  
Using artificial materials to heal the human body arguably dates back thousands of years, with 
examples found throughout history.  A Gallo-Roman corpse dated to the 1-2nd century CE was 
found fitted with an iron false tooth - one of the earliest examples of a functional oral medical 
prosthesis 1, 2.  Archeologists have also discovered in Iran an ancient ocular prosthesis (‘glass eye’) 
that was dated to 2800 BCE 3.  A prosthetic wooden toe dated to 1064-740 BCE was recovered in 
Egypt near Thebes 4.  Beyond merely attaching wood or metal to the human body, the legend of 
Saints Cosmas and Damian (in which the two saints replace a Caucasian man’s wounded leg with 
that of an Ethiopian) depicts an early example of a limb transplant 5.  This miracle is celebrated in 
Western art and has been referenced by Vacanti (a pioneer in the field of biotechnology) as a 
depiction of the goals of tissue engineering, though Vacanti argues that an even earlier reference may 
be found in Genesis 1:1 (subject of perhaps Michelangelo’s best known work, The Creation of 
Adam) 2, 5.   
The advent of modern science, the rapid advancement of medicine in the past century, and the even 
more recent breakthroughs achieved in molecular biology and genetics has given scientists and 
medical clinicians new tools for engineering materials that interact with life.  In particular, 
biomaterials have become a key field in medicine and biotechnology, with applications in areas 
ranging from biomedical devices such as stents to in vitro cell culture to tissue engineering4.  A 
2 
 
‘biomaterial’ can be broadly defined as any material that is designed to interact with living tissue, but 
this encompasses a large family of polymers, metals, ceramics, hydrogels, and even ‘natural’ materials 
that have been re-engineered or modified, such as proteins like collagen 6, 7.  However, it has been 
argued that natural tissues themselves (such as a skull) are not biomaterials8. Picking a particular 
biomaterial depends on the application – metals are often used for stents, while polymers are more 
commonly used as catheters and ceramics for dental fillings6.   Essentially, biomaterials serve as an 
artificial microenvironment for cells to grow, die, and differentiate in.  By controlling a cell’s 
microenvironment through proper design of biomaterials, its behavior can also be controlled.   
Initially, biomaterials were simply the bulk material of whatever was being used; however, they have 
been increasingly surface modified in order to induce some biological activity4.  In particular, the 
extracellular matrix (ECM) has served as both a source of inspiration and a source of functional 
groups for enhancing the activity of biomaterials9.  The ECM is essentially a dynamic scaffolding 
secreted by cells in tissue and composed of a large variety of structural proteins, glycoproteins, 
proteoglycans, and bound signaling factors10.   The ECM is not merely a static background onto 
which cells bind; it can directly influence cell behavior via pathways like integrin signaling, including 
differentiation and cell proliferation10, 11.  It is this feature of the ECM that inspired many of the 
recent advances in making cell culture surfaces bioactive, rather than simply inert platforms.  Choi et 
al. engineered a hybrid protein which fused short peptides derived from ECM molecules that 
promoted cell adhesion (such as argine-glycine-aspartic acid (RGD), derived from fibronectin) with 
another previously engineered protein based on extremely adhesive proteins secreted by mussels (so-
called ‘MAPs’) – the adhesive protein would then stick to an inert surface such as polystyrene, while 
presenting the bound small peptide for cultured cells to bind12.  This is a great example of modifying 
the surface of a polymer with something that directly interacts with cells – a theme that will reoccur 
again and again in this dissertation.  Multiple reviewers refer to a new paradigm in biomaterials, 
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where bottom-up construction via self-assembly (much like how ECM is constructed in vivo) should 
be the strategy for creating new substrates4, 9. 
Dissertation Overview 
The overarching theme of this thesis is studying how mammalian cells interact with functionalized 
materials.  In this dissertation, a variety of material synthesis techniques are applied to create 
multimodal susbtrates.  Much as biomaterials have many uses and applications, each project also has 
a different end use (Chapter 2 details multimodal substrates created via chemical vapor deposition 
for potential use in medical devices or cell culture, while Chapter 4 reports a project in which 
‘biorobots’ are the goal).  Yet fundamentally each involves the incubation of a line of mammalian 
cells with a biomaterial and a designed set of experiments meant to confirm or reject a logical 
sequence of hypotheses.  Cell area and spreading, protein expression, and cell morphology were 
characterized and quantified as a way of gaining insight into the complex interactions between the 
cells and the biomaterial to which they are attached.   
Answering the question of how mammalian cells will behave given a particular modified biomaterial 
that compromises an entire microenvironment serves as a unifying theme for this thesis.  Chapters 2 
and 3 involve the culture of cells on two-dimensional substrates designed to somehow influence or 
even change their behavior.  Cells are presented with an environment that has multiple ligands, and 
their reaction to this multimodal substrate is carefully quantified in Chapter 2.  In Chapter 3 human 
mesenchymal stem cell proliferation are compared for culture on different substrates; expression of 
characteristic markers is also compared.  In Chapter 4, substrates are also multimodal (for example, 
biphasic fibers and cylinders with different cell-selective properties on each phase); however, instead 
of being flat 2D surfaces they are now cylindrical three-dimensional particles and fibers designed to 
be chemically selective for cells on only one particular side.  Finally, Chapter 5 expands on this 
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theme.  Instead of using only a collection of microcylinders or single fibers, a three-dimensional 
scaffold composed of stacks of many fibers is used to perform true three-dimensional cell cultures.  
This is important, as 2D cell culture has increasingly been recognized as unrepresentative of the 
physiological environment cells naturally reside in (for example, the quintessential cell ‘focal 
adhesion point’ was characterized on 2D substrates, but more recent work suggests that these FAPs 
are quite different on 3D substrates)13, 14.   Fig 1.1 summarizes both the individual aims of each 
chapter in this thesis, and emphasizes that while the individual projects are not directly related, they 
all ask fundamentally what the resulting gross cell behavior will be when presented with a particular 
microenvironment. 
All four projects have relevant applications in tissue engineering and medicine (especially Chapters 2 
and 5).  They are proof-of-concept projects that demonstrate the ability of each microenvironment 
platform in obtaining a certain cell behavior or morphology (for example, growth of cells as sheets, 
or the activation of an epidermal growth factor receptor, or the bending of a microcylinder).  In 
 
Figure 1.1:  In this thesis, we created multiple selected microenvironments (the blue line) designed to 
influence cell behavior (illustrated in this figure as a green oval with a blue nucleus), and we seek to 
understand the outcome of culturing cells in these surroundings  
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summary, biomaterials will continue to play an important role in modern medicine and clinical 
sciences, and by better understanding how to design them so we can observe a desired cell behavior 
as a result, we hope to both advance new toolboxes for producing complex functionalized substrates 
(from chemical vapor deposition to atom transfer radical polymerization to electrohydrodynamic co-
jetting) and continue to improve on our understanding of how mammalian cells interact with 
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Chemical Vapor Deposition Coatings for Orthogonal Dual Biomolecule Immobilization 
 
Parts of this chapter have been adapted and/or paraphrased from the following published articles 
with minor modifications (reproduced by permission from John Wiley and Sons). 
1.  Deng, X., Eyster, T.W., Elkasabi, Y. and Lahann, J. (2012), Bio-Orthogonal Polymer 
Coatings for Co-Presentation of Biomolecules., Macromol. Rapid Commun., 33: 640-645. 
Overview  
In this chapter, we take advantage of chemical vapor deposition (CVD) to create a multimodal 
substrate that can bind two biomolecules in precise ratios.  While there exist many methods for 
attaching biomolecules to surfaces, there are relatively few for precise immobilization of multiple 
biomolecules.  In the Introduction, we discuss the motivating factors behind the development of 
techniques for modifying surfaces for biological and medical applications, along with the current 
state of the field for tethering molecules to a surface. We address those techniques’ inherent 
advantages and disadvantages.  In particular, the issue of precise immobilization arises as a key 
disadvantage for a lot of strategies available.  Residual toxic solvents left behind during the 
immobilization step can also be a detriment.  We also provide background on the chemical reactions 
we plan to use in tethering biomolecules, including substitution via Pfp-ester and copper catalyzed 
click chemistry.  CVD of functionalized poly-p-xylylene co-polymers presents a convenient 
technique for creating surfaces that can bind biomolecules in predetermined ratios.  We used CVD 
to bind two biomolecules:  epidermal growth factor (EGF) and the cell adhesive factor arginine-
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glycine-aspartic acid (RGD).  We next demonstrate that these biomolecules remain active by 
culturing the model cell lines HUVEC and A431 respectively on CVD-coated surfaces featuring 
tethered RGD, EGF, and RGD simultaneously with EGF.  We also examine the capability of a new 
p-lutidinylene-co-p-xylylene coating to induce HUVEC spreading. 
Introduction and Background – Bulk and Surface Modification of Substrates 
 
Ever since some of the first bacteria cultures were grown on agar in glass Petri dishes, scientists have 
used artificial substances to grow and support proliferating cells and tissues 1.  Traditionally these 
bulk materials were simple (unlike the incredibly complicated milieu of structural proteins, signaling 
proteins, and small molecules that make up the environment that cells typically occupy in a tissue).  
Glass was the original substrate used for culturing cells – this has mostly been replaced by 
polystyrene (which is sometimes labeled ‘tissue culture polystyrene’ as it is often rendered more 
hydrophilic by a gas plasma treatment to enhance its ability to adhere cells) due to its similar optical 
properties, superior reproducibility, disposability, and relative ease of production and molding into a 
variety of different products2.  Recently though, there has been interest in further modifying 
substrates through chemical functionalization in order to influence cell behavior.   By modifying 
substrates through attaching proteins, short peptides, nucleotides, and other small biologically active 
molecules (‘biomolecules’), materials can be constructed that interact with living tissue and 
microscopic life, including bacteria and cells.  Having such factors incorporated in or coated on a 
bulk material can radically change how it interacts with cultured cells. For example, conjugating 
transforming growth factor-β (TGF-β) into a polyethylene glycol (PEG) hydrogel led to a significant 
increase in extracellular matrix (ECM) protein production by cultured vascular smooth muscle cells 
in comparison to a control which lacked this growth factor 3.  Tethering a peptide that promotes cell 
adhesion such as arginine-glycine-aspartic acid (the cell binding motif in the ECM protein 
9 
 
fibronectin) to a surface or scaffold is a very common strategy4, 5.  Other times one may wish to limit 
the adhesion or spreading of cells – polymers like PEG or proteins like albumin (which resists cell 
adhesion) can be polymerized or tethered onto a surface 6, 7.  There are applications where the 
mechanical properties of a certain bulk material might be very ideal (e.g., Young’s modulus, or 
Poisson’s ratio, or density), but the surface properties (for example its ability to bind cells or induce 
an immune response) may be very non-ideal.  For instance, titanium is an ideal substrate for medical 
implants because it is generally biocompatible and can induce osseointegration (i.e., growth of new 
bone on the implant itself and its integration into the skeletal structure) – however, it has been 
known to fail and not integrate8, 9.  Hauser et al. improved a titanium alloy’s ability to bind SAOS-2 
cells (an osteosarcoma line) by a plasma-mediated coating of collagen I, thus demonstrating a 
successful change to a material’s ability to bind cells without changing its bulk mechanical 
properties10.   By changing the surface properties of the bulk material, one can effectively separate 
the two.  The properties of the bulk material can be decoupled from the surface through a thin 
polymer film coating, thus retaining the gross mechanical properties of the substrate while 
(sometimes greatly) altering how its surface interacts with proteins or cells 11. 
Appropriate surface functionalization could also be designed to ward off or minimize undesirable 
biological responses (such as the immunogenic response common with implanted materials, or 
unwanted thrombosis)12, 13.  Heparin (which prevents blood clotting) has been coated onto poly(vinyl) 
chloride (a common material found in medical devices) in order to favorably alter this material’s 
biological interactions with blood 14.  Such materials have many applications, including as biosensors, 
implanted medical devices (e.g., mechanical stents, pacemakers, catheters), and components of 
engineered tissue 3, 15, 16.   
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Surfaces can be modified and functionalized directly, either through a chemical reaction resulting in 
a covalent bond with the bulk material, or adsorption as exemplified with self-assembled monolayers 
(SAMs).  For example, alkanes have been covalently bonded to a hydrogen-terminated silicon 
substrate by submerging the substrate in molten diacyl peroxide 17.  SAMs are commonly created by 
adsorbing long amphiphilic molecules featuring a functional group on one end, and a ‘head’ group 
on the other that strongly (but non-covalently) interacts with the substrate18.  Alkanethiols for 
example strongly interact with a gold substrate, and are commonly used to pattern mammalian cells 
on a surface18, 19.  One disadvantage of SAMs is that they usually require a metal substrate such as 
gold (they can also be assembled on silicon), which may not always be desired for a particular 
application20, 21.   Thermal grafting is another method for coating surfaces – materials are placed in a 
UV/ozone environment to generate peroxides on the substrate, followed by submersion in a high 
temperature solution of monomer22.  The monomers then polymerize on the substrate by reacting 
with the peroxides22. To support feeder cell-free human embryonic stem cell culture, Villa-Diaz and 
Nandivada et al. used thermal grafting to prepare poly[2-(mathacryloyloxy)ethyl dimethyl-(3-
sulfopropyl) ammonium hydroxide] (PMEDSAH) surfaces23.  However, polymer grafting generally 
involves liquid solvents (which can include toxins such as acetone)24, which along with the 
sometimes high temperatures required can damage the substrates that need to be coated (such as 
medical devices containing sensitive electronics), or leave behind toxic residues.   In fact, residual 
toxic chemicals from materials processing can be a critical problem in biomaterials manufacturing25, 
26.  A technique for immobilizing biomolecules onto a surface that does not require a liquid solvent 
would thus be ideal. 
Aside from generating SAMs on metallic surfaces and thermal grafting, there are many other 
methods for modifying substrates or depositing thin films onto surfaces.  These include 
electroplating, layer-by-layer assembly, Langmuir-Blodgett deposition, and chemical bath deposition 
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27-30.  However, one of the most versatile and well-characterized techniques available is chemical 
vapor deposition. 
 
Chemical Vapor Deposition 
Chemical vapor deposition (CVD) can be generally thought of as a  process for depositing a 
chemically homogenous film from a gas via a heterogeneous reaction between the surface of the 
solid being coated and the gas which is being deposited 31. The gas or vapor itself is typically 
generated by high temperature heating of solid reactants, which then can undergo reactions in the 
vapor phase before deposition 31.  CVD is commonly used to deposit metals and inorganic films 
such as titanium nitride, copper, and aluminum, and finds wide application in the semiconductor 
industry31-34.  CVD can also be used to deposit thin films of polymers for a broad range of 
applications35.  Perhaps the most well-known CVD polymerization reaction is the Gorham process36, 
37.   
Developed in 1966 by a scientist at Union Carbide, the Gorham process creates thin films of poly-p-
xylylenes (PPX) (commonly referred to as ‘parylene’) from the free radical polymerization of [2.2] 
paracyclophanes through thermal pyrolysis at low pressures (near vacuum) (Fig. 2.1)36, 37.  Solid 
monomer [2.2] paracyclophane is loaded into a quartz deposition chamber, and then placed under 
 
 
Figure 2.1:  Radical polymerization of [2.2] paracyclophane to form poly-p-xylylene (parylene) 
(adapted from Hopf et al. with permission)37  
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vacuum (Fig 2.2)35.  A stream of argon gas then carries the monomer into a pyrolysis chamber, 
which is heated to a temperature hot enough to symmetrically cleave the paracylcophane (between 
550-600 C°)35.  This leads to the formation of two diradicals (p-quinodimethane); once these are 
carried into a low temperature deposition chamber (15-30 C°), they undergo free radical 
polymerization to form PPX 35, 37.      
In addition to its use in the biomedical field, parylene and parylene-derivatives have also found 
application in gas chromatography and microfluidic devices 38-40.  In particular, CVD has certain 
advantages over other surface modification strategies that make it ideal for biomedical applications.  
It is a solventless process (e.g., no worries about toxic residues being left behind, or about the 
compatibility of what is being coated with a liquid solvent such as water or chloroform), does not 
require a catalyst, generates few byproducts, and the film undergoes deposition at relatively 
moderate temperatures (10-25 °C) so substrates that might otherwise be temperature sensitive (such 
as anything electronic) could be coated as well 41. 
While parylene does not feature any reactive functional groups, Lahann et al. have generated a large 
library of modified paracylcophanes featuring a wide variety of different chemical moieties 35, 41, 42.  
These groups are attached to one of the benzyl carbons on [2.2] paracyclophane via various 
synthetic routes; there are now many such substituted paracyclophanes available.  These include 
 
Figure 2.2:  Basic chemical vapor deposition (CVD) schematic for deposition of poly(p-xylylene) (the 
Gorham process) (adapted from Lahann with permission)35  
13 
 
paracylcophanes featuring amines, alkynes, aldehydes, hydroxides, halogens such as bromine, ethers, 
esters, carboxylic acids, nitrates, and lactones 35, 41.  Paracyclophanes with these functional groups can 
be polymerized by CVD to form reactive thin functionalized PPX films, which can go on to react 
with such things as proteins, nucleic acids, or other functional groups such as linkers for further 
chemistries, divorcing in a single step the bulk chemistry of the substrate from its surface in a 
completely customized fashion.  Limitations include difficulties in synthesis, the non-
biodegradability of PPX, and the necessity for the functional group to not independently react 
during pyrolysis.  For example, proteins tethered to a paracyclophane could not be coated via CVD 
because the intense heat would immediately denature them.  However, functional groups like Pfp-
esters or aldehydes could be incorporated into a substituted paracyclophane, coated onto a surface, 
and then through a variety of available reactions allow for the post-CVD immobilization of proteins.  
This has already been successfully done with several proteins, including EGF and r-hirulin11, 43.  
Picking the right functional group to immobilize a protein depends greatly on the protein being 
tethered (along with whether or not it needs modifications such as biotintylation or azido groups 
attached) and the desired outcome. 
Furthermore, multiple reactive groups can be deposited in precise ratios on surfaces, as 
demonstrated by Elkasabi et al.42.  This is important for immobilization of biomolecules such as 
peptides, nucleic acids, and proteins, as control over their ratio on the surface of a material is directly 
related to the ratio of the initial reactive groups present42.  In this work, Elkasabi et al. used CVD to 
deposit co-polymer films with various starting ratios of precursor monomers (paracyclophanes 
functionalized with an amine and trifluoroacetyl group respectively) – subsequent FTIR results 
showed that as the molar feed ratio of amine to trifluoroacetyl groups changed, the resulting C-F 
band adjusted up or down accordingly, and that a 1:1 molar feed of each monomer resulted in the 
expected N/F ratio of 0.332 (as measured by XPS)42.  Further studies were conducted by varying the 
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molar loading ratios of paracyclophanes functionalized with an amine versus a ketone (-COC2H5) – 
as the amount of ketone to amine was increased from 1:5 to 5:1, the FTIR showed the characteristic 
C=O peak at 1687.2 cm-1 increasing while the N-H stretch peak at 3361.6 cm-1 went away44.  Also, 
1:1 ratios of PPX-NH2 to PPX-COC6H5, PPX-COC2H5, PPX-COC2F5, and COCF3 mostly showed 
the predicted ratios of surface-bound atoms and bonds via XPS, though there were exceptions44.   
 
Cell Adhesion and Small Peptides 
 
Cell spreading has been found to be critical for avoiding apoptosis45.  By careful patterning of ECM 
protein islands, Chen et al. demonstrated that as the area of endothelial cells becomes smaller, their 
likelihood of dying becomes higher45.  This seems to imply that the larger the area of a cell on a 
surface, the better chance it has of surviving, making it clear why tissue engineers and material 
scientists focus so much on generating substrates that can support cell adhesion.  In fact, most 
mammalian cells in culture proliferate and survive much better when adhered to a surface (this is 
referred to as anchorage-dependence), with a few exceptions such as blood cells, transformed cells 
and certain cell lines grown under special conditions (for example, Peehl et al. grew anchorage 
independent non-tumor fibroblasts with high cortisol and serum concentration in the growth media) 
46, 47.  Cell adhesion is a critical part of native tissues, and understanding it is important for trying to 
recapitulate these tissues artificially48.  Methods such as CVD can be used to adhere cell adhesive 
factors onto artificial substrates. 
When promoting cell adhesion on a surface, the membrane proteins that mediate this response are 
often targets.  Integrins are the main family of proteins who anchor a cell to its environment – they 
are heterodimers composed of an α and β subunit of which there are many variants (e.g., αV, α5, β1, 
etc)49-51.  Integrins not only help coordinate cell binding, but can also act as signaling receptors and 
regulate apoptosis and cell survival52, 53.  Thus, they are an important regulator of cell behavior and 
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can be actively targeted by proteins and peptides which they bind to elicit a desired cell response – 
usually cell adhesion.  Artificial materials can be coated with extracellular matrix proteins such as 
vitronectin or fibronectin to enhance their ability to bind cells 49.  However, while using whole 
proteins can be fine for simple cell culture, using them to promote cell adhesion in vivo could lead to 
unwanted immunogenic effects49.  Kantlehner et al. also points out that whole proteins are ripe 
targets for degradation by proteases49.  The solution is to tether only the parts of the ECM protein 
that directly participate in integrin-protein interactions during cell binding, so that immunogenicity 
and degradation is minimized.  Many of these small peptides have been successfully synthesized and 
used to bind cells on scaffolds or surfaces, including REDV (which is selective for endothelial cells), 
IKVAV (derived from laminin), and KQAGDV3, 54, 55.  However, the most popular small adhesive 
peptide is RGD (mentioned previously), mostly thanks to the many different integrin heterodimers it 
is able to bind (nearly half of those known)51.  The geometric patterning of RGD in a material is also 
important in how it influences cell spreading, signaling, and proliferation – alginate hydrogels 
containing RGD spaced by hydrogels lacking RGD can be generated, and it has been shown that the 
relative distance between these RGD ‘islands’ can directly regulate several key cell behaviors56.  This 
indicates that the density of RGD bound to a surface could play an important role in cell culture – 
thus, techniques for modifying surfaces which can tune this density (such as those generated by 
CVD) would be a powerful tool.  One disadvantage of using small peptides is their propensity to 
actually lower the long term production of ECM molecules by cells3.  Mann et al. helped remedy this 
by co-immobilization of the growth factor TGF-β with a variety of small peptides – the growth 
factor subsequently stimulated new ECM production by cells cultured on these small adhesive 





Bioconjugation and Click Chemistry 
 
The ability to functionalize a surface with single or multiple chemical groups allows for the 
conjugation of biomolecules such as proteins or small peptides to a surface.  Aside from those 
already discussed, there are several reasons this may be useful in material design – tethered proteins 
have been shown in multiple studies to exert different effects than their soluble counterparts (such 
as superior in vivo wound healing)57, 58.  In particular, the tethering of growth factors such as EGF or 
FGF has been the goal of many projects59.  In his large review of the subject, Ito postulates that 
immobilized proteins which signal through receptors can avoid down regulation by receptor-ligand 
degradation and recycling, as ligands (in this case the proteins) which are tethered cannot be taken 
up by the cell59.  Chen et al. tethered EGF to a polystyrene surface via UV photo-irradiation (the 
EGF was previously modified with an N-(4-azidobenzoyloxy)succinimide to form an azidobenzoyl 
derivatized EGF, which could then be photo-immobilized to polystyrene via a secondary amine 
linker)60.  They found that tethered EGF had a greater proliferative effect than soluble EGF for 
anchorage dependent cells, and attribute it to a lack of receptor-ligand internalization, which would 
subsequently down regulate the effect of EGF60.  To support this hypothesis, they demonstrated via 
a radiolabeled EGF that tethered EGF was not subsequently found inside the cell after incubation, 
while soluble EGF was60.  Sometimes it can be advantage to immobilize more than one protein, in 
order to obtain a synergistic effect.  Ito et al. did exactly this by immobilizing insulin with the cell 
adhesive protein fibronectin61.  They found synergistically that cell growth was stronger with both 
proteins tethered compared to only insulin or fibronectin alone – this makes sense given the 
hypothesis of long-term signaling through inhibition of receptor-ligand internalization (the more 
area the cells occupy as promoted by fibronectin, the more signaling that can occur via tethered 
insulin)61.  Taking advantage of this potential for synergy thus could require techniques (such as 
CVD) which allow for the presentation of multiple tethered biomolecules on a surface.  
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There are many different available strategies for covalently tethering proteins to a substrate, and 
almost all take advantage of reactive functional groups present on proteins.  These include amines 
and sulfhydryls among others, and are targets for a variety of chemistries that result in a protein (or 
peptide) being linked to another protein or substrate62.  These strategies of covalently linking 
biomolecules together (which includes proteins, nucleic acids, peptides, carbohydrates, and lipids) to 
other materials such as polymers are generally referred to as ‘bioconjugation’63.  There are also other 
non-covalent methods for tethering proteins to a surface – these can be as simple as adsorption or 
involve more complicated strategies such as the relationship between biotin and streptavidin40.  
Pfp-ester protein linkage is a popular way to tether proteins to a surface.  These highly reactive 
esters will react with any primary amine to form an amide bond – all amino acids have a primary 
amine at their N-terminus, and the amino acid lysine also contains a primary amine as its side chain 
50, 64.  Lee et al. used Pfp-ester to tether amine-terminated RGD and biotin to a poly(glycolic acid) 
(PGA) substrate in patterns; subsequently, they were able to grow cells in patterns that followed the 
patterned Pfp-ester 64.  One disadvantage of using Pfp-ester is the lack of control over which 
primary amine it will react with – a protein with three lysine groups (and thus four primary amines) 
could react with a tethered Pfp-ester via any of those amines.  Tethering a protein always limits its 
degrees of freedom – if the Pfp-ester immobilizes the protein in an orientation that is incompatible 
with a cell receptor (which requires a specific protein orientation to signal downstream), then it is 
possible that the protein will not lead to a downstream biological effect even though the protein 
itself has been successfully tethered to the surface.  Lahann et al. had a similar problem with the 
protein r-hiuridin (which was tethered via reactive CVD using a different chemistry than Pfp-ester 
but still involved immobilizing a protein on the surface using a reactive primary amine)43.  This was 
solved by temporarily protecting the amine that they did not want to react with the surface via 
protection with a N-(methyl sulfonyl ethoxy carbonyloxy) sucinimide, then deprotecting it after 
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immobilization with piperidine43.  A similar strategy could be pursued with proteins containing 
biologically critical primary amines that are to be tethered with Pfp-ester.  Attaching the protein to a 
spacer molecule through which the protein is linked to the surface can also increase its flexibility and 
allow it to act more like its soluble counterpart59 - this could also be employed to help cope with 
initially poor binding orientation through Pfp-ester tethering.   
Other methods of protein bioconjugation in addition to Pfp-ester include NHS-EDC chemistry (in 
which a carboxylic acid and amine are coupled to form an amide, with NHS ester helping to increase 
the reaction efficiency), sulfydryl reactions such as those which use 4-(4-N-maleimidophenyl)butyric 
acid hydrazide to link sulhydryls to carbonyls (there are other types of these reactions, many of 
which use a maleimide to form a thioester bond), and crosslinking a carboxylated protein with 
another protein containing a strong nucleophile (such as a primary amine) via photoactivated 4-(p-
azidosalicylamido)butylamine62. 
“Click” chemistry has recently emerged as a powerful new strategy for conjugating molecules.  Click 
chemistry is not a particular reaction or even family of reactions, but a general philosophy that 
Sharpless et al. and Nandivada et al. succinctly summarized as follows (paraphrased here): a click 
reaction is any reaction which binds two molecules together that react completely (typically with a 
thermodynamic driving force higher than 20 kcal/mol), has a minimal number of byproducts (and 
ideally only one product), has low cross-reactivity with functional groups other than its target (an 
important feature of bioorthgonality), results in stereospecific products if applicable, generates 
products which are easy to separate after the reaction is complete (Sharpless specifies it must be 
nonchromatographic), and can happen at simple laboratory conditions (such as at room temperature, 
atmospheric pressure, use non-caustic solvents such as water, etc) 65, 66.  It is a powerful tool for 
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functionalizing materials such as polymers in the hands of chemists, material engineers, and 
increasingly medical scientists65. 
While there are many reactions that can fall under the umbrella of ‘click’ (such as the Diels-Alder 
reaction – another sort of cycloaddition), the two used in this thesis are the Huisgen’s 1,3-dipolar 
cycloaddition and strain promoted cycloaddition of cyclooctyne67.  1,3-dipolar cycloaddition can link 
two molecules together via a five-membered heterocyclic ring by a reaction between what Huisgen 
terms a dipole and a “dipolarophile”68.  The dipole is generated by resonance across double or triple 
bonds (such as an azide with its double bonds), which can then react with a dipolarophile such as an 
alkyne68.  Copper catalyzed 1,3-dipolar cycloaddition between an azide and an alkyne is commonly 
referred to as CuAAC, while the five-membered heterocyclic ring is defined as a 1,2,3-triazole69.  A 
copper(I) catalyst is often used in order to keep the reaction conditions at room temperature and 
pressure (though other catalysts have been reported, such as the ruthenium catalyst Cp*RuCl(PPh3)2) 
– copper (II) sulfate can be added to the reaction solvent and kept reduced via the further addition 
of ascorbic acid (other copper catalysts are also used depending on the solvent, such as 
CuBr(PPh3)4)
67, 69, 70.  In the language of cycloaddition chemistry, this sort of addition is termed 
“[3+2]” (as three atoms from the 1,3-dipole form a 5 member ring with two atoms on the 
dipolarophile)68.  CuAAC has been used with great success in such fields as drug synthesis, activity-
based protein profiling, polymer architecture, and surface modification for cell adhesion69,11, 71, 72.  
Proteins modified at their N-terminal to feature an azide or an alkyne have been joined together to 
form dimers through CuAAC, making it a powerful bioconjugation technique 73. 
However, CuAAC suffers from a potentially critical defect when it comes to surface modification 
for cell culture.  Copper is toxic to mammalian cells – Cao et al.  demonstrated that L929 mouse 
fibroblasts have a greater than 99% incident of death within 24 hours after exposure to only 62 µM 
of copper ion74.  This is much lower than the standard 100 µM used for CuAAC in Deng et al.11.  
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While residual copper can be washed off with a phosphate buffer saline solution (PBS) or even 
chelated with ethylenediaminetetraacetic acid (EDTA), this still sometimes does not fully eliminate it 
– and there are instances where a click chemistry reaction would be desirable to occur in situ with 
living cells or tissue (in which case the strategy of washing away copper catalyst would be moot)75.  
Thus, a variety of copper-free click chemistry reactions have been developed and characterized – 
such reactions could then be exploited for things like live in vivo imaging (where copper would not 
be tolerated)75. 
One such copper-free click chemistry is cyclooctyne strain promoted [3+2] azide-alkyne 
cycloaddition, developed by Bertozzi et al.67.  Here, the ring strain itself provides the thermodynamic 
driving energy (measured at 18 kcal/mol) and a catalyst is not required – Bertozzi proceeded to use 
this new click chemistry to do live labeling of Jurkat cells (a T-lymphocyte), and did not observe any 
toxic effect67.  Other catalyst-free triazole-forming chemistries include a 1,3-dipolar cycloaddition-
retro-Diels-Alder reaction with oxanorbornadiene as the dipolarophile – this was successfully used 



















Rationale, Project Goals, and Hypotheses 
 
As discussed in the previous section, there are many different methods and techniques available for 
functionalizing surfaces aside from chemical vapor deposition.  However, there exist several 
problems in the field that need to be addressed.  Having precise control over the ratios of 
immobilized proteins can be critical for fine tuning some biological processes (such as tissue 
morphogenesis, where the concentration of a signaling factor can dictate tissue development), yet 
the ability to do so with current methods is limited42, 77.  For example, if one is trying to adsorb two 
proteins to a surface to get a defined surface ratio (say, 10 molecules of insulin for every 1 of 
epidermal growth factor (EGF)), it is simple to alter their ratio in solution to be 10:1.  However, the 
hypothesis that this ratio of proteins in solution (10:1) will be the ratio of proteins on the surface is 
not true, as the proteins will diffuse down to the surface at different rates and can displace each 
other over time78, 79.  This replacement of low molecular weight proteins initially adsorbed to a 
surface (due to having a high rate of diffusion down to the substrate interface) by other larger 
molecular weight proteins which have a higher affinity for it is termed the ‘Vroman effect,’ and has 
been observed with blood proteins adsorbed to glass79, 80.  The same would generally be true if 
instead of absorption, one was attempting to react two biomolecules onto a surface using the same 
surface chemistry (for example, both insulin and EGF featured azido-groups and were to be clicked 
via CuAAC onto a surface functionalized with an alkyne)81.  Each protein competes with the other 
during the reaction for alkyne sites and would react at different rates, resulting in a ratio of proteins 
that is different from that in the solution.  The ultimate ratio of proteins tethered on the surface in 
this case would not be the ratio of proteins in the solution during the reaction81.  Thus, if one was 
immobilizing multiple biofactors, a reasonable strategy would be to bind them to a reactive coating 
which itself had a defined ratio of functional groups.  Furthermore, these two functional groups must 
react independently of one another and uniquely to only one of the population of biomolecules 
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being immobilized in order to preserve this desired ratio (otherwise side reactions may ‘use up’ some 
of the reactive groups intended for a separate immobilization reaction).  Of course, one may still not 
get the exact desired ratios of proteins due to steric hindrance of the reactive groups on the surface 
and nonspecific adsorption, but this will be far closer than simple adsorption or reaction with only 
one functional group 44.  Controlling this ratio at the level of the attached reactive functional groups 
themselves can be difficult by methods other than chemical vapor deposition – by developing a 
multimodal substrate where there are two (rather than one) functional groups that undergo reactions 
which are independent of each other, we can create a surface that will immobilize different 
biomolecules with precision.  There are many different methods for coating substrates (as reviewed 
earlier) – we want a method that is pinhole free, results in a homogenous coating regardless of the 
geometry of the substrate, and allows us to deposit precise ratios of functional groups.  Chemical 
vapor deposition is the preferred thin polymer film deposition method that has all these features.  
Herein, we used CVD to fabricate multipotent polymer coatings with controlled ratios of alkyne and 
pentafluorophenyl ester groups (Fig. 2.3).  As outlined in Fig. 2.3, we accomplished this by 
performing CVD with two initial monomers:  4-pentafluorophenyl ester[2.2]paracyclophane and 4-
ethynyl[2.2]paracyclophane.  With regards to the labeling in Fig. 2.3, polymer 1 is poly[(4-ethynyl-p-
xylylene)-co-(p-xylylene), polymer 2 is poly[(4-pentafluorophyenyl ester-p-xylyene)-co-(p-xylylene), 




We refer to the idea of two independent reactions (which will not react with bioligands other than 
those targeted to them – in other words no cross reactions) as ‘bioorthogonality.’  This is critical for 
precise immobilization of multiple biomolecules.  As proof of the concept of bioorthogonal co-
presentation, we picked two biomolecules to conjugate to our surface, each reacting independently 
with one or the other functional group present (effectively decoupling their chemistries).  The first is 
a cyclo-RGD-azide, which we tethered via CuAAC.  We then picked human epidermal growth 
factor (EGF), and orthogonally bound it through reaction with the pentalfuorophenyl ester (Pfp-
ester).  We used human EGF because it is inexpensive, small (~6 kDa), has only one known 
receptor (EGFR),  and possesses only three primary amines, limiting the degrees of freedom which 
it has with respect to reacting with the Pfp-ester82, 83.   EGF has been tethered via EDC chemistry to 
nanofibers functionalized with primary amines in order to heal diabetic ulcers, and showed better 
outcomes in a mouse diabetic ulcer model over a nanofiber scaffold that was only soaked with a 
solution of EGF (and not immobilized with it)58.  Thus, there is clearly medical benefit to tethered 
EGF. Finally, to demonstrate that these biomolecules were still active biologically after binding them 
to our surfaces, we cultured our substrates with either human umbilical vein endothelial cells 
(HUVECs) or A431 epithelial carcinoma cells (Fig 2.4).  
 
Figure 2.3:  CVD copolymerization of [2.2] paracyclophanes functionalized with either alkyne 




We first hypothesize that the copolymer will possess both functional groups, and that a 1:1 ratio of monomer will 
lead to a 1:1 ratio of the functional groups on the surface.  No cross-reactions between the functional groups will occur 
during CVD.  The first hypothesis was tested by loading a 1:1 molar ratio of monomer into the CVD, 
then examining the resulting Fourier transform infrared spectroscopy (FTIR) and x-ray 
photoelectron spectroscopy (XPS).  This was compared to coatings made by using the individual 
monomers.  The FTIR spectra should demonstrate that the functional groups we claim are present 
with the single polymers and copolymer are in fact present, and that they have not cross reacted with 
each other (thus eliminating their characteristic bands).  XPS will reveal the chemical composition 
and confirm the concentrations of Pfp-ester and acetylene present on the surface conform to a 1:1 
ratio if the amount of monomer loaded into the CVD is also set at a 1:1 ratio.  Secondly, we 
hypothesize that EGF and cyclo-RGD-azide can be tethered to CVD-coated multipotent surfaces featuring a 
reactive Pfp-ester and acetylene, respectively.  This will be tested with two experiments.  First, EGF will be 
microcontact printed (µCP) on CVD-coated surfaces in a grid pattern.  If the Pfp-ester is still 
reactive and tethers the EGF, then after washing, the bound EGF should still be detectable using 
 
 
Figure 2.4:  Cartoon illustrating the overall project aims:  CVD of multiple functional groups in 
controlled ratios, reactions for biomolecule immobilization, and cultured cell’s gross 
physiological response (figure by Dr. Xiaopei Deng)   
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immunofluorescence.  Secondly and on a separate surface, cyclo-RGD will be µCP and reacted in a 
grid pattern with the acetylene.  While immunofluorescence is not possible for such a small peptide, 
it could be indirectly detected as a height difference between where the RGD was printed on the 
grid line, and the surrounding area where it was not.  If the RGD is there, there should be a 
measureable height difference that can be observed with imaging ellipsometry.   
Next, we hypothesize that the RGD remains biologically active after CuAAC with the multipotent surfaces. The 
presence of EGF on the surface (both by itself and with RGD) will not affect their spreading.  This will be tested 
by incubating the surfaces with human umbilical vein endothelial cells (HUVECs).  HUVECs, which 
express integrins and are already known to attach and spread preferentially on cyclic RGD, should 
show greater cell area when cultured on coated surfaces that have been clicked with azide-RGD84.  
This was measured by incubating the cells for a limited amount of time with media sans serum.  This 
was done in order to minimize unknown variables, and to prevent any proteins in the serum from 
reacting with any leftover unreacted Pfp-ester.  Pfp-ester was passivated on all surfaces (except for 
the ones reacted with EGF) by a reaction with 2-(2-aminoethoxy)ethanol – this was done in order to 
prevent any unreacted Pfp-ester from inadvertently binding any proteins the cells generate while 
incubated with the coated substrates, potentially leading to confusing results.  Furthermore, we 
hypothesize that the presence of EGF on the surfaces alongside RGD will not greatly impact cell 
spreading, given that HUVECs do not have appreciable levels of EGFR85. 
Finally, we hypothesize that EGF tethered to our surfaces via reaction with Pfp-ester will remain biologically 
active and induce tyrosine phosphorylation on their receptor, EGFR.  The presence of RGD will not impact their 
ability to do so.  This hypothesis cannot be tested with HUVECs, as they have a relatively low level of 
EGFR expression85.  Thus, we tested the viability of our tethered EGF using the A431 epithelial 
carcinoma cell line, which overexpresses EGFR 86.  We will incubate serum-starved A431 cells in 
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media sans serum with our surfaces, then perform immunofluorescence for the phosphorylated 
EGFR (pEGFR).  The presence of pEGFR indicates EGF activation of that receptor, which is 
powerful evidence that our tethered EGF remains biologically potent.  These will be compared to 
AEE-passivated surfaces which do not have tethered EGF.  In addition, we hypothesize that the 
presence of RGD will not interfere with tethered EGF signaling.  Furthermore, we compared 
tethered EGF to soluble EGF at varying concentrations. 
In addition, we performed CVD with a new monomer – pyridinophane (synthesized by Joshua 
Kramer at the Karlsruhe Institute of Technology).  Pyridinophane is nearly identical in molecular 
structure to paracylcophane, except for the replacement of one of the benzyl carbons with a 
nitrogen atom, creating a pyridine-like aryl group.  An alkyne-functionalized pyridinophane 
monomer was also synthesized (4-ethynylpyridinophane), and both were successfully polymerized 
via CVD, with pyridinophane polymerizing to poly(p-lutidinylene-co-p-xylylene) and  4-
ethynylpyridinophane polymerizing to the alkyne-functionalized copolymer poly(4-ethynyl-p -
lutidinylene-co-p-xylylene) (Fig 2.5). 
   
 
The presence of the predicted polymer was verified via FTIR and XPS by Dr. Florence Bally.  
 
 
Figure 2.5:  Polymerization of (a) pyridinophane and (b) 4-ethynylpyridinophane via CVD to 




Among other measured properties, it was noticed that contact angles for the p-lutidinylene-co-p-
xylylene surfaces were lower than those for PPX surfaces (Fig. 2.6) 
It is not surprising that polymerizing pyridinophanes onto surfaces leads to a higher wettability than 
paracyclophanes, given that the nitrogen has a lone pair of electrons (which can act as a Lewis base) 
and the polymer exhibits some polarity.  We believe this is due to the presence of a partial charge on 
the surface.  A cell’s ability to adhere to a surface based on hydrophilicity is difficult to predict, and 
quite a few studies initially focused on this parameter and its relationship to a cell’s ability to adhere.  
Endothelial cells grown on poly(N-isopropylacrylamide) (PIPAAm) will detach at temperatures 
below the material’s lower critical solution temperature, which leads to PIPAAm becoming hydrated 
and thus more hydrophilic87.  Thus, it would seem that cells favor surfaces which are more 
hydrophobic.  However, another study found that mesenchymal stem cells preferred hydrophilic 
surfaces which were topologically rough over smooth hydrophobic surfaces88.  van Wachem et al. 
also examined endothelial cells on a variety of polymer coatings featuring different hydrophilicities89.  
They discovered that cells would adhere well to what they called ‘moderately wettable surfaces’ (such 
as tissue culture polystyrene (TCPS) and tissue culture poly(ethylene terephthalate)), while not 
 
 
Figure 2.6:  Contact angle measurements for PPX, PPX-alkyne, poly(p-lutidinylene-co-p-
xylylene), and poly(4-ethynyl-p-lutidinylene-co-p-xylylene)  (figure by Dr. Florence Bally) 
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adhering well to surfaces that had extremely large or small contact angles89.  But confusingly, when 
they alter the wettability of cellophane (by esterfication of its hydroxyl groups) to three different 
contact angles, as hydrophobicity increased (from 16° to 52°) cell adhesion also increased89.   
Furthermore, they hypothesize that the ability of fibronectin from the serum to adsorb onto a 
surface was key to cell adhesion and spreading, and that extremely hydrophilic monomers would not 
absorb protein well due to their tendency to expand when placed in water (but glass does not do this 
and can adsorb proteins, which is why despite being very hydrophilic it can also readily support cell 
adhesion and spreading)89.   It is not as simple as just saying that a surface with X contact angle will 
be good or bad for cell adhesion. 
 Any charge present on a surface will also play a role in cell adhesion.  Surfaces featuring a positive 
charge such as those grafted with N,N-dimethyl aminopropyl acrylamide (DMAPPA) when cultured 
with CHO cells (Chinese hamster ovary) show a large amount of cell adhesion, which is not 
surprising given that cell plasma membranes are negatively charged (due to the charges present on 
phosphatidylserine and phosphatidylinositol) 90, 91.  This is likely why cells attach so well to a surface 
modified with low amounts of poly-l-lysine (PLL), as it carries a strong cationic charge (high 
concentrations have been found to be toxic to human mesenchymal stem cells however)92.  
However, negatively charged surfaces present more of a problem – some have been shown to repel 
cells (like acrylic acid) while others have been shown to support cells (such as sodium p-styrene 
sulphonate)90.  There have been attempts to decouple surface charge from surface wettability to 
independently study their effects on cell adhesion.  When Lee et al. controlled for hydrophilicity by 
testing a polymer coating of polyethylene featuring four different functional groups with roughly 
similar contact angles (within 13°) but different charges (a positively charged -CH2NH2, neutral –
CONH2 and CH2OH, and negatively charged –COOH), they discovered that CHO cells preferred 
the positively charged amine groups the most, followed by the hydroxyl group, then the amide, and 
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finally the carboxylic acid 93.  Furthermore, they noted that they and others have observed that ECM 
proteins (e.g., fibronectin) found in media serum adhere better to positively charged surfaces93.  
Non-functionalized parylene generally resists cell adhesion, but the conversion of the benzyl carbon 
to a nitrogen gives this surface a partially positive charge.  We hypothesized that this polymer will 
demonstrate enhanced cell adhesion and spreading over those cultured on n-PPX.  We tested this hypothesis by 
culturing primary human umbilical vein endothelial cells (HUVECs) on them in media sans serum, 
and after fixation and staining we measured the average cell areas and numbers of cells on each 
sample.  It would also make sense to take zeta-potential measurements of our coated surfaces to 
determine their charges; however, at the time of writing this thesis those experiments have not been 



























Parts of the experimental section and the results section are paraphrased or unaltered directly from 
originally published text in  
1. Deng, X., Eyster, T.W., Elkasabi, Y. and Lahann, J. (2012), Bio-Orthogonal Polymer 
Coatings for Co-Presentation of Biomolecules., Macromol. Rapid Commun., 33: 640-645 
Other parts are paraphrased from unpublished text by collaborator Dr. Florence Bally  
CVD co-polymerization 
Monomer precursors’ 4-pentafluorophenyl ester [2.2] paracyclophane and 4-ethynyl [2.2] 
paracyclophane synthesis is described elsewhere21, 94.  Co-polymerization via chemical vapor 
deposition was accomplished with a 1:1 molar ratio of the monomers (as shown in Fig. 2.3). The 
monomers first underwent sublimation at 0.3 mbar and a temperature above 100 °C.   They were 
then carried by a stream of argon gas (20 sccm) to a pyrolysis zone (560 °C), where they reacted to 
form diradicals.  After this reaction, the diradicals entered the deposition chamber.  Deposition was 
optimized with a chamber wall temperature of 120 °C and substrates temperature of 15 °C, along 
with rotation of the substrates to guarantee a uniform polymer film thickness. 
 
Surface Characterization 
A Nicolet 6700 spectrometer equipped with a grazing angle accessory (Smart SAGA) was used to 
perform IR spectroscopy (grazing angle = 85°) on the surfaces.  An Axis Ultra X-ray photoelectron 
spectrometer (Kratos Analyticals, UK) outfitted with a monochromatized AlKα X-ray source further 
characterized the surfaces via XPS.  A non-functionalized aliphatic carbon showing a binding energy 
of 285.0 eV was used to calibrate the spectra obtained.  An Imaging Spectroscopic Ellipsometer 
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(Accurion, Nanofilm EP³-SE) measured the polymer film thicknesses.  A Cauchy model was used to 
fit the ellipsometric parameters. The 10× objective has an imaging lateral resolution of roughly 2 µm. 
 
Immobilization of EGF 
The PDMS stamps used for microcontact printing (µCP) were generated as described elsewhere95. 
Oxidation of the stamps was first performed with a UV-ozone cleaner for 20 minutes. Next, an 
EGF solution (10 µg/ml in PBS) was inked to the stamps, and then placed onto the surface for 10 
minutes.   The now-patterned surfaces were then rinsed in PBS.  EGF sans µCP was immobilized to 
surfaces at the same concentrations as those used for µCP, but the incubation time was 1 hr as 
opposed to 10 minutes.  For immunofluorescence, the substrates were first incubated with an anti-
EGF antibody (mouse IgG), diluted in PBS containing 0.1 % (w/v) bovine albumin and Tween 20 
(0.02 % (v/v)) (10 μg/ml) for 1 hr.  These were then washed in a PBS/BSA/Tween buffer, then 
incubated with a FITC-conjugated anti-mouse IgG secondary antibody for 1 hr (10 µg/ml in a 
PBS/BSA/Tween buffer).  Finally, the now-stained samples were thoroughly washed with PBS, 
rinsed with distilled water, and examined with a fluorescence microscope (Olympus BX-51, Tokyo, 
Japan). 
 
Immobilization of the cRGD peptide 
Azide-functionazed cycloRGD (cyclo(azidoK-RGDf), Kinexus, Canada) previously aliquoted in PBS 
was added to an aqueous solution of sodium ascorbate (50 mg/ml) and the catalyst copper(II) 
sulfate (0.1 mM) at a concentration of 50 µg/ml.  A PDMS stamp inked with this peptide-catalyst 
solution was placed on a substrate sample for 4 hr.  Finally, this substrate was washed with PBS and 
deionized water.   The concentration of cRGD was the same for non-µCP modification of surfaces, 
but the reaction was allowed to take place over night.   
32 
 
Adhesion and Spreading of Endothelial Cells 
 
Copolymer 3 was deposited via CVD onto silicon and modified as outlined above to present 
tethered EGF, cRGD, EGF+cRGD, or passivated with 2-(2-aminoethoxy)ethanol (AEE). Once 
modified, these surfaces were washed thoroughly and placed in a 24-well plate. Human umbilical 
vein endothelial cells (HUVEC, Lonza) were cultured on the modified surfaces at a concentration of 
5×104 cells/ml for 4 hours in serum-free EBM (Lonza). Passages 3-6 were used for all experiments. 
The cells were then fixed with 4% paraformaldehyde in DPBS and stained for actin with Alexa 
Fluor® 568-phallodin (Life Technologies).  The surfaces were mounted with ProLong Gold + DAPI 
(Life Technologies) and imaged using an Olympus BX-51 fluorescence microscope.  The average 
area of the cells was measured via ImageJ, and performed by dividing total cell area by total number 
of cells (equated to total number of individually counted DAPI stains).  The results show three 
independent trials averaged; error bars are standard error (standard deviation divided by the square 
root of the total number of images taken over three trials), and p-values are calculated using all 
images from all trials. 
 
Phosphorylated EGFR Immunofluorescence 
 
The epidermal carcinoma line A431 (ATCC, Manassas, VA) was cultured in polystyrene flasks 
(Corning, Lowell, MA) at 37 ºC and in a humidified 5% CO2 atmosphere until 100% cell confluence 
was observed.  Passage 3 was used for all experiments. 18 hours prior to incubation with the 
modified surfaces, the A431 culture was serum-starved. A431 cells were trypsinized, spun down at 
100xg, and resuspended with serum-free DMEM (ATCC) to a cell concentration of 5×104 cells/ml. 
A volume of 0.5 ml of A431 suspension was added to each well containing a surface. After 90 
minutes of incubation at 37 ºC/5% CO2, the cells were briefly washed with PBS, and then fixed with 
4% paraformaldehyde. After three 5 minute PBS washes, the surfaces were incubated with blocking 
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buffer (5% normal goat serum (Life Technologies, Carlsbad, CA), 0.3% Triton-X 100 (Sigma-
Aldrich) in PBS) for 1 hour followed by overnight incubation with primary antibody Phospho-EGF 
Receptor (Tyr1068) (D7A5) XP™ Rabbit mAb (Cell Signaling Technology, Danvers, MA). 
Incubation with secondary antibody anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 
Conjugate) for 2 hours followed; finally the surfaces were mounted on glass slides with ProLong 
Gold + DAPI (Life Technologies) and imaged using an Olympus BX-51 fluorescence microscope. 
The quantity of immunofluorescence as a ratio of total grey pixilation to cell area minus threshold 
was measured via ImageJ. The results show three independent trials averaged; error bars are 
standard error (standard deviation divided by the square root of the total number of images taken 
over three trials), and p-values are calculated using all images from all trials (treating each image as 
statistically independent). 
 
EGF EC50 measurement 
 
A431 cells were cultured as previously described, and starved for 18 hours prior to incubation. Cells 
were trypsonized and cultured on AEE-modified surfaces, then incubated with a range of soluble 
EGF concentrations from 0.1 to 1000 ng/ml for 1 hour. pEGFR was then measured via the 
immunofluorescence protocol described above, including the same primary and secondary 
antibodies. EC50 data was fitted and analyzed using GraphPad Prism version 5.01 for Windows 
(GraphPad Software, San Diego California USA) using the modified variable slope model. 
 
Chemical Vapor Deposition of Pyridinophane Surfaces 
The monomers were first sublimated at near vacuum (<0.007 torr) and high temperature (100 °C), 
and were transported into a furnace by an argon gas stream (20 sccm) where they underwent 
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pyrolysis.  The products of pyrolysis then entered a cooled deposition chamber (15 °C) where they 
polymerized onto substrates which were rotating to ensure uniform thickness.   
 
Endothelial Cell Adhesion on Poly(p-lutidinylene-co-p-xylylene) Surfaces 
Primary HUVECs at passage 2 were initially harvested by Amy Baek and obtained as a kind gift 
from the Pinsky group (University of Michigan).  Silicon substrates were coated using CVD, then 
placed into a 24-well plate.  We used n-PPX, alkyne-functionalized PPX, poly(p-lutidinylene-co-p-
xylylene), and poly(4-ethynyl-p-lutidinylene-co-p-xylylene).  Samples were run in triplicate.  After 
trypsonization, 30,000 cells in Medium 199 (no serum) (Life Technologies) were added to each well, 
and the cells were allowed to incubate for 4 hours.  After incubation, the surfaces were fixed with 4% 
formaldehyde, then stained with phalloidin and mounted with DAPI-containing ProLong Gold for 
imaging with an Olympus BX-51 fluorescence microscope.   
Image and Statistical Analysis 
The software package ImageJ (NIH) was used to analyze all images. Normalized cell spreading was 
quantified by measuring the total cell area and dividing by the total number of cells (counted by 
DAPI spot). Magnitude of fluorescence quantification was performed by converting the images to a 
32-bit gray scale and then measuring the mean gray value. All error bars with the exception of the 
EC50 graph (which show standard deviation) represent standard error (one standard deviation from 
the mean divided by the square root of the total number of images averaged).  Statistical significance 
was determined using Student’s two-tailed t-test assuming unequal variance, with p<0.05 considered 






A copolymer coating of poly[(4-ethynyl-p-xylylene)-co-(4-pentafluorophenyl ester p-xylylene)-co-(p-
xylylene) (polymer 3) was deposited by co-deposition of monomers 4-pentafluorophenyl ester[2.2] 
paracyclophane and 4-ethynyl[2.2] paracyclophane.  We also coated surfaces with polymer 1 (poly[(4-
ethynyl-p-xylylene)-co-(p-xylylene)] by deposition of the monomer 4-ethynyl[2.2] paracyclophane, 
and polymer 2 (poly[(4-pentafluorophyenyl ester-p-xylyene)-co-(p-xylylene)] by deposition of 4-
pentafluorophenyl ester[2.2] paracyclophane; these served as controls.  Fourier transform infrared 
spectroscopy of polymer 3 can be compared to that of polymer 1 and 2 – as Fig. 2.7 shows the 
expected functional groups (alkyne and pentafluoroester) are present in polymer 3 (with bands at 
3287 and 2101 cm-1 for the alkyne, and 1762, 1523, and 1250-990 cm-1 for the pentafluoroester).   
X-ray photoelectron spectroscopy (XPS) was also used to further characterize the coated surfaces, 
and confirm the functional groups were deposited and did not undergo cross-reactions in the CVD 
chamber before deposition.  As shown in Fig. 2.8, the measured values are close to those expected 
based on the chemical formulas of the monomers and stoichiometric conversion into the polymer.  
The concentration of F-C bonds in polymer 3 are roughly half of polymer 2 – this confirms the 
hypothesis that feeding monomers at a molar ratio of 1:1 will result in a 1:1 ratio of functional 
 
 




groups on the surface.  In addition, this demonstrates the power of CVD in exerting precise control 
over the surface coating composition. 
 
Next, we need to verify that our functionalized polymers can be conjugated to our peptide and 
growth factor.  First we microcontact printed cRGD via Huisgen’s [1,3] dipolar cycloaddition, with 
the unstamped area serving as an internal control.  We then examined the printed substrate with 
imaging ellipsometry – the resulting thickness of the stamped area was roughly 0.5 nm above the 
background unpatterned area (Fig. 2.9).  This confirms that the alkyne remained reactive and that we 
had successfully conjugated cRGD to our functionalized surface. 
  
 
Figure 2.9:  Imaging ellipsometry thickness map of patterned cRGD with thickness profile 
(measured along the red line)  (experiment performed by Dr. Xiaopei Deng) 
 
Figure 2.8:  Chemical composition in atom% shown as experimental values (with the calculated 
values based on stoichiometry in the brackets) measured by XPS; experimental values of O and 
F atom ratios [%] were obtained from survey results and other experimental values are from 
high resolution C 1s spectra peak fitting calculated based on an equimolar distribution of 
monomers. (experiment performed by Dr. Xiaopei Deng) 
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We next evaluated the Pfp-ester’s ability to conjugate EGF.  EGF was reacted with Pfp-ester via 
microcontact printing (a primary amine on EGF reacts with the ester to form an amide bind), then 
immunostained with anti-EGF antibody and a FITC-conjugated secondary antibody.  We then 
imaged the substrate with fluorescence microscopy to see if the immobilization of EGF worked as 
hypothesized.
As shown in Fig 2.10, the area where EGF was printed (the grid lines) was the only area to show 
fluorescence (besides occasional spots caused by non-specific binding of the secondary antibody).   
As immunofluorescence is relatively specific for the antibody being stained for, this is strong 
evidence that our EGF is tethered to our surface.  Thus, we can claim that our substrates have been 
successfully functionalized with two independent reactive groups that can tether biofunctional 
molecules independently of each other. 
 We then evaluated the immobilization of cRGD via click reaction and assessed peptide activity in 
the presence of immobilized growth factor. The RGD tripeptide is a well-studied cell adhesion motif 
present in many proteins, but perhaps most prominently in extracellular matrix (ECM) molecules, 
such as fibronectin and vitronectin (among others)96.  RGD (and other small peptide adhesion 
 
Figure 2.10:  Fluorescence microscopy of microcontact printed EGF on surfaces 
functionalized with Pfp-ester (experiment performed by Dr. Xiaopei Deng) 
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molecules) have been widely explored for use in tissue engineering and presents several advantages 
over full-length proteins such as fibronectin (as discussed previously)97.  A cRGD peptide was 
employed in this study. The major advantages of these cyclic peptides are automatable synthesis, 
resistance against proteolysis, weak immunogenicity, high specificity to integrin αvβ3, and enhanced 
biological activity (up to 240 times of linear analogues)98.  
Human umbilical vein endothelial cells (HUVEC) spreading on polymer 3 surfaces with different 
treatments was shown in Fig. 2.11. The surfaces were passivated with 2-(2-aminoethoxy) ethanol 
(AEE), immobilized only with cRGD, only with EGF or with both biomolecules, respectively99. 
 
 
Figure 2.11: Fluorescence micrographs of HUVEC line seeded onto modified surfaces of polymer 3 
after 4 h incubation. The surfaces were tethered with: (a) AEE, (b) cRGD-only, (c) EGF-only, (d) 
cRGD + EGF. (e) Quantification of spreading by ImageJ (three trials combined). 
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HUVEC spreading is significantly enhanced by the presence of cRGD (Fig. 2.11). The cell area on 
the surface with both cRGD and EGF was approximately the same as the one with only cRGD. The 
surface immobilized only with EGF only had a slight increase in cell area. The observance that EGF 
did not have any obvious effect on HUVECs is consistent with other studies showing the absence 
of EGFR expression in normal HUVECs85.  
 
Tethering growth factors has gained more interest from the scientific community within the last 
three decades100.  Studies showed that the immobilized growth factors, compared to the soluble ones, 
 
 
Figure 2.12: Immunofluorescence of phosphorylated EGFR in A431 cells cultured on CVD-
coated surfaces with tethered (a) AEE, (b) cRGD, (c) EGF, and (D) cRGD+EGF. (e) 
Quantification of pEGFR immunofluorescence (three trials combined). 
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had higher mitogenic effect, longer-term signal transduction and were resistant to endocytosis, 
degradation and diffusion 82. In order to verify that the immobilized EGF still has biological activity, 
we investigated our modified surfaces' ability to induce phosphorylation of EGFR (pEGFR), the 
receptor of EGF.  The A431 line is a human epidermal carcinoma and a well-characterized positive 
control for EGFR activity101.  A431 cells overexpress EGFR roughly 10–50-fold over many other 
cell lines, and thus are an ideal cell type for examining the bioactivity of tethered EGF 86. Surfaces 
with tethered EGF successfully induce phosphorylation of EGFR in serum-starved A431 cells, as 
observed using immunofluorescence (Fig. 2.12).  This shows that the immobilized EGF on polymer 
3 maintained its biological activity.  Surfaces exhibiting both the adhesion factor cRGD and EGF 
show statistically similar (p < 0.001, with data from all three trials combined) pEGFR 
phosphorylation compared to those exhibiting EGF alone, demonstrating that multiple biofactors 
do not affect this particular growth factor's ability to interact with its receptor.  We next examined 
A431 EGFR phosphorylation in response to soluble EGF and compared it to tethered EGF (Fig. 
2.13).  Various literature indicate that A431 respond to EGF with EC50 values of 12.1 ng mL
−1 and 
20 ng mL−1, respectively 102, 103. From four independent trials, an average EC50 value was 14.8 ng 
mL−1 ± 3.02 ng mL−1 (standard error), well matching the reported literature values previously cited. 
In all four trials, EGFR phosphorylation of tethered EGF as measured by quantification of 
immunofluorescence was either statistically equivalent to or higher (p < 0.05) than the highest 




Primary HUVECs (harvested at the University of Michigan from umbilical cords by a collaborator) 
were next cultured on pyridinophane-derived surfaces, with n-PPX and n-PPX-alkyne surfaces as 
controls (Fig. 2.14). 
 
 
Figure 2.14: Fluorescence microscopy of HUVECs cultured for four hours sans serum and 
stained with phalloidin/DAPI on (a) n-PPX, (b) n-PPX-alkyne, (c)  poly(p-lutidinylene-co-p -
xylylene) and (d) poly(4-ethynyl- p -lutidinylene-co-p-xylylene).  Average cell areas on (e) non-
functionalized substrates and (f) alkyne-functionalized substrates 
 
Figure 2.13: (a) EC50 plot for EGF (individual trial); (b) Quantification of pEGFR 
immunfluorescence of phosphorylated EGFR in A431 cells in bar graph form (individual trial). 
The cells were cultured on CVD-coated surfaces passivated with AEE and in media with soluble 





HUVECs spread out significantly better on n-PPX functionalized with alkyne, (poly(p-lutidinylene-
co p-xylylene),  and poly(4-ethynyl-p-lutidinylene-co-p-xylylene).  Thus, the pyridinophane-based 
substrates showed a marked enhancement over n-PPX with respect to cell spreading - there was also 
no difference in cell spreading between (p-lutidinylene-co-p-xylylene) and poly(4-ethynyl-p-
lutidinylene-co-p-xylylene).  However, HUVECs grown on poly(4-ethynyl-p-lutidinylene-co-p-
xylylene) did not spread significantly less than those on n-PPX-alkyne.  We next looked at the 
average number of cells per surface by taking three images of each substrate, counting the number 
of cells individually, and then adding those three numbers to get a ‘total’ count based on three 
representative images.  These were then averaged with other substrates with the same surfaces 
across three trials (for n = 9), and compared via Student’s t-test (Fig. 2.15): 
 
Once again, the hypothesis bears out as pyridinophane-based substrates show a far higher number 
of HUVECs attached over paracyclophane-based substrates.  In this case, the functionalization of 




Figure 2.15: Quantification of the number of cells for three images taken per substrate and 
averaged (three trials combined) for both non-functionalized and alkyne-functionalized substrates 
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Conclusions and Future Work 
In this chapter, we have successfully bound two different ligands (an azido-cyclic RGD and EGF) 
onto a surface with a controlled ratio of reactive groups.  Furthermore, we demonstrated that these 
ligands remained potent biologically by culturing surfaces that featured them with two model cell 
lines (HUVEC and A431).  We also demonstrated that the individual tethered biomolecules did not 
interfere with one another – RGD induced HUVECs to spread just as much whether or not EGF 
was present, and A431 EGF receptors showed the same amount of phosphorylation regardless of 
the presence or absence of RGD.  This is an important result, as it demonstrates the true 
bioorthogonality of these reactions and the resulting immobilized biomolecules influence cell 
behavior independently.  However, no real synergistic interaction between the two ligands was 
observed with either cell line, though by casual observation it appears that A431 cells actually show 
some inhibited spreading on surfaces coated with RGD and EGF in comparison to cells grown on 
EGF only.  However, this was not formally measured and quantified, and did not affect the 
measurement of EGFR phosphorylation via ImageJ analysis, which is normalized to cell area.  
Shahal et al. observed that high concentrations of EGF co-immobilized with RGD on surfaces leads 
to A431 detachment104.  This could potentially explain this observation – though we never measured 
the density of EGF or RGD on our surfaces, we know that the amount of bound EGF is likely high 
as the resulting EGFR phosphorylation is similar to that observed with soluble EGF at 1000 ng/ml. 
Clearly, there are drawbacks to the strategies used above.  While Pfp-ester is an excellent functional 
group for constructing polypeptides and binding proteins to a surface, it is indiscriminate in how it 
binds proteins featuring multiple primary amines.  This means it may bind proteins in an 
unfavorable confirmation.  Even if a protein only has a terminal primary amine and no others, it is 
possible that this amine plays a role in how the protein functions with its receptor or another protein, 
making Pfp-ester a poor functional group for tethering it.  However, the functional group could 
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instead be biotin– then a protein could be biotintylated at a point where if it interacts with 
streptavidin it will be in an ideal confirmation.  Of course, this means biotintylating every protein 
one wants to put on a surface, which would require some synthetic chemistry beforehand (whereas 
immobilizing via Pfp-ester requires no such modifications).  Another strategy could be to 
copolymerize an aldehyde-functionalized paracyclophane over a Pfp-ester, then tether heparin to the 
surface via a carbohydrazide linker.  Many proteins associate non-covalently with heparin, and would 
thus likely bind to the surface with a favorable conformation81.  In fact, this strategy has also been 
studied by a colleague, and will hopefully pave a way forward for binding some growth factors (such 
as VEGF) that currently do not show much activity on our surfaces when tethered via Pfp-ester 
(data not shown) 81.  Furthermore, PPX films are not biodegradable, which could present problems 
for certain biomedical applications. 
We have also demonstrated how altering even one atom (in this case, exchanging a carbon atom on 
a benzyl ring in paracylcophane for a nitrogen atom to create pyridinophane) can radically change 
how cells behave on our surface.  We hypothesize that this effect is due to the presence of a partial 
charge on the surface, but this needs to be confirmed with zeta-potential measurements.  
Nevertheless, we can create a surface that attracts and adheres cells even in media which has no 
serum proteins present to pre-adsorb onto the surface.  We also have already functionalized this new 
CVD precursor with an alkyne group (poly(4-ethynyl-p-lutidinylene-co-p-xylylene)) – thus, we 
hypothesize that after patterned atomic transfer radical polymerization of poly(ethylene glycol), 
HUVECs will only grow in areas where PEG is not present.  This would demonstrate that the 
coating remains reactive after CVD and can be used to create surfaces that are selective for cell 
adhesion.  If this is true, then we can generate coatings with all the listed advantages of CVD 
(including reactive functional groups which can then be modified orthogonally with further factors) 
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which cells tightly bind to and spread on without any sort of biological modification (such as 
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In this chapter, we characterize the behavior of mesenchymal stem cells on the zwitterionic hydrogel 
poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH), 
previously shown to maintain embryonic stem cells and prevent spontaneous differentiation.  We 
deposited this hydrogel onto polystyrene using both thermal grafting and atom transfer radical 
polymerization (ATRP) respectively, and examined mesenchymal stem cell morphology, 
proliferation, and characteristic markers after culture on these surfaces.  Embryonic stem cells are 
normally cultured on feeder layers or substrates with adsorbed or tethered biomolecules – when 
these are differentiated into a mesenchymal-like stem cell, they are transferred and cultured on a 
different substrate.  With PMEDSAH, we wish to create a universal substrate for stem cell culture 
and differentiation, obviating the need for feeder cells or expensive substrates featuring attached 
peptides. In the Introduction and Background, we discuss the biology and clinical relevance of 
both embryonic and mesenchymal stem cells, along with current substrates used to culture and 
maintain them.  We focus specifically on the disadvantages of feeder cells and current alternatives 
available.   We also briefly review ATRP and the characteristics of PMEDSAH hydrogels generated 
by it. We next demonstrate how mesenchymal stem cells, like embryonic stem cells, can be grown 
and maintained on PMEDSAH.  Thermally grafted PMEDSAH leads to lower proliferation rates of 
mesenchymal stem cells in comparison to that of ATRP deposited PMEDSAH.  However, both 
maintained the characteristic markers that define mesenchymal stem cells. 
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Introduction and Background – Stem Cells and their Maintenance on Artificial Substrates 
Human stem cells, with their ability to generate nearly any type of cell found in the body, have 
ushered a revolution in biology and medicine, offering a possibly infinite renewable source of 
differentiated cells.  While an obvious use for these cells could be in repairing diseased or injured 
tissues in patients, stem cells could also serve as a reservoir for in vitro cell models that were 
previously difficult to obtain in large quantities (such as human cardiomyocytes, or non-cancerous 
neural cells)1, 2.   Some have even called embryonic stem cells’ pluripotency a sort of biological 
alchemy3.  Stem cells essentially can do three things:  die, self-renew (i.e. proliferate as stem cells), 
and differentiate down tissue lineages towards functional tissues3.   
Initially isolated human embryonic stem cells (hESCs) were cultured on a mouse embryonic 
fibroblast feeder layer, or MEF4-7.   These feeder cells prevent hESCs from spontaneously 
differentiating while in culture (important for maintaining and expanding stocks of pluripotent cells)4, 
7.  The feeder layer cells are thought to provide essential nutrients, growth factors, cytokines, and 
extracellular matrix proteins in order to support the hESCs, along with inducing a signaling cascade 
which prevents them from differentiating8.  Activin A, basic fibroblastic growth factor (bFGF), and 
transformation growth factor beta (TGFβ) are among the many known proteins which play a critical 
role in maintaining hESC pluripotency – but while there have been many studies of the proteins 
produced by feeder cells, the precise mechanisms behind feeder cell maintenance remain unclear8, 9.  
Concerns rapidly arose regarding the safety behind this xenogenic cell culture, particularly with the 
risk of pathogenic transmission or biological factors that could provoke an immunogenic response 
(Villa-Diaz et al. cites animal-derived sialic acid as a major concern)10.  Furthermore, fundamental 
studies of hESC biology are hampered by ill-defined substrates that can vary from batch-to-batch – 
their impact on the results obtained can be difficult at best to gauge10. 
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Engineers and scientists began to develop methods and strategies for culturing hESCs without using 
a MEF feeder layer, or even any feeder layer.  In an attempt to not use any feeder cells directly with 
hESC culture, Xu et al. coated dishes with Matrigel and conditioned their growth media with MEFs 
(in other words, the growth media was first incubated with MEFs so their soluble factors could 
enter into it, collected, supplemented with a further 4 ng/ml of bFGF, and fed to the hESCs)11.  
While this method worked (hESCs showed all the characteristics of remaining pluripotent for 
multiple passages, along with typical karyotype), it remains xenogenic and thus the raised concerns 
are not alleviated11.  Matrigel itself is derived from tumors grown in mice, and is composed of a 
variety of ECM proteins and some growth factors12.   
As a result, more completely artificial environments were engineered.  One of the most successful 
was poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide], or PMEDSAH.  
This zwitterionic polymer was one of six derivatives of poly(methyl methacrylate) tested by Villa-
Diaz and Nandivada et al. –most (such as poly[[2-(methacryloyloxy)ethyl]trimethyl ammonium 
chloride]) (PMETAC)  and poly[3-sulfopropyl methacrylate] (PSPMA)) led to spontaneous 
differentiation after hESCs were cultured on them (Fig. 3.1)13.  All six polymers were coated onto 
TCPS by thermal grafting, in which TCPS was exposed to UV irradiation to generate ozones on the 
polystyrene, which could then react with a solution of the monomer plus heat to form covalently-
linked polymer chains13.  The polymers were picked systematically – PSPMA had the sulfate group 
of PMEDSAH, while PMETAC had the quaternary amine13.  Nevertheless, only the two functional 
groups together on the same polymer led to hESC maintenance.  Of the two zwitterions tested - 
PMEDSAH and poly[carboxybetaine methacrylate]- only PMEDSAH allowed hESCs to adhere13.  
Hydrophilicity and elastic modulus were correlated to successful hESC culture, as PMEDSAH had 





hESCs were confirmed to remain pluripotent and phenotypically normal through the standard 
testing methodology (staining for pluripotent markers, karyotyping, differentiation down the three 
germ lines, etc) for up to 25 passsagings13.  It has been hypothesized that hESC behavior on 
PMEDSAH is due to PMEDSAH mimicking the properties of the natural carbohydrate heparin 
through its charged functional groups10.  Heparin strongly binds bFGF and has even been found to 
be necessary for bFGF to signal to cells through its receptor14.  bFGF in turn is known to be 
essential for hESCs to maintain their undifferentiated state; even hESCs cultured with MEFs still 
need their media supplemented with bFGF in order to thrive and maintain pluripotency, 
highlighting the importance of this growth factor15.   
Other groups have attempted to directly bind heparin for xenogenic-free culture of hESCs16.  
Kolhar et al. cultured hESCs on a cyclic disulphide-bridged CRGDC functionalized substrate – 
compared to linear RGD, this peptide was able to also maintain hESCs, and they observed higher 
hESC adhesion17.  However, this solution is not ideal in comparison to a grafted polymer, as small 
peptides are expensive (and are normally synthesized in small amounts) and these surfaces require 
 
Figure 3.1: The process of thermal grafting after UV-ozone treatement, and the six different 




complicated chemistries (as in Kolhar et al.) or rely on non-covalent binding (such as seen by Klim 
et al.) 10, 16-18.   
Other fully synthetic substrates have emerged which bind FGF and maintain hESC pluripotency.  
Chang et al. recently developed a variety of co-polymer hydrogels composed of various amounts of 
crosslinked monomers sodium 4-vinylbenenesulfonate and acrylamide – these were then 
polymerized to form polyacrylamide–co-poly(sodium-4-styrenesulfonate), or PAmx-PSSy  (where x 
and y were varied depending on the desired mechanical properties and hydrophilicity)19.  They had 
previously observed that the muscle progenitor cell line C2C12 grown in media with supplemented 
poly (sodium-4-styrenesulfonate) (PSS) had enhanced differentiation rates comparable to 
supplemented heparin, then proceeded to demonstrate through PAGE that bFGF binds to PSS 20.  
Thus, they speculated that this polymer may support hESCs19.   hESCs were able to maintain 
pluripotency for over 20 passages on the hydrogel Pam6-PSS2 with both MEF conditioned media 
and chemically defined media19.   Yet again, it seems that an ability to bind bFGF and mimic heparin 
leads to a surface which can support hESCs, though this was not directly proven in this work.  
Interestingly, the group also noted that co-polymer hydrogels of polyacrylamide and PMEDSAH 
could not maintain hESCs19.  As Villa-Diaz et al. note in their review of stem cell culture conditions, 
Irwin et al. are the only other group besides Villa-Diaz et al. (and now Chang et al.) who have 
developed a completely synthetic polymer that can maintain hESCs10, 21.  In their work, hESCs are 
maintained on an amino-propylmethacrylamide (APMAAm) hydrogel, who’s ability to adsorb BSA 
was critical for this result21.   
 
Mesenchymal Stem Cells 
Mesenchymal stem cells (MSCs) are also able to differentiate down different lineages, though they 
are not as potent as embryonic stem cells (hence why they are often called ‘multipotent’ as opposed 
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to ‘pluripotent’).  These cells normally are thought to originate and reside in bone marrow and are 
often isolated from superior iliac crest marrow, though cells with similar properties have been 
isolated from many different other organs such as lungs, muscles, teeth, and even neural tissue in the 
brain 22-24.  The name ‘mesenchymal’ (where ‘mesenchymal’ itself refers to connective tissue 
originating from the mesodermal germ layer during embryogenesis) speaks to their general ability to 
differentiate down three major mesodermal lineages:  osteogenic (bone), chondrogenic (cartilage),  
and adipogenic (fat) 25-27.  MSCs are often identified by the presence or absence of a list of markers.  
The International Society for Cellular Therapy recommended in 2006 that MSCs be identified based 
on the following:  ability to adhere to a tissue culture substrate; positive expression of CD105, CD73, 
and CD90; negative expression of CD45, CD34 (a prime marker for another type of cell, the 
hematopoetic stem cell), CD14 or CD11b, CD79α or CD19, and HLA-DR; and the ability in vitro to 
differentiate down the three primary lineages (chondrogenesis, osteogenesis, and adiposgenesis)28, 29.   
They have also successfully been differentiated into other lineages, including cardiomyocytes, neural-
like cells, and even hepatocytes 30-32.  When cultured in vitro, human mesenchymal stem cells (hMSCs) 
have a fibroblastic morphology – smaller hMSCs tend to be more multipotent than larger ones33.  
They are of interest to biologists who study skeletal development, tissue engineers interested in 
creating bone-like scaffolding, and even for use in personalized biosensors for diagnostics and 
medicine (a patient’s own hMSCs can be isolated and examined with a variety of assays looking at 
toxicity or gene expression – with an eye towards then recommending treatments based on the 
results)25, 27.  They also lack the ethical controversy (and resulting limitations and regulations) that 
surround hESC research and use in treatments29. 
 hMSCs are normally differentiated down three main mesenchymal lineages – bone, cartilage, and fat.  
This is often done by adding a cocktail of growth factors, hormones, and small molecules along with 
altered culture conditions (such as pellet culture or elimination of serum)29.   Osteoblasts, for 
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example, are created by the addition of dexamethasone (a steroid) and β-glycerophosphate to normal 
growth media (at final concentrations of 0.1 µM and 2 mM respectively), while hMSCs can be 
differentiated into adipocytes by the same amount of dexamethasone as used for osteoblastic 
differentiation, but also require 3-isobutyl-1-methylxanthine and indomethacin34.  Cartilage is more 
difficult – it usually is done in pellet culture at extremely high densities of cells (250,000 cells/well in 
a 96-well plate is recommended by one protocol), and requires TGF-β, dexamethasone, ascorbic 
acid, sodium pyruvate, and ITS (insulin, transferring, and selenium) supplementation to serum-free 
media35.  Differentiation of hMSCs can also be heavily influenced by their mechanical environment 
36.  Engler et al. demonstrated that hMSCs grown on soft materials tended to go down a neurogenic 
differentiation pathway, those on stiffer materials became myogenic, and those on very stiff 
materials tended towards osteogenic differentiation – all incubated with the same media36.  It is a 
common strategy in tissue engineering to culture hMSCs on a scaffold or construct and then 
differentiate them in situ to form whatever final lineage is desired37-40.  hMSCs are normally grown 
and proliferated on standard tissue culture plastic dishes, and do not require a feeder layer or feeder-
layer conditioned media like hESCs typically do34, 35.  Like hESCs, there have been worries about 
using media with xenogenic products in it (like animal serum), so efforts have been made to grow 
hMSCs under defined conditions33.  Furthermore, hMSCs lose their potency after too many passages 
(and thus are not infinitely self-renewing like hESCs), and eventually will only be able to go down 
the osteogenic lineage41.  Thus, it is important to know that if they are to be cultured on a new 
material (like PMEDSAH) they will continue to have similar growth rates to what they have on 
standard TCPS, as a slower proliferation rate might impact their clinical use given that too many cell 
divisions results in a loss of potency. 
Native adult hMSCs can be difficult to harvest though and it is a painful and invasive process, so 
recently there has been an effort to differentiate hMSC-like cells directly from hESCs and other stem 
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cell lines18, 42.  hESCs, thanks to their self-renewing properties, could potentially generate an 
enormous number of hMSCs43. Barberi et al. generated hMSC-like cells from hESCs; they 
appropriately expressed markers associated with hMSCs, and could be differentiated into 
mesenchymal lineages like adipocytes, osteocytes, and chondrocytes 44.  However, a feeder layer was 
used to maintain the hESCs before differentiation, and in order to differentiate into hMSC-like cells, 
the group cultured hESCs on a layer of mouse OP9 stromal cells 44.  The resulting hMSC-like cells 
were separated out via fluorescence-activated cell sorting (FACS) and then replated onto TCPS – a 
complicated procedure requiring three different substrates (two of which are xenogenic co-
cultures)44.  PMEDSAH could potentially replace these two substrates, if mesenchymal stem cells 
can be shown to grow and maintain multipotency when cultured on it.  Villa-Diaz et al. was able to 
generate hMSCs from a pluripotent stem cell without using any feeder cell layers; however, instead 
of hESCs they used induced pluripotent stem cells (hiPSCs)18.   iPSCs were initially generated by 
Takahashi et al. from an adult mouse fibroblast line by transfection of four hESC pluripotency 
markers (OCT4, c-MYC, SOX2, and KLF4) – they were found to express hESC pluripotency 
markers and could differentiate much like hESCs when transplanted into mice45, 46.  This was a very 
exciting development, as it potentially means that cells with the same advantages as hESCs but with 
none of the ethical concerns or immunogenic issues could be generated on demand for patients46.  
While the creation of iPSC cells took place on MEF feeder layers, Villa-Diaz et al. subsequently 
transferred them to PMEDSAH substrates to grow in feeder-free conditions18.  hMSCs were then 
obtained by creating embryoid bodies, growing these in suspension culture with low-attachment 
substrates, and then culturing these again on a gelatin coated substrate and subculturing them until 
the cells looked like fibroblasts (the gross morphology of hMSCs)18.  These cells could then 
differentiate down the three major mesenchymal stem cell lineages, had all the appropriate markers, 
and osteogenic cells generated from them resulted in new bone growth with a bone defect mouse 
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model18.  Nevertheless, there is still little known about how hMSCs would behave if cultured on 
PMEDSAH-coated dishes.  Letsche et al. tried to culture hMSCs on a variety of polymer brushes 
coated onto silicon substrates in patterns, and found that hMSCs prefer to grow in between the 
patterned PMEDSAH rather than on it47.  Furthermore, thermal grafting of PMEDSAH results in 
largely uncontrolled polymerization with respect to chain length and dispersity – both important 
variables in dictating surface properties such as hydrophobicity.  We wish to investigate a different 
reaction that gives us more control over polymerization – atom transfer radical polymerization. 
 
ATRP 
Atom transfer radical polymerization (ATRP)  is a recently developed reaction that uses a transition 
metal catalyst and halogenated initiation group to create carbon-carbon bonds, with low reaction 
temperatures and a large library of available monomers48, 49.  It is categorized as a type of ‘living’ 
polymerization because there is no chain termination (though as Patten et al. points out technically 
there is a termination step that occurs at a very initial low rate) – this is because ATRP controls the 
number of radicals present during the reaction50-52.  ATRP is able to generate a monodisperse  
population of polymers by having the chemical reaction equilibrium favor the non-radical form of 
the growing polymer chain, with the number of propagating free radical polymers in much smaller 
numbers than the dormant polymer51, 53, 54.    ATRP can be combined with chemical vapor deposition 
by functionalizing [2.2] paracyclophane with the initiator ester bromide via Rieche formulation 
followed by reduction to form a hydroxylated paracyclophane49.  2-bromoisobutyryl bromide can 
react to form the new desired initiator, which can undergo CVD via the Gorham process49.  This 
allows for an easy way to modify the surfaces of bulk materials with ATRP-produced polymer chains 
– other methods of doing so exist, but are limited by the bulk material surface chemistry given the 
usual difficulty of immobilizing the necessary initiator49.  Decoupling the surface chemistry from the 
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bulk material via CVD solves this issue.  After deposition of the resulting PPX-esterbromide on a 
substrate, ATRP can be performed with the initiator, growing long polymer branches from the 
surface (Fig. 3.2)49. 
 
Jiang et al. used CVD and ATRP to pattern PEGMA against a PMMA background (poly(methyl 
methacrylate)  generated on a silicon substrate via vapor-assisted micropatterning in replica 
structures, or ‘VAMPIR’)49.  Subsequently, cultured NIH3T3 fibroblasts would only grow on the 
portion of the surface that did not contain the ATRP-generated PEGMA49.  Jaewon et al. used 
ATRP generated PEGMA chains to prevent unwanted cell attachment during experiments55. 
PMEDSAH can also be deposited via ATRP, as illustrated in Fig. 3.3 and performed by Cheng et al 
56.   ATRP allows for controllable polymer brush thickness, and Cheng wanted to study how 
zwitterionic brushes change with regards to certain mechanical properties such as wettability as 
thickness is increased 56.  Azzaroni et al. postulate that PMEDSAH chains progress through three 
conformational states based on the individual ionic interactions between the sulfonate and 
quaternary ammonium (Fig. 3.3)57. 
 
Figure 3.2 – ATRP of PMEDSAH after CVD deposition of the initiator PPX-esterbromide (figure 





At a shorter polymer brush height (less than 50 nm), it is hypothesized that the zwitterions do not 
interact and are in a non-associated conformation – but as thickness or density increases, the chains 
begin to interact with each other more, and eventually at a certain height will collapse onto each 
other with all of the ions interacting either within the individual chain itself or with ions in other 
chains (Fig. 3.4)57.  Co-currently with this, Cheng et al. discovered that as the chain length is 
increased, the polymer brush transitions from being hydrophilic to being hydrophobic, with a critical 
brush height hcrit that depends on the chain density and rate of polymerization
56.  The change in how 
the zwitterionic chains associate with each other and water as height or density changes is proposed 
as a mechanism for explaining this transition – when ions are not associating with each other, they 
are free to be hydrated by water and thus show a low contact angle measurement57.  However, once 
taller or denser chains start to show ion-pairing, water becomes excluded and the brush switches to a 
hydrophobic regime57.   As previously discussed, surface wettability can be an important criterion for 
 
Figure 3.3 – PMEDSAH conformations based on zwitterionic interactions (reprinted with 




a cell’s ability to adhere or spread onto a surface – ATRP of PMEDSAH allows for precise control 

























Rationale, Project Goals, and Hypotheses 
 
Clearly hMSCs represent an important and valuable type of adult multipotent stem cells that can 
further differentiate down lineages with critical applications in medicine and tissue engineering. 
While thermally grafted PMEDSAH has been very successful for maintaining hESCs and iPSCs, 
little work has been done to study hMSCs themselves on PMEDSAH.  Early work in differentiating  
hESCs into mesenchymal stem cells required them to be first cultured on a MEF feeder layer, then 
OP9 stromal cells, then regular TCPS44.  More recent research has attempted to remove the 
necessity for MEFs by using PMEDSAH as a feeder-free substrate, but this PMEDSAH was 
prepared using a UV-ozone thermal grafting polymerization without any control over polymer chain 
length18.  Furthermore, while the iPSCs were maintained on PMEDSAH, the resulting hMSCs were 
not18.   Much is known about how hESCs and iPSCs grow and maintain themselves on PMEDSAH 
- relatively little is known about how hMSCs would act.  hMSCs can be maintained on traditional 
TCPS without fear of spontaneous differentiation (unlike hESCs and iPSCs).  Nevertheless, if 
PMEDSAH is to be used as a universal substrate for hESC/iPSC differentiation towards hMSCs, it 
is important to know how hMSCs will behave on it (with respect to attachment, proliferation, 
morphology, and maintenance of multipotency).  We want to grow hMSCs on PMEDSAH dishes 
coated via ATRP, as thermal grafting operates by an uncontrolled mechanism of polymerization.  
Thermally grafted PMEDSAH results in chains which are less dense and more prone to defects than 
those generated by ATRP.  By contrast, ATRP allows us to directly control the thickness of the 
polymer brush, gives us a monodisperse coating (i.e. the individual chain lengths of PMEDSAH are 
the same height), and lets us control the wettability.  Given that these parameters may play a role in 
embryonic stem cell maintenance10, it is reasonable to hypothesize that they could also influence 
mesenchymal stem cell culture as well, yet this has not been well characterized.  Thus, this chapter 
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characterizes and compares hMSCs grown on ATRP PMEDSAH to those grown on grafted 
PMEDSAH. 
We cultured hMSCs on PMEDSAH surfaces coated with PMEDSAH of various chain lengths, 
along with grafted PMEDSAH and TCPS as controls.  We measured various biological properties of 
the hMSCs after they were cultured in order to characterize how they grow and whether or not they 
remain pluripotent on the ATRP PMEDSAH.  Work by Villa-Diaz et al. showed that MSCs 
differentiated from iPSCs grown on grafted PMEDSAH expressed all relevant markers and could be 
differentiated down the three major mesenchymal lineages, but the hMSCs themselves were not 
grown on PMEDSAH18.  We first hypothesized that hMSCs cultured on PMEDSAH deposited by 
ATRP at a similar length to grafted PMEDSAH will remain multipotent.  We tested this by growing hMSCs 
for seven days on ATRP PMEDSAH, grafted PMEDSAH, and TCPS then used flow cytometry to 
measure the presence or absence of undifferentiated hMSCs.  We also did RT-PCR on hMSCs 
cultured on grafted PMEDSAH and TCPS, looking at the expression rates of a battery of genes 
related to hMSC maintenance and differentiation.  While it is possible that the new orientation of 
the PMEDSAH chains could through mechanotransduction radically change hMSC gene expression, 
it was felt to be unlikely given that the overall stiffness of the material was largely the same (that of 
TCPS).  Secondly, we hypothesized that varying the lengths of the PMEDSAH chains by varying the ATRP 
reaction time will result in morphological and growth rate differences due to differing mechanical properties.  The 
second hypothesis was tested by culturing hMSCs on ATRP PMEDSAH of differing brush 
thickness for seven days, then fixing and staining them with phalloidin and DAPI/Hoescht probe.  
This hypothesis was shown to be incorrect – hMSCs grew to the same levels of confluency after 7 
days of culture no matter the length of the PMEDSAH chains.  However, there were noticeable 
morphological and viability differences between hMSCs grown on ATRP PMEDSAH and those 
grown on grafted PMEDSAH.  This lead to our third hypothesis:  that due to differences in the orientation 
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of the PMEDSAH chains with respect to the substrate, hMSCs cultured on ATRP PMEDSAH will grow at a 
different rate and have different morphological characteristics than those grown on grafted PMEDSAH of a similar 
height.  This was partially tested by measuring the growth rate of hMSCs cultured on grafted 
PMEDSAH and ATRP PMEDSAH with an XTT assay over seven days, along with microscope 























Parts of this experimental section were paraphrased from original unpublished text by collaborator 
Dr. Aftin Ross. 
Ultraviolet Ozone Thermal Grafting Polymerization 
A 10 L reaction vessel was degassed through an argon-vacuum purging performed three times 
sequentially.  During the reaction vessel purging, a solvent of 4:1 water/ethanol was prepared and 
degassed for 40 minutes after being placed under vacuum.  After degassing, PMEDSAH (Sigma 
Aldrich, St. Louis, MO) was dissolved into the solvent at a concentration of 0.06 g/ml and the 
mixture was placed into the reaction vessel.  This was then heated to 76-82 °C.  During heating, 
tissue culture polystyrene cell culture well plates were placed in a UV ozone environment for 25 
minutes to generate free radicals.  The plates were then inserted into the reaction vessel for 2.5 hr 
for thermal grafting polymerization.  After the reaction, the plates were washed with a 1% saline 
solution overnight at a temperature of 50 °C. 
 
Atom Transfer Radical Polymerization 
Brushes of PMEDSAH (Monomer-Polymer and Dajac Labs, Trevose, PA) were created using atom 
transfer radical polymerization (ATRP).  A 4:1 methanol/water solvent was prepared and degassed 
with three freeze-pump-thaw cycles in a 50 ml Schlenk flask.  Another 10 ml Schlenk flask was also 
degassed after three argon-vacuum cycles.  At room temperature, 10% of the solvent was transferred 
by syringe to this 10 ml Schlenk flask, and a catalyst composed of CuCl (3.6 mg/ml), CuCl2 (0.96 
mg/ml) and 2’2 bipyridyl (14 mg/ml) was added to the mixture.  PMEDSAH was dissolved into the 
remaining solvent in the 50 ml Schlenk flask at a concentration of 0.5 g/ml, and each mixture 
underwent ten minutes of stirring to ensure all reactants and catalysts were dissolved. The 
catalyst/solvent mixture was then added to the 50 mL PMEDSAH mixture, and after stirring the 
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mixture was placed under an argon environment in a purged glove box and aliquoted to the 
substrates needing to be coated (tissue culture polystyrene cell culture well plates, or flat silicon 
substrates in 20 ml scintillation vials that had previously been degassed – 1 ml to each sample).  
Substrates had previously undergone chemical vapor deposition to coat them with the initiator PPX-
esterbromide.   The ATRP reaction time was varied depending on the desired PMEDSAH chain 
length, and afterwards the substrates were washed in a 1% saline/water solution and allowed to dry.  
Copper catalyst was removed by washing with a 5 mM solution of EDTA along with further 
deionized water rinses.  
 
RT-PCR 
hMSCs at passage 6 were grown for 7 days on TCPS and thermally grafted TCPS.  They were 
harvested with trypsin/EDTA 0.25% (Gibco), then RNA was harvested with a RNEasy Minikit and 
QIAshredder (Qiagen).  These RNA samples were taken to the RT-PCR core facility at the NCRC, 
where they were converted into cDNA libraries.  Gene expression for the following genes was 
measured using a Human Mesenchymal Stem Cell PCR Array (Qiagen) (some genes repeated for 
completeness of their category):  FGF2, INS, LIF, POU5F1, SOX2, TERT, WNT3A, ZFP42 
(stemness markers); ALCAM, ANPEP, BMP2, CASP3, ENG, ERBB2, FUT4, FZD9, ITGA6, 
ITGAV, KDR, MCAM, NGFR, NT5E, PDGFRB, PROM1, THY1, VCAM1 (MSC-specific 
markers); ANXA5, BDNF, BGLAP, BMP7, COL1A1, CSF2, CSF3, CTNNB1, EGF, FUT1, 
GFT3A, HGF, ICAM1, IFNG, IGF1, IL10M, IL1B, IL6, ITGB1, KITLG, MITF, MMP2, NES, 
NUDT6, PIGS, PTPRC, SLC17A5, TGFB3, TNF, VEGFA, VIM VWF (other genes associated 
with hMSCs); BMP2, BMP6, FGF10 HDAC1, HNF1A, KDR, PTK2, RUNX2, SMURF1, 
SMURF2, TBX5 (genes involved in osteogenesis); PPARG, RHOA, RUNX2 (genes involved in 
adipogenesis); ABCB1, BMP2, BMP4, BMP6, GDF5, GDF7, HAT1, ITGAX, KAT2B, SOX9, 
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TGFB1 (genes involved in chondrogenesis); JAG1, NOTCH1 (genes involved in myogenesis); and 
BMP2, GDF15, SMAD4, TGFB1 (genes involved in tenogenesis).  ΔΔCt values were calculated, and 
the natural scale fold change was outputted as 2- ΔΔCt.  p-values were calculated and then adjusted for 
multiple comparisons via the false discovery rate.  
 
Flow Cytometry 
hMSCs (a kind gift from Dr. Paul Krebsbach, University of Michigan) at passage 6 were thawed 
from cryogenic storage and plated on TCPS, grafted PMEDSAH, and ATRP PMEDSAH surfaces 
at a concentration of 6000 cells/cm2 (all 6 well plates).  After 166 hours of proliferation in complete 
media (α-MEM + 10% FBS + 1% P/S), the cells were trypsonized and labeled with 1 µg/ml of 
antibody conjugated with a fluorescent marker.  The following antibodies were used:  PE 
(phycoerythrin) isotype-matched control, FITC (fluorescein isothiocyanate) istotype-matched 
control, CD34 (FITC), CD45 (FITC), CD73 (PE), CD90 (PE), and CD105 (PE).  The samples were 
then run through a FACSCalibur 1 and analyzed. 
 
hMSC Spreading Microscopy 
hMSCs at passage 6 were seeded at a seeding density of 6000 cells/cm2 onto silicon substrates in a 
24-well plate coated with grafted PMEDSAH and ATRP PMEDSAH grown to various thicknesses.  
Cells were fed at 24 hr, 72 hr, and 120 hr complete media (α-MEM + 10% FBS + 1% P/S).  At 168 
hr (7 days), cells were fixed in 4% paraformaldehyde in DPBS and stained for actin with Alexa 
Fluor® 568-phallodin (Life Technologies). The surfaces were mounted with ProLong Gold + DAPI 
(Life Technologies) and imaged using an Olympus BX-51 fluorescence microscope.  The average 
area of the cells was measured via ImageJ, and performed by dividing total cell area by total number 
of cells (equated to total number of individually counted DAPI stains).  For statistical purposes, all 
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images were treated as independent with regards to calculating p-values.  Other trials used a 6-well 
plate – cell seeding density was kept the same, along with feeding times and phalloidin staining 
technique (except Hoescht probe was used to stain nuclei instead of DAPI). 
 
hMSC Growth Assay 
 
hMSCs at passages 6-7 were thawed from cryogenic storage and plated on TCPS, grafted 
PMEDSAH, and ATRP PMEDSAH surfaces, at a plating density of 6000 cells/cm2.  Cells were fed 
at 24 hr, 72 hr, 120 hr, and 168 hr complete media (α-MEM + 10% FBS + 1% P/S), and an XTT 
assay (ATCC) was conducted to measure metabolic activity at 72 hr, 120 hr, and 168 hr.  Briefly, an 
XTT solution composed of two parts complete media and one part XTT mixture (XTT mixture is 
composed of XTT reagent (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide) and activating agent (N-methyl dibenzopyrazine methyl sulfate) at a ratio of 50:1) was 
incubated with the cells for 65 minutes along with an equal number of blanks, and then pipetted into 
a 96 well plate.  Using a plate reader, specific absorbance was measured at 475 nm and non-specific 
absorbance at 660 nm.  The following formula was then used to calculate final specific absorbance:  












Various surface properties of the grafted PMEDSAH and ATRP PMEDSAH plates were measured, 
including hydrophobicity via contact angle measurement and the brush thickness.  Generally as 
expected with ATRP, the longer the plates spent in the ATRP reactor, the longer the branch chains 
became and the more hydrophobic the surfaces became (and all are much longer than the relatively 
short thermally grafted PMEDSAH chains) 56.  Table 3.1 highlights the measured physical properties 
(measured by Dr. Aftin Ross) 
Time in ATRP Reactor Contact Angle Brush Thickness 
1 hr 17° 27.1 nm 
12 hr 37.7° 93.4 nm 
24 hr 65.6° 108.3 nm 
Grafted PMEDSAH 17° 10-20 nm 
 
Next, differences were examined between hMSCs grown on thermally grafted PMEDSAH and 
ATRP PMEDSAH. The gross morphology and confluency of hMSCs on ATRP PMEDSAH 
surfaces of differing thickness was imaged, with growth on grafted PMEDSAH as a control.   
hMSCs were grown on PMEDSAH surface-modified silicon substrates for 166 hr, fixed and stained 
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with phalloidin and DAPI, then imaged using a fluorescence microscope (Fig.3.4) 
 
Interestingly, while grafted PMEDSAH surfaces (with a thickness between 10-20 nm) and ATRP 
surfaces coated to a thickness of 27.1 nm showed similar hydrophilicity (with a contact angle of 
~17°), the behavior of the hMSCs on each was very different.  hMSCs grew to confluency on all 
ATRP surfaces irrespective of hydrophilicity or thickness (contrary to our initial hypothesis), while 
the number of hMSCs on grafted PMEDSAH was significantly lower (in line with our last 
hypothesis).  Cells grown on PMEDSAH had a marginally but statistically significantly higher 
average area than those grown on 27.1 nm and 108.3 nm ATRP PMEDSAH; this could be due to 
the overall lower level of confluency on grafted PMEDSAH, and thus greater area over which 
individual cells could freely spread in comparison to hMSCs grown on ATRP PMEDSAH.  As the 
 
Figure 3.4:  Fluorescent microscopy of hMSCs grown for 7 days on (a) 27.1 nm ATRP 
PMEDSAH, (b) 93.4 nm ATRP PMEDSAH, (c) 108.3 nm ATRP PMEDSAH, and (d) grafted 




cells had reached confluency on the ATRP surfaces by seven days, it was difficult to gauge any 
distinctive morphological differences.   
hMSCs were also cultured on 6-well plates coated with either grafted or ATRP PMEDSAH, and 
grown for 7 days.  The results were similar to that observed with the silicon substrates (Fig. 3.5), 
with cells showing near confluency on all surfaces except the grafted PMEDSAH.  hMSCs grown on 
TCPS in a separate trial also grew to confluency after 7 days. 
 
While the hMSCs grown on UV graft PMEDSAH looked very different from those grown on 
ATRP PMEDSAH, both the 27.1 nm ATRP PMEDSAH and the grafted PMEDSAH had the same 
contact angle.  Thus, we decided for future experiments to only use the 27.1 nm ATRP PMEDSAH 
in order to keep the contact angle consistent (and thus eliminate wettability as a variable), and try to 
understand why hMSCs grew more vigorously on it in comparison to grafted PMEDSAH. 
Flow cytometry was next performed to determine whether hMSCs spontaneously differentiate after 
 
 
Figure 3.5:  Fluorescent microscopy of hMSCs grown for 7 days on (a) 27.1 nm ATRP 
PMEDSAH, (b) 93.4 nm ATRP PMEDSAH, (c) 108.3 nm ATRP PMEDSAH, (d) TCPS (from 
a separate trial with the same conditions), and (e) Grafted PMEDSAH.    
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culture on grafted PMEDSAH and ATRP pMEDAH (27.1 nm thick).  hMSCs were cultured for 
nearly 7 days, then removed from the surface and labeled with various markers associated with 
identifying hMSCs.   hMSCs were also grown on TCPS as a positive control.  CD34 and CD45 are 
negative on multipotent hMSCs, while CD73, CD90, and CD105 are positive markers. 
 
As shown in Fig. 3.6, hMSCs grown on all three surfaces are negative for CD34 and CD45, and 
positive for CD73, CD90, and CD105.  This indicates that hMSCs do not spontaneously 
differentiate after extended culture on PMEDSAH surfaces, which is necessary if PMEDSAH is to 
be used as a universal substrate for stem cell culture. 
Changes in gene expression on the grafted PMEDSAH (but not ATRP PMEDSAH) were also 
probed by RT-PCR, with TCPS as a control.  A microarray able to probe 83 different genes related 
 
 
Figure 3.6:  Flow cytometry dot plots (APC vs. PE or FITC) of  (a-e) TCPS-grown hMSCs 
labeled with (a) CD34, (b) CD45, (c) CD73, (d) CD90, and (e) CD105; (f-j) Grafted 
PMEDSAH-grown hMSCs labeled with  (f) CD34, (g)CD45, (h) CD73, (i) CD90, and (j) 
CD105; (k-o) ATRP PMEDSAH-grown hMSCs labeled with (k) CD34, (l)CD45, (m) CD73, 
(n) CD90, and (o) CD105 
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to hMSC differentiation and multipotent maintenance was used.  Fig. 3.7 plots ΔΔCt values for a 
selection of these genes, related to such differentiation lineages as osteogenesis (BMP 2, RUNX2), 
adipogenesis (RUNX2), chondrogenesis (BMP 2, RUNX2, SOX9), myogenesis (JAG-1, NOTCH1), 
and other genes associated with hMSCs (EGF, FGF 2, VEGF, NGFR, IGF-1). 
 
Of the 83 genes examined, only two changed significantly in expression on grafted PMEDSAH vs. 
TCPS.  Both EGF and NGFR were slightly downregulated after 7 days of growth on grafted 
PMEDSAH in comparison to those grown on TCPS (p = 0.0367 and p = 0.0138).  Genes used as 
markers for hMSCs showed no significant changes after culture on either surfaces, and the 
appropriate amount of expression expected (e.g., CD29 is not expressed as it is a negative marker 
for undifferentiated hMSCs, while CD45 shows significant expression given that it’s a positive 
marker for undifferentiated hMSCs)  (Fig. 3.8).  This corresponds well with the flow cytometry data, 
both of which present strong evidence that hMSCs do not undergo spontaneous differentiation 
when cultured on PMEDSAH. 
 






As it seems that the growth rate on grafted PMEDSAH was much lower than that on ATRP and 
TCPS, growth was dynamically assessed through a measurement of metabolic activity over the 
course of a week.  hMSCs were cultured for 7 days on TCPS, thermally grafted PMEDSAH, and 
ATRP grafted PMEDSAH.  While growth occurred as expected with the TCPS and PMEDSAH 
plates, hMSCs would avoid growing in certain areas of the ATRP PMEDSAH plates while growing 
to full confluency in other parts.  This was so apparent at times that one could even see a clear 
boundary which divided where the hMSCs would grow and where they would not (Fig. 3.9-b). 
 





The XTT results for the TCPS and grafted plates (which displayed no inhomogeneity with regards 
where cells would grow) were consistent with the previous microscopy results shown in Figure 3.5 – 
cells grew slower on the grafted PMEDSAH than the TCPS (though in the trial shown above they 
caught up to TCPS by day 7).  The data for growth by days 3 and 5 is completely consistent through 
four trials, though by day 7 two of the trials showed the graft PMEDSAH cells catching up to the 
TCPS cells, while two others did not (Fig. 3.9, 3.10).  
 
 
Figure 3.10:  XTT assay results for hMSCs grown on TCPS (blue) and grafted PMEDSAH 
(red) for two different trials (a and b) 
 
Figure 3.9:  (a) XTT assay results for hMSCs grown on TCPS (blue), grafted PMEDSAH (red), 
and ATRP PMEDSAH (green).  (b) Brightfield microscopy of the hMSCs growing on ATRP 
PMEDSAH after seven days in culture   
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We hypothesized that the inhomogeneity occurring on the ATRP PMEDSAH was due to residual 
ethylenediaminetetraacetic acid (EDTA).  This is normally used to wash the surfaces after ATRP to 
bind away all residual copper catalyst – failure to do this leads to surfaces where few cells will adhere 
and proliferate (data not shown).  While after EDTA washing ATRP PMEDSAH surfaces could 
subsequently support hMSCs, we would consistently observe areas where the cells would refuse to 
grow despite other areas bordering them where the cells would grow to confluency.  We 
hypothesized that as the acidic EDTA was not very soluble in water (0.4 g/L), it would remain on 
the surfaces despite washing.  As EDTA chelates calcium, this would cause problems for cells trying 
to attach to each other via cadherins (which proteases will digest if calcium is not present)26.   
Therefore, we switched to a different chelation agent – EDTA disodium salt dihydride, which was 
far more water soluble (100 g/L).   
To test our hypothesis, we washed our ATRP plates with a 5 mM solution of EDTA disodium salt 
dihydride and repeated the experiment (Fig. 3.11, n = 10).  We no longer observed any areas on the 
ATRP PMEDSAH surfaces where the hMSCs would not go, strong evidence that our hypothesis 
was correct.  As is consistent with microscopy (Fig. 3.11), hMSCs grew faster on ATRP and there 
were more cells present (as indirectly measured by XTT) than those on the grafted PMEDSAH 
surfaces.  While at 72 hr the cells grown on ATRP PMEDSAH and grafted PMEDSAH show 
statistically similar XTT assay results, by 120 hr the cells on the ATRP surfaces have outgrown those 
on the grafted and continued to do so by 168 hr.  As in previous trials, hMSCs grown on the grafted 
PMEDSAH grew far slower than those on TCPS, reinforcing this observation.  TCPS also showed 












Figure 3.11:  (a)  Brightfield microscopy of hMSCs growing on various surfaces at indicated 
time points, (b) XTT results over seven days 
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Conclusions and Future Work 
hMSCs are a valuable cell line with many desirable properties, including their relatively fast growth 
rate, simple culture conditions, and potential for autologous transplant .  In this chapter, we 
confirmed that hMSCs maintain markers for multipotency when grown on grafted PMEDSAH and 
ATRP PMEDSAH via flow cytometry.  This is further backed up for grafted PMEDSAH based on 
RT-PCR results.  However, hMSCs do not grow as well on PMEDSAH surfaces (either the grafted 
or the ATRP) as they do on TCPS.  This was disappointing, though it is interesting that there is a 
clear difference in growth rate between the thermally grafted PMEDSAH and ATRP PMEDSAH 
with similar contact angles.  Thus, we supported our first hypothesis (hMSCs retain their 
characteristic markers on grafted and ATRP generated PMEDSAH surfaces), rejected our second 
(as the contact angle and thickness of the surfaces did not seem to affect the growth of the hMSCs 
when it was varied on the ATRP-generated PMEDSAH surfaces), and supported our third (hMSCs 
do grow at slower rates on thermally grafted pMEDSAH over ATRP pMEDSAH).  Why they fail to 
grow as well on the grafted PMEDSAH in comparison to the other surfaces is unclear.  The RT-
PCR results indicate that hMSCs grown on grafted PMEDSAH very slightly downregulate 
expression of EGF, and EGF has been shown to increase hMSC proliferation and motility58.  
However, while the result is significant statistically, it is so small (not even two-fold) that this 
hypothesis is not very likely to be true.  It is also unlikely to do with the hydrophilicity of the 
surfaces, as both grafted PMEDSAH and the thickness of ATRP pMEDAH tested (27.1 nm) have 
essentially the same contact angle (17°).  As the conformation of the polymer chains is likely 
different on a short polydisperse thermally grafted coatings vs. the thicker and more monodisperse 
ATRP coatings, it is likely that this is the source of the difference observed.  Perhaps the thermally 
grafted co-polymer does not support cell proliferation as well due to a difference in how it binds 
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proteins (such as growth factors or extracellular matrix) generated by the cells during culture in 
comparison to the ATRP PMEDSAH. 
For future work, we need to confirm that the hMSCs still differentiate down their three major 
lineages (osteo, chondro, and adipo) by differentiating them in vitro after culture on PMEDSAH 
surfaces.  The results with the EDTA suggest a new method for preventing cell growth on 
PMEDSAH surfaces.  As our hypothesis seems to be correct, it may be possible to microcontact 
print the insoluble acidic form of EDTA onto bare PMEDSAH in order to create patterned regions 
where cells will not bind.  Unlike reaction schemes such as ATRP deposition of PEGMA or click 
chemistry of azido-PEG onto a surface, this would be an incredibly simple procedure (just 
physisorption of EDTA) – yet it may result in resistance to cell adhesion over long times much like 
these already well-known surface modifications.  Controlled experiments testing this are underway as 
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In this chapter, we created a biohybrid material consisting of anisotropic flexible microcylinders and 
mammalian cells.  These microcylinders were generated using electrohydrodynamic co-jetting.  We 
subsequently demonstrated that this resulted in bioactuators if the cell line used were spontaneously 
contracting rat neonatal cardiomyocytes.  In the Introduction and Background, we discuss current 
bioactuators that have been crafted using muscle cells and flexible polymers.  We highlight the 
successes as well as the shortcomings of these approaches, particularly with regards to their 
comparatively large size.  We also briefly review the technique of electrohydrodynamic co-jetting, 
emphasizing the ease with which it can create anisotropic materials.  We built a new free floating 
cylindrical bioactuator that is smaller than those currently in the literature, and characterize the force 
generated by cardiomyocytes attached to it using confocal microscopy.   
 
Introduction and Background - Bioactuators 
 
An actuator is simply defined as a mechanical device which converts energy into motion.  Micro-
electromechanical systems (MEMS) and devices comprise a major industry, and actuators are an 
important component for these devices and their ability to interact with the outside world1.  Bell et 
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al. categorizes MEM actuators into four broad families based on how they function:  electrostatic, 
piezoelectric, thermal, and magnetic1.  Picking a particular actuator for a MEMS device is a project in 
determining the desired frequency, force, and displacement along with looking at factors like 
fatigability, efficiency, and material failure1, 2.  For example, piezoelectric actuators can exert a 
maximal force between 10-5-10-3 N, while ones based on magnetic fields range around 10-7-10-4 N1.  
Shapeshifting materials such as polypyrrole are a popular choice for actuators, as they have high 
stress/strain performance and require a low voltage in order to work3, 4.   Another factor to consider 
is the source of energy needed for the actuator to move and generate force2.    For example, 
polypyrrole acts as an actuator by changing its volume due to the entrance or exit of ions – this is 
often accomplished with a battery providing the voltage necessary5.  Recent work by Küttel et al. 
accomplished this same effect without a battery by adding the redox reagents hexacyanoferrate and 
L-ascorbic acid to a solution bathing the actuator5.  Thus, there is interest in eliminating the necessity 
of batteries for actuators, especially MEMS devices which might require a sophisticated microbattery 
to operate6. 
A potentially new class of actuator has recently been developed.  Rather than depending on 
inorganic substrates, they attempt to mimic an actuator already found in nature:  muscle7.  So-called 
‘bioactuators’ have several potential advantages over traditional actuators.  One of these is that 
unlike some microactuators, bioactuators do not require an external microbattery6. In fact, glucose 
alone has been measured to result in 1000 J of work per gram – this fact is often noted in arguments 
for the energy-density advantages of bioactuator2, 8, 9.  In comparing their bioactuator to a 
polypyrrole actuator, Feinberg et al. note the energy advantage of using glucose over a battery, along 
with marked advantages in strain, frequency, and force generation (though not in stress, where 
polypyrrole actuators have a marked advantage over bioactuators by more than an order of 
magnitude)6.  They are also able to potentially self-repair themselves if damaged10. 
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One class of bioactuators was engineered by Feinberg et al.  PDMS was spin coated on top of 
poly(N-isopropylacrylamide) (PIPAAm) and then functionalized with µCP fibronectin6.  
Cardiomyocytes were then grown on top of this flat film, which could be cut with a scalpel into any 
shape desired6.  Cardiomyocytes are often an ideal choice for proof-of-concept bioactuators, as 
neonatal cardiomyocytes will spontaneously beat in culture without any need for an external electric 
potential (depending on how they are cultured, adult cardiomyocytes can also exhibit spontaneous 
contractions)11, 12.  The bioactuator was next placed into a colder temperature; as PIPAAm is 
temperature sensitive and has a tunable wettability (discussed at length in Chapter 5), the cooler 
temperature releases the PDMS-cardiomyocyte actuator from the PIPAAm substrate (which 
transitions from a hydrophobic to a hydrophilic state when the temperature is lowered)6.  Key to this 
work was the anisoptropy of the initially flat thin film of PDMS –  both fibronectin and 
cardiomyocytes were µCP/cultured on one side, thus enabling it to bend in a desired direction 
 
Figure 4.1: Cardiomyocytes cultured on thin films of anisotropic PDMS will bend it in culture 
(reprinted and modified with permission from Feinberg et al.)6   
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without other cardiomyocytes opposing it6.  The individual alignment of the cardiomyocytes was 
also a part of the anisotropy of the thin films – on films where fibronectin was printed in alternating 
lines of high and low concentration, the cardiomyocytes formed aligned sarcomeres and fibers and 
deformed the PDMS along in a uniaxial manner6.  Cardiomyocytes grown on an isotropic surface 
exhibited no preferred alignment, and thus showed no net stress (which is not ideal for an actuator)6.  
Feinberg therefore demonstrates how important material anisotropy is for preparing bioactuators. 
This work was recently extended to create a ‘heart on a chip’ platform where cardiomyocytes were 
grown on a similar anisotropic PDMS platform as before, but that was previously cut with a laser 
tool to create individual cantilevers that the cardiomyocytes could bend (rather than crudely cut out 
with a scalpel as before)13.  This essentially creates a high throughput assay for testing how drugs 
affect cardiomyocyte contractility (measured by examining diastolic, systolic, and twitch stress) – as 
proof of concept the experimenters looked at the dose response of the beta-adrenergic agonist 
isoproterenol 13.  This project demonstrates that platforms for bioactuators have more applications 
than simply as replacements for inorganic materials such as polypyrrole, but could also be useful for 
the study of cardiomyocyte biology itself in addition to their potential development as a diagnostic 
tool (for example, one could culture diseased or genetically altered cardiomyocytes on this heart-on-
a-chip platform rather than simply healthy ones)13. 
All three types of muscle cells (cardiac, smooth, and skeletal) have been used in the production of 
bioactuators.  Cardiomyocytes may not always be ideal depending on the application, as they 
spontaneously contract and would be more difficult to control in settings where actuation needs to 
be performed only at certain intervals14.  Sun et al. (collaborating with Feinberg) printed lines of 
fibronectin on spin coated PDMS bound to PIPAAm, and then cultured the mouse muscle 
progenitor cell line C2C1215.  They were then differentiated (via switching the serum in the media 
from 10% FBS to 2% horse serum) into myotubes15.  As before, the anisotropy was important for 
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generating unaxial force, and the authors optimized the spacing between the printed fibronectin 
lines so cells in individual muscle fibers do not ‘bridge’ over to interface with cells in other muscle 
fibers15.  Smooth muscle cells are also candidates for bioactuators – Tanaka et al. used vascular 
smooth muscle cells to bind and bend micropillar PDMS14. 
Other ‘biorobots’ have been developed using the principles of bioactuators.  Herr et al. developed 
one of the earliest of these devices (colloquially referred to as swimmers) using frog muscle that had 
been surgically removed and incorporated into a macroscopic mechanical device9.  Energy was 
provided by a solution of glucose, along with batteries for the embedded microcontrollers9.  This 
biorobot could then be remotely controlled and perform swimming exercises with the ability to turn9.  
The muscle thin films produced by Feinberg et al. could be thought of as biorobots6.  Naworth et al. 
in collaboration with Parker and Feinberg created a millimeter-sized biorobot they termed a 
‘medusoid,’ as it resembled and was inspired by the swimming method of the jellyfish16.  This was 
constructed out of PDMS and rat cardiomyocytes, and resembled actual jellyfish when they swam in 
the bath16.  Hoshino et al. cultured a cardiomyocyte/collagen gel in a PDMS network cast into 
patterns such as grids and lattices, and some of these could crawl across a surface17. 
Electrohydrodynamic co-jetting (EHD jetting or electrospinning) provides an excellent platform for 
creating anistropic materials, and is a powerful fabrication technique that could be used to produce 
bioactuators.  A solution of charged polymer (dissolved in either organic or aqueous solvent) is 
‘jetted’ from a syringe via a pump and applied voltage; once the force from the electrical potential 
overwhelms the surface tension of the polymer a fiber will ‘spin’ down from a ‘Taylor cone’ (a stable 
fluid geometry reached at some critical potential) to be collected below (Fig. 4.2)18-20.  
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Viscosity, surface tension, and solution conductivity are all important factors, along with velocity of 
the flow21.   Bhaskar et al. jetted poly(lactide-co-glycolide) (PLGA) into fibers and particles18, a 
biodegradable polymer often used in tissue engineering due to its biocompatibility and FDA 
approval.  Key to this work is developing a technique for co-jetting two different variants of PLGA 
at the same time to create biphasic fibers; in this case unmodified PLGA is jetted alongside 
poly[lactide-co-(propargyl glycolide)] (i.e. acetylene-PLGA)18.  This resulted in an anisotropic material 
that could be selectively altered depending on the material and functional properties of a particular 
phase.  For example, one could modify the PLGA featuring acetylene via click chemistry (CuI-
catalyzed Huisgen 1,3-dipolar cycloaddition), adding either cell resistant molecules like azido-PEG-
amine or cell adhesive factors like the RGD or IKVAV peptide18, 22.  Mandal et al. jetted acetylene-
functionalized PLGA to create a fiber which promotes NIH3T3 fibroblast adhesion on one phase 
featuring IKVAV (derived from the extracellular matrix molecule laminin) clicked on beforehand22.  
 
Figure 4.2: Schematic of electrohydrodynamic jetting (reprinted with permission by Kaul et al)20.  
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Highly selective attachment resulted, with the majority of cells only attaching to the side containing 









































Rationale, Project Goals, and Hypotheses 
 
Bioactuators have been successfully created using cardiomyocytes, smooth muscle cells, or skeletal 
muscle cells6, 14, 15.  However, many of these actuators can more accurately be described as cantilevers, 
where the actuator is fixed at one end to a solid support14, 23-25.  While this makes sense in the context 
of overall device design (that is, building a cardiomyocyte cantilever as part of some larger design 
that is executed), these bioactuators have to be individually designed and fitted for each application 
and cannot be mass produced.  Freely detached bioactuators on the other hand can almost be 
thought of better as ‘biorobots’ – while these could be inserted into larger devices as building blocks, 
so far most of them are large (on the order of millimeters) and thus unable to be used for 
microrobotic operations (whose main advantage is their ability to enter into small spaces) 9, 16, 17, 26.  
One of the smallest free crawling devices was built by Xi et al., and even that was 138 µm7.  We 
believe that smaller freely contracting bioactuators are possible. 
We proposed creating a new bioactuator to address these issues and push the boundaries of this 
field towards more truly microbiorobots, taking advantage of EHD co-jetting to create anisotropic 
fibers.  Previous work has already demonstrated that fibers can be aligned and cut at precise lengths 
to create microcylinders, using a microtome27.  This allows for the mass production of tens of 
thousands of microcylinders – something that current methods for creating bioactuators and 
biorobots cannot achieve.  Bhaskar et al. created several types of multiphasic microcylinders: with 
the right chemistry each phase in theory could be conjugated with a different functional group that 




We took advantage of this platform to create a bioactuator.  We jetted biphasic fibers (with one 
phase featuring either an acetylene or cyclooctyne functional group) constructed out of PLGA-
PLGA/PLCL (e.g., one phase was PLGA-PLA, while the other phase was PLCL) and cut them into 
microcylinders.  PLCL was used to provide increased flexability for bioactuation.  With one side 
functionalized with PEG, we would prevent cells such as cardiomyocytes from binding to half of the 
cylinder – providing the critical anisotropy needed for uniaxial actuation.  In order to promote cell 
adhesion to the other phase, the microcylinders were incubated with a solution of fibronectin.  
Fibronectin, a sticky and large protein, adsorbed to the phase not containing PEG.  After we created 
our microactuators, we incubated them with rat neonatal cardiomyocytes until they began to 
contract, and then imaged and took videos via confocal microscopy.  Fig. 4.4 shows step-by-step the 
process we used for creating our bioactuators. 
 
 
Figure 4.3: Microcylinders created from microtoming of EHD cojetted fibers.  Bi and triphasic 
cylinders are possible (among other configurations) (reprinted and modified with permission from 
Bhaskar et al.)27   
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In a survey of the literature, no one has yet constructed a free-floating bioactuator or biorobot with 
the dimensions reported here.  The closest is a 20 µm diameter/40-45 µm long microcylinder 
propelled by attached bacteria via flagellar motion28. Significantly, this microcylinder also uses an 
anisotropic design strategy – by attaching Pluronic block copolymer F108 (a PEG triblock 
copolymer) to the sides of the cylinder (but not the back end), bacteria only attach to the end of the 
cylinder to propel it28.  This does not really meet the definition of an actuator per se, as the bacteria 
are not deforming the material itself, but rather translating the entire device from one point to 
another28. 
In creating our microcylinder bioactuators, we came up with a series of experiments to characterize 
and demonstrate that they selectively adhere proteins and cells to one side due to their anisotropic 
properties.  We first hypothesized that EHD jetted biphasic fibers and microcylinders conjugated with PEG on 
one phase will only adsorb protein on the other phase.  We tested this hypothesis by incubating PEGylated 
fibers and cylinders (along with an unPEGylated control) with a fluorescently labeled protein, then 
observing where the protein binds.  This hypothesis would be validated if the protein only attaches 
to the side without PEG.   Next, we hypothesized that cells will only attach to one side of the biphasic fibers 
 
Figure 4.4: Microcylinder actuator schematic (based on a previous figure by Dr. Jaewon Yoon)29   
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and microcylinders if PEG is conjugated onto the other side and will attach to both phases indiscriminately if PEG is 
not present.  We tested this hypothesis by incubating fibers and cylinders with NIH3T3 fibroblasts.  
This was done before using cardiomyocytes because we wanted to validate that cells would 
selectively bind the fibers and microcylinders before moving on to the far more sensitive and 
expensive cardiomyocytes.  Finally, we hypothesized that cardiomyocytes attached to biphasic microcylinders 
will only bind to the side not featuring PEG, will retain their ability to contract on microcylinders, and will be able to 
bend them inward as they contract.  We support this hypothesis by incubating the microcylinders with 
neonatal rat cardiomyocytes, then observing them in culture with a confocal microscope. The three 
hypotheses follow in logical order of complexity (from protein to simple fibroblasts to 
cardiomyocytes) and validate the most important aspect of our work:  the anisotropy of our material 


















Parts of this experimental section were paraphrased from original text by collaborator Dr. Jaewon 
Yoon29 
 
Fabrication of Bicompartmental Microfibers 
Several different microcylinder polymer formulations were used throughout this work. For BSA 
incubation, 30% w/v PLGA and 30% w/v PLGA + 9% w/v COT-PLA with a blue dye (poly[(m-
phenylenevinylene)-alt-(2,5-dihexyloxy-p-phenylenevinylene)]) were individually dissolved in a 
solvent mixture of chloroform and DMF (chloroform:DMF 95:5 (v/v)).  For NIH3T3 cell 
incubation, 30% w/v PLGA + 0.9% w/v magnetite and 30% w/v PLGA + 9% w/v COT-PLA 
with a blue dye (poly[(m-phenylenevinylene)-alt-(2,5-dihexyloxy-p-phenylenevinylene)]) were 
individually dissolved in a solvent mixture of chloroform and DMF (chloroform:DMF 95:5 (v/v)).      
For cardiomyocytes bioactuators, a 25% w/v solution of PLCL with 7.5% w/v of iron oxide 
nanocrystals (3% by weight of PLGA) was dissolved in a solvent mixture of chloroform, 
cyclohexane and DMF (45:50:5, v/v/v), and a 30% w/v solution of PLGA and 9% w/v of COT-
PLA was dissolved separately into a solvent of chloroform/DMF (95/5 v/v).  A syringe pump 
(Fisher Scientific, Inc., USA), rotary collector, and powers supply (DC voltage, Gamma High 
Voltage Research, USA) comprised the electrohydrodynamic jetting station set-up.  The polymers 
were put into vertically positioned syringes, and set to flow at a constant rate of 0.05 ml/hr through 
26 G needles (Hamilton Company, USA).  A Taylor cone was emitted from the liquid at the end of 
the needles after application of a 11-12 kV driving voltage, and collection occurred at a 7 cm 




Fabrication of Bicompartmental Microcylinders 
Microfibers were sectioned using a cryostat microtome (Microm HM550, Thermo Fisher Scientific 
Inc., USA) after placement in a cryostat mold along with a freezing medium.  After sectioning, the 
resulting microcylinders underwent washing with a solution of 0.01% v/v Tween in deionized (DI) 
water to remove the freezing medium. 
 
Selective Surface Modification via Copper-Free Click Chemistry 
Glass coverslips were PEGylated using atom transfer radical polymerization (ATRP) of 
oligo(ethyleneglycol) methacrylate (OEGMA) to form PEGMA  in order to prevent unwanted cell 
and protein adhesion. After collection on these modified glass coverslips, microfibers functionalized 
with cyclooctyne (COT) were taped down and submerged in a 45 mg/ml deionized water solution 
of 8-armed PEG azide.  The resulting click reaction took place at gentle agitation for 24 hours at 
room temperature, and leftover reactant was removed with a 0.01% v/v Tween20 solution in DI 
water.  Microcylinders were PEGylated via a COT reaction in much the same fashion – ~50,000 
microcylinders were placed in a 1.5 ml Eppendorf tube with a 45 mg/ml 8-armed PEG azide and 
0.01% v/v Tween20 solution and rotated for 24 hours at room temperature.   
 
Bovine Serum Albumin (BSA) Incubation 
PEGylated microfibers on PEGMA-coated glass substrates were incubated with a solution of 100 
µg/ml of bovine serum albumin (BSA) dissolved in phosphate buffer saline (PBS) at room 
temperature for 3 hours.  These were washed with a 0.01% v/v Tween20 solution in PBS to remove 





Incubation of NIH3T3 Fibroblasts on Microfibers 
Microfibers were taped with double-sided tape to PEGMA-coated glass slides and incubated with a 
50 µg/ml solution of fibronectin (FN) in PBS at room temperature for 1 hr under gentle orbital 
rotation.  These were washed with PBS three times for 5 minutes each, then incubated with 1 ml of 
NIH3T3 cells (3.8 x 105 cells/ml at passage 1) for 6 hr in serum-free medium (DMEM).  After 
incubation (6 hr), the cells were fixed with 4% paraformaldehyde in DPBS, stained with 1 µl/ml of 
cytocalasin D, and imaged using a confocal microscope. 
 
NIH3T3 culture with cylinders 
Cylinders were sterilized under a UV lamp overnight, and then incubated with 0.1 mg/ml of human 
fibronectin dissolved in H2O at room temperature for one hour on a rotator.  After washing the 
cylinders three times with DPBS at five minute increments, NIH3T3 cells (ATCC) at passages 3-5 
(range over multiple trials; passages were not mixed for individual experiments) were thawed, 
centrifuged, and resuspended in DMEM (ATCC) + 10% calf bovine serum (ATCC).  3.8 x 105 
cells/vial were incubated with the cylinders and rotated for 5 hr in a 5% CO2 incubator at 37
oC, after 
which they were transferred to a stationary PEG-coated glass surface on a 12 well plate and 
incubated in media under the same conditions as rotation.  After 5 hr, the cells were fixed in 4% 
formaldehyde for 15 minutes at room temperature. 
 
Rat Cardiomyocytes with Cylinders 
 
Cylinders were sterilized under a UV lamp overnight, and then incubated with 0.1 mg/ml of human 
fibronectin dissolved in H2O at room temperature for one hour on a rotator.  After washing the 
cylinders three times with DPBS at five minute increments, neonatal rat cardiomyocytes (Lonza) 
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were thawed and carefully resuspended drop-by-drop (to avoid osmotic shock) in Rat Cardiac 
Myocyte Cell Medium (Lonza) supplemented with 5-bromo-2'deoxyuridine in order to prevent 
fibroblast proliferation.  80% of the media was replaced after 4 hr to remove dead cells, and 
thereafter if necessary 50% of the media was replaced every 72 hr.  8 x 105 cells/vial were incubated 
with the cylinders and rotated for various times in a 5% CO2 incubator at 37
oC, after which they 
were transferred to a 24-well plate for the remainder of the experiment.  In some trials, 24 hours 
before imaging/filming via confocal microscope, 1 µmol/L of aldosterone dissolved in ethanol was 
added to the media in order to enhance cardiomyocyte beating.  Some samples were stained with 15 
µM of CellTracker Green CMFDA for 1 hr before imaging.  Some samples were also fixed in 4% 


















Preliminary work was done with biphasic PLGA fibers, with one phase functionalized with acytalene 
for copper-catalyzed Huisgen’s 1,3-dipolar cycloaddition (referred to as ‘PLGA/PLGA-acetylene’).  
However, PLGA is too stiff of a material for cardiomyocytes to bend, as PLGA is a relatively 
inflexible material30.  Previous work indicated that poly(L-lactide-co-caprolactone) (PLCA or PLCL) 
was far more flexible, and that blended with PLGA could result in materials less stiff than pure 
PLGA, but with better tensile strength than pure PLCL31.  Pure PLCL microcylinders however were 
observed to deform during cell culture (performed at 37°C for multiple days).  In addition, there was 
a desire to avoid using copper as a catalyst as copper is cytotoxic to cells32.  Thus, the fiber 
composition was changed.  While still biphasic, one phase is now a blend of PLGA and PLA 
(polylactic acid)-COT (cyclooctyne), while the other phase is pure poly(L-lactide-co-caprolactone) 
(PLCL).  As discussed earlier, COT can undergo a strain-promoted azide-alkyne cycloaddition 
reaction similar to 1,3-dipolar cycloaddition, except a copper catalyst is not required32.    Biphasic 
PLGA/PLCL fibers were measured to have far greater elasticity and lower Young’s moduli than 
fibers composed of pure PLGA (data not shown)29.  Microcylinders made from PLGA-PLA-
COT/PLCL were subsequently picked as the ideal substrate for a cardiomyocyte bioactuator.  These 
microcylinders maintained their shape after incubation at 37°C for several days, while microcylinders 
composed of pure PLCL slowly seemed to deform and melt (data not shown).  For the initial 
experiments with bovine serum albumin and NIH3T3 fibroblast incubation, we use a slightly 
different formulation that does not include PLCL, as we do not need the added flexibility of this 
polymer for those projects.  For the bovine serum albumin incubation experiments, we used 
microfibers and microcylinders composed of 30% w/v PLGA and 30% w/v PLGA + 9% w/v 
COT-PLA.  For the NIH3T3 fibroblast incubation experiments, we used microcylinders composed 
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of  30% w/v PLGA + 0.9% w/v magnetite and 30% w/v PLGA + 9% w/v COT-PLA – the 
addition of magnetite was useful for both observing and isolating the microcylinders via a magnet. 
To demonstrate that the PEGylated phase of the anisotropic fibers and cylinders effectively resisted 
protein adsorption, fibers were incubated with 200 µg/ml of Alexa Fluor 647-bovine serum albumin 
(647-BSA) for 3 hrs.  Albumin is known for being a ‘sticky’ protein that binds to a large variety of 
other materials, so it is a good control for all protein binding 33.  Fibronectin has also been 
characterized as sticky 34.  A UV-fluorescent dye (poly[(m-phenylenevinylene)-alt-(2,5-dihexyloxy-p-
phenylenevinylene)] - colored blue with the confocal microscope software) was included with the 
phase which was PEGylated to highlight the region which should be resistant to protein adsorption.  
647-BSA bound to both sides of an unPEGylated fiber (Fig. 4.5-a), as expected.  However, after 
PEG was “clicked” on using a copper-free cyclooctene (COT) reaction, 647-BSA only bound to the 
side which did not contain PEG (Fig. 4.5-b).  This result was repeated with cylinders composed of 
the same polymers and also PEGylated on the blue-fluorescent side. 
 
This same experiment was earlier performed with PLGA/PLGA-acetylated fibers, with similar 
results (Fig. 4.6). 
Figure 4.5: Confocal microscopy after 647-BSA incubation with (a) PLGA-PLA-COT/PLGA 
fiber without PEG (b) PLGA-PLA-COT/PLGA fiber with PEG (b’) PLGA-PLA-





Before using cardiomyocytes (which cannot typically proliferate, making expansion in culture 
impossible and thus necessitating a newly purchased stock for each experiment), the fibers and 
microcylinders were tested for single-compartment cell selectivity using NIH3T3 fibroblasts.  The 
NIH3T3 fibroblast line was derived from mouse embryonic tissue by Todaro and Green in an effort 
to establish new cell lines - they spontaneously became immortalized and are now a model fibroblast 
cell line 35.  They grow quickly, are hardy, and have simple media requirements (DMEM + 10% calf 
bovine serum).  Cells were first cultured with fibers taped across PEGMA-coated glass slides 
(PEGMA prevents unwanted cell adhesion to the bottom of the well plate, which otherwise due to 
surface area would outcompete the fibers for cells).  This was done to confirm the cell-selectivity of 
the jetted material, before moving on to the more complicated culture with microcylinders.  When 
cultured with PLGA/PLGA-acetylene fibers clicked with PEG and subsequently incubated with 
fibronectin (100 µg/ml in H2O for 1 hr at room temperature), they demonstrated some moderate 
 
 
Figure 4.6: Confocal microscope demonstrating selectivity of PEG-modified PLGA fibers to 
protein adsorption. (a) PLGA/PLGA-acetylene fiber without PEG, (b) Alexa Fluor 647-BSA 
present on both sides, (c) compilation image, (d) PLGA/PLGA-acetylene fiber with clicked 
PEG on blue-stained side, (e) Alexa Fluor 647-BSA only attached to phase lacking PEG 
(stained green), (f) compilation image (experiment performed by Dr. Jaewon Yoon) 
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selectivity for the nonPEGylated side, though there were examples where cells were still found 
bound to the PEGylated side (Fig. 4.7).   
However, NIH3T3 fibroblasts incubated with PLGA-PLA-COT/PLGA microcylinders were 
incredibly side-specific (Fig. 4.8).  It was found that rotating the NIH3T3 cells first in an Eppendorf 
tube with the cylinders for five hours, followed by depositing them onto a static well plate with a 
PEGMA-coated glass substrate bottom covering (to prevent fibroblast adhesion to the well plate 
surface) lead to optimal cell attachment.  Almost all the cells were found bound to the side 
PEGylated, with only a minimal number of contrarian counterexamples.  Magnetite (a natural 
mineral composed mainly of iron oxides such as Fe3O4)
36 was added to the PLGA phase in order to 
provide further contrast for microscopy, and to create an easy method for isolating microcylinders 
when they were suspended in solution by simply pulling them to the wall of the Eppendorf tube 
with a powerful magnet (very useful when washing them after fibronectin incubation, or media 
changes).  While not exploited further in this thesis, this incidentally leads to the creation of 
anisotropic magnetic cell transporters or building blocks, which in theory could be manipulated with 
 
Figure 4.7: Confocal microscope demonstrating selectivity of PEG-modified PLGA fibers to 
cell adhesion (a) PLGA/PLGA-acetylene fiber without PEG incubated with NIH3T3 
fibroblasts; note that cells readily attach to both sides (b) PLGA/PLGA-acetylene fiber with 
PEG; now cells are specific to one side (c) PLGA/PLGA-acetylene fiber with PEG and cells 
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magnetic fields to move to a particular place and be isolated (perhaps for further experiments on 
individual cells), or to assemble a structure.  
 
Upon successful selective attachment of NIH3T3 cells, PLGA-PLA-COT/PLCL microcylinders 
were incubated with neonatal rat cardiomyocytes (purchased from Lonza). Cardiomyocytes cannot 
normally divide in culture (though there exist the immortalized line HL-1 which can divide and 
continues to spontaneously contract, these are difficult to obtain), so these experiments were 
performed with a fresh vial of cardiomyocytes each time37.   We continued to incubate our 
microcylinders in fibronectin in order to attach cardiomyocytes, though laminin has also been used14. 
 
Figure 4.8: Confocal microscope demonstrating selectivity of PEG-modified PLGA-PLA-
COT/PLGA microcylinders to cell adhesion (a) PLGA-PLA-COT/PLGA microcylinders 
without PEG incubated with NIH3T3 fibroblasts; cells readily attach to both sides (b) PLGA-




Cardiomyocytes were first allowed to rotate with the cylinders for 8 hours, and then were deposited 
onto well plates with PEGMA substrates (to prevent unwanted attachment) for 16 hours before 
imaging. As shown in Fig. 4.9, cardiomyocytes prefer to attach to the non-PEGylated side on 
PEGylated cylinders (Fig. 4.9, a-e), while on non-PEGylated cylinders cardiomyocytes may be 
observed binding to either side (Fig. 4.9, f-j, especially Fig 4.9-g).  Of course, there were 
counterexamples present as well (see Fig. 4.9, c), but overall this pattern held for the majority of 
cylinders observed. Generally, there were fewer cells on the blue-stained side even when not 
PEGylated, in comparison to the NIH3T3 experiments.  As expected, the cardiomyocytes would 
spontaneously contract on the microcylinders. 
It became apparent that the amount of time we allowed cells to incubate on the rotator versus on a 
static well plate needed to be optimized.  We cultured cardiomyocytes with PEGylated PLGA-PLA-
COT/PLCL cylinders and rotated them for 24, 48, and 72 hr.  The 24 hr sample was then incubated 
in a well plate for 48 hr, the 48 hr sample in a well plate for 24 hr, and the 72 hr sample was not 
 
 
Figure 4.9: Microcylinders cultured with cardiomyocytes.  PEG (when present) is on the blue 
side.  Cells primarily attach to the non-PEGylated side on PEGylated cylinders (a-e), while on 
non-PEGylated micocylinders (f-j) cells can be observed attaching to either side more often.  
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incubated at all in a well plate.  In this experiment, cardiomyocytes were stained with 15 µM of 
CellTracker Green CMFDA for 1 hr before imaging, in order to better differentiate them from the 
other components present in the media. 
Cardiomyocytes rotated for 24 hr and incubated on well plates for 48 hr (Fig. 4.10-a) showed the 
highest amount of cell attachment, with cardiomyocytes often forming large aggregates of cells on 
the microcylinders.  These aggregates were commonly observed through all experiments, and would 
often beat.  Cardiomyocytes rotated for 48 hr and incubated on well plates for only 24 hr still 
showed cell adhesion to the microcylinders, but it was overall lower than that for the 24 hr 
rotated/48 hr well plate samples with far fewer aggregates.  Cardiomyocytes rotated for 72 hr with 
no subsequent well plate incubation were mostly found still suspended in the media and completely 
unattached to the microcylinders, with a few exceptions.  Thus, it seems that by varying the time 
spent rotating versus the time spent in an incubator, we can control and optimize the amount of cell 
adhesion and aggregation on our microcylinders. 
Beating frequency and contractile force was found to be further optimized by the addition of 1 
µmol/L aldosterone 24 hours before inspection – aldosterone has been previously demonstrated to 
 
Figure 4.10: Cardiomyocytes (a) rotated for 24 hr and incubated in a well plate for 48 hr, (b) 
rotated for 48 hr and incubated in a well plate for 24 hr, and (c) rotated for 72 hr with no 
subsequent well plate incubation 
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raise neonatal rat cardiomyocyte’s beating frequency38.  Cardiomyocytes were rotated for 8 hr, then 
transferred to a well plate and allowed to incubate for roughly 72 hours before imaging.  We took 
many movies via confocal microscopy to observe the cardiomyocytes beating, in an attempt to 
capture one bending a microcylinder and thus functioning as a bioactuator.  After finding one, we 
analyzed it using software to determine the extent of bending (Fig. 4.11). 
 
By fixing the bottom left corner of the cylinder and looking at the movie frame-by-frame, we could 
measure the extent of displacement performed by the cardiomyocytes.  The cylinder’s upper 
displacement was nearly double that of its initial starting point.  With fixing the bottom to estimate 
the amount of displacement by the top, the stress can be modeled like that for a micropillar, which 
has been worked out by Tan et al. (Fig. 4.12)39.  This equation assumes that the cells bending the 
microcylinder are concentrating their force on the top, which is not entirely true – nevertheless, it is 
 
 
Figure 4.11: Cardiomyocytes after rotation and well plate incubation bending a microcylinder 
(figure by Dr. Jaewon Yoon, modified)29 
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a reasonable first approximation, and the force needed to bend it from the sides would be even 
higher according to Tanaka et al. 23.   
 
Here, L is the length of the microcylinder, I is the geometric moment of inertia (here πd4/64 for a 
bending bar, where d is the diameter of the microcylinder,)24, δ is the cylinder’s upper displacement, 
and E is the Young’s modulus of the microcylinder39.  We measured E to be 476 ± 31 MPa, L is 
78.5 µm, d is 20 µm, I is 7.854 x 10-21 m4, and δ is 8.25 µm.  The following equation is then used to 
calculate the force of displacement39: 
   
   
  
   
From this, we get a total force of 191 ±12 µN.  This is very large in comparison to those measured 
for other bioactuators, but not surprising given that our biomicroactuators have a far greater number 
of cardiomyocytes tethered in comparison.  For example, Akiyama’s dorsal vessel tissue robot 
exerted a force of 4.7 µN for bending of their microcylinders (though they were calculating the 
contracting force at the center of the pillar rather than the top)24.  Tanaka’s peg micropillars were 
bent with a force of 3.8 µN, which is unsurprising given that they only have one or a few 
cardiomyocytes attached 23.  Nishimura et al. averaged the amount of force generated by a single 
 
Figure 4.12:  Model for calculating the amount of force needed to bend a micropillar (reprinted 
with permission from Tan et al.)39 
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adult rat cardiomyocyte (with a population of 18 measured) with isometric conditions as 5.720 ±0.41 
µN  40.  Visual inspection of the cylinder reveals there are ~ 26 cardiomyocytes attached (this is a 
rough figure), giving them an average individual force of ~7.3 µN.  This is not too far from the 
forces measured by Nishimura et al. for a single cardiomyocyte.  Unfortunately, the number of 
experiments undertaken with the aldosterone added was limited, and we could only isolate this single 
cylinder in film for analysis.  Clearly, more experiments are necessary for further analysis and 




















Conclusions and Future Work 
Bioactuators are a novel idea for confronting some of the issues that face traditional bioactuators.  
As shown by several previous groups, material anisotropy can be very important for creating a 
functional bioactuator.  We have successfully used EHD-cojetting to create a biphasic fiber to which 
cells are selective for only one side.  While Mandel et al. have accomplished this as well, we took it a 
step further by also developing key protocols for attaching our cells to microcylinders created via 
microtoming and rotation culture22.  In essence we created a sort of magnetized cell carrier, which in 
itself is an accomplishment.  Finally, we cultured these microcylinders with neonatal rat 
cardiomyocytes, and while we need to further optimize our protocols for creating successful 
microcylinder-cardiomyocyte hybrids that bend, we were able to isolate and take video of one 
actuating.  This is one of the smallest free floating bioactuators that has been developed by any 
group.  The force generated by our bioactuator was measured to be much higher than that of those 
previously reported in the literature, chiefly due to the far larger number of cardiomyocytes present 
in comparison.  All three hypotheses posited have been supported by the experiments performed 
herein. 
For future work, as previously pointed out further experiments are needed to optimize and continue 
to observe other cardiomyocytes bending our cylinders.  Furthermore, it would be a good idea to try 
other compounds to further stimulate beating force and frequency – while aldosterone worked well, 
compounds such as epinephrine could also be used (Baar et al. measured that application of 
epinephrine to a culture of cardiomyocytes increased force production by 253 ± 58%)41.  It is true 
that not every PEGylated fiber and microcylinder was cell selective, but after optimization the 
majorities observed were.  It would be beneficial to optimize this further.  Finally, other contracting 
cell types previously mentioned such as C2C12 could be used in addition to cardiomyocytes – 
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skeletal muscle may be preferable as it does not spontaneously contract and is thus easier to control 
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We use three-dimensional PLGA grid scaffolds to induce the formation of cell sheets.  These 
scaffolds are constructed using electrohydrodynamic co-jetting and a programmable x-y collection 
stage.  In the Introduction and Background, we examine how others generate cell sheets and their 
relative importance to the field of tissue engineering.  The cell sheets currently created lack 
mechanical robustness, making it difficult to shape them into higher ordered structures (other than 
simply stacking them atop one another).  We propose generating cell sheets that contain a PLGA 
grid, making them less flimsy and easier to manipulate by comparison to other cell sheets.  We 
demonstrate this technology with a series of cell lines, beginning with fibroblasts and concluding 
with mesenchymal stem cells and keratinocytes.  We examine such things as extracellular matrix 
protein deposition, dynamic gross cell morphology and organization as they form the sheets, and use 
co-culture techniques to create a keratinocyte sheet that otherwise would not form easily.   
 
Introduction and Background – Tissue Engineering 
 
As the name suggests, tissue engineering proposes the creation of designed functional tissue de novo 
and ex vivo for use in a clinical setting (potentially for repairing injured or diseased tissue, or even 
completely replacing a dysfunctional organ), or for better in vitro assays than 2D culture1.  Given that 
allogenic sources for organs can be on short supply, the ability to recapitulate these tissues for 
patients would be a very powerful tool for medicine2.  Native tissue is composed of a variety of cells, 
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structural proteins/proteoglycans/glycosaminoglycans/connective proteins/etc. that make up the 
extracellular matrix, and a vast number of proteins and small molecules that regulate the cells within 
3.   The ECM is particularly important as it gives tissue its mechanical properties and serves as a 
scaffold onto which cells can attach while also playing an active role in regulating them through 
mechanotransduction and serving as a reservoir for growth factors 2-4.  The current paradigm for 
tissue engineering is then creating microenvironments which are composed of cells, a scaffold of 
some sort, and growth factors (Fig. 5.1); furthermore, how cells interact with each other, their 
scaffold, and the growth factors present greatly dictates the viability and behavior of the overall 
tissue construct 5.   
 
There are several important parameters when it comes to creating scaffolding for tissue engineering, 
and each must be optimized depending on the type of tissue being engineered.  These include 
biocompatibility, geometry (i.e. the design of the structure needs some porosity for nutrient 
transport), and material properties such as stiffness/mechanical strength/flexibility/etc.6.  It is also 
often desired for scaffolds to eventually degrade as the implanted engineered tissue creates its own 
matrix after surgery and becomes incorporated into the native tissue surrounding it7.  The ability to 
promote cell adhesion and surface area can also be important parameters as well7.  Collagen is often 
 
Figure 5.1: A conceptual framework for tissue engineering.  Interactions between cells themselves 
(1), growth factors present (2), and their matrix (3) dictate outcome behavior 
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used for creating scaffolding for tissue engineering, thanks to its biocompatibility and porosity8.   
The carbohydrate chitosan has also been used for creating scaffolds used to generate cartilage in vitro 
– like other materials, it was selected partly due to its biocompatibility and ease in processing9.    
There are advantages in creating scaffolds from a predetermined design –one can specify exactly the 
desired mechanical properties/architecture/etc. using a large array of available natural and synthetic 
materials (primarily biocompatible and biodegradable polymers such as PLGA) 6, 7.  Artificial 
materials have the advantage of being more customizable than natural structural proteins like 
collagen to the particular mechanical and microstructural needs of the engineered tissue, given that 
they are completely chemically defined and can be fine-tuned via functionalization or surface 
modification to alter how cells behave when attached to them6.  PLGA is a common synthetic 
polymer which degrades into harmless lactic and glycolic acid – it is popular partly because of its 
approval by the FDA for implantation in people7, 10.   PLGA also has other properties that make it 
appealing – it is a stiff material that is still easy to shape, and can be made very porous through 
several techniques (such as room-temperature compression molding/particulate leaching)10.  
Furthermore, its mechanical properties and rate of degradability can be tuned by adjusting the ratio 
of lactic to glycolic acid groups in the polymer (for example, increasing the amount of glycolic acid 
groups in PLGA will increase the degradation rate)10.  Huang et al. used PLGA to create a scaffold 
embedded with poly(β-hydroxybutyrate-co-β-hydroxyvalerate) (PHBV), which was then seeded with 
hMSCs11.  Cartilage-like engineered tissue has also been created using a PLGA-collagen hybrid 
scaffold seeded with hMSCs which were subsequently incubated in chodrogenic differentiation 
media12.  These and many other examples demonstrate that PLGA is a widely used biomaterial for 
scaffolding able to host a large variety of cells.  Other artificial materials used for tissue engineering 




Electrospinning has been heavily exploited for constructing scaffolds, given its ability to form 
meshes that have similar features to extracellular matrices16, 17.  Many electrospun scaffolds are a 
matting of randomly oriented fibers, which cells are then seeded18.   Yoshimoto et al. jets a randomly 
distributed PCL scaffold onto which they culture hMSCs that they go on to differentiate into 
osteocytes, while Shalumon et al. electrospins a blended scaffold of carboxymethyl chitin/poly(vinyl 
alcohol) (CMC/PVA) also for hMSC seeding 18, 19.  The random orientation of the fibers can be seen 
in Fig. 5.2.  This can be an advantage, as it allows for the creation of a highly porous material that 
has a thickness on the order of hundreds of nanomaters and a high surface area18-20.    
 Melt electrospinning has also been used to create scaffolds for tissue engineering21, 22.  Brown et al. 
was able to create patterned grid scaffolds from stacks of poly-(ε-caprolactone) (PCL) using melt 
electrospinning and a movable x-y stage – the resulting scaffolds could be composed of stacked 
fibers or a weave 21.  Tubular PCL scaffolds for bone tissue engineering were also generated using a 
similar technique (except with a rotating collector) – Brown et al. then cultured osteblasts on these 
scaffolds and demonstrated their ability to support the proliferation of cells 22.  While melt 
electrospinning does not require (potentially toxic) solvents, it has several disadvantages in 
comparison to electrohydrodynamic jetting – it normally requires high temperatures (which can 
 
Figure 5.2: (a) PCL scaffold jetted by Yoshimoto et al, and (b) CMC/PVA scaffold jetted by 
Shalumon et al (figures used with permission by Yoshimoto et al. and Shalumon et al.)18,19 
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degrade the polymer or any drugs loaded into it for later release), and has only been performed with 
a limited number of polymers (listed by Hutmacher et al.) 23, 24.    
Furthermore, scaffolds created via EHD-cojetting can be made multicompartmental and 
functionalized for further modification with proteins or peptides or other biomolecules (as discussed 
earlier) – as of the writing of this thesis, the author could find no examples of multicompartmental 
fibers generated by melt electrospinning in the literature25.  Recently a collaborator set out to 
develop a similar technique for creating geometrically defined scaffolds à la Brown et al. (i.e. through 
the use of a movable x-y stage), except using EHD jetting instead of melt electrospinning. As before, 
instead of a rotating drum that simply collects the fibers, a stage moves at precise intervals 
(programmed via MATLAB) while the jet is descending from its Taylor cone.  Thus, the jet deposits 
on the surface of the stage in a pattern.  Furthermore, that pattern could be repeated, resulting in a 
stacked three dimensional structure (Fig. 5.3, b-d).  A ring electrode was necessary in order to 
stabilize the jet.  We used this apparatus to create PLGA stacks, in which the fibers were laid on top 
of one another in a continuous pattern (Fig. 5.3, b-d).  While nearly any stacked geometric shape can 
be created with the right MATLAB program, the first was a simple square grid pattern, with each 
square having a side length of 750 µm.  PLGA was chosen because of its mechanical strength and 
biocompatibility, along with a lack of brittleness (a PLGA scaffold created with this method can be 
easily manipulated with forceps, and rolled up into a tube or any other shape without breaking the 
fibers).  This scaffold was created in order to produce intact sheets of cells that can be mechanically 




Cell Sheet Engineering 
Tissue architecture can be conceptualized as a hierarchy in complexity, as Atala et al. propose26. The 
bottom of this hierarchy is the flat cell sheet, followed by rolling this structure into a tube shape for 
the simple transport of fluids such as blood (which feature two layers of cells with one acting as a 
barrier and the other acting as supportive tissue), then the formation of hollow shapes (like spheres 
or cylinders such as the stomach), and finally solid tissues and organs like the brain26.  Thus, there 
has been a recent focus on engineering cell sheets for clinical applications, as they form a basic unit 
of tissue architecture and could be used like building blocks to create more complicated tissue 
shapes.   
One method of creating cell sheets was developed by Teruo Okano at the Tokyo Women’s Medical 
University.  His group developed a method for isolating sheets of cells from 2D culture intact, along 
with their extracellular matrix without using any sort of proteolysis (e.g., trypsin)27.  Furthermore, it 
requires no scaffold to support the sheet, as Okano et al. worried about the chances of it causing 
infection28.  Instead, they grew the cells on a poly(N-isopropylacrylamide) surface (PIPAAm), which 
 
Figure 5.3: (a) Movable stage and ring electrode apparatus for controlled electrohydrodynamic jetting.  
(b-d) Various SEM images of stacked PLGA grid scaffolds (scale bars are 100 µm for b and c, 1 mm 
for d) (cartoon in (a) by Jacob Jordahl) 
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has a tunable wettability depending on the temperature29.  At temperatures below 32°C it shows a 
low contact angle (and is thus very hydrophilic), but above this temperature the surface rapidly 
becomes hydrophobic (this has to do with changes in the chain conformation which directly 
controls the level of hydration)29.  When the surface is placed in a cooler temperature and becomes 
hydrophilic, the cells growing on top of it will detach as complete sheets along with their 
extracellular matrix (Fig. 5.4)27, 30.  These cell sheets can be used as is, or layered on top of each other 
to create thicker tissues – more complicated tissues can be generated by layering different cell lines 
on top of one another as well27.  Okano et al. have successfully generated sheets composed of many 
types of cells, ranging from cardiomyocytes to bone, all without requiring any sort of premade 
scaffold 28, 31-36.  Multilayered sheets of corneal epithelial cells generated with this method were 
transplanted into a ocular-injury rabbit model (via keratectomy), and successfully regenerated the 
cornea28.  In order to mechanically lift and transport the relatively flimsy cell sheets, a PVDF donut-
shaped membrane was applied to the cell sheets before they were harvested, which allowed the 
sheets to be easily moved via forceps28. 
 
 
Figure 5.4: (a) General process used by Okano et al. to detach cell sheets from PIPAAm in order 
to harvest cell sheets, which can then be layered on top of one another (either in mono or co-
culture). (b) A single sheet of smooth muscle cells created by this method; (c) five sheets of smooth 
muscle cells stacked on top of each other (figure modified with permission from Yang et al.)30  
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Other co-culture sheets created include stacking sheets of myoblasts onto a culture of endothelial 
cells using a complicated system whereby the myoblast sheet is released from a surface via PIPAAm 
and cold temperature, then harvested with a gelatin stamp, which is then placed on top of a layer of 
pre-grown HUVECs (the gelatin is subsequently removed, leaving behind only a top layer of 
myoblasts) – these are then allowed to incubate together34.  They observed that the HUVECs 
migrated through the myoblast sheets and formed various shapes and networks depending on the 
myoblast sheet thickness – demonstrating how cell sheets can be used to look at fundamental cell 
biology and interactions between two distinct populations34.  The gelatin stamp was likely used 
because handling the cell sheets otherwise appears to be difficult, as they are very thin.  A similar 
gelatin stamp manipulator was used to stack endothelial cell sheets on top of hepatocytes in co-
culture31.   
There are alternative methods for reliably creating a multi-cell stack.  Ito et al. tethered magnetic 
particles to heptaocytes and feeder NIH3T3 cells with a cationic liposome containing magnetite37.  
They could then be cultured on a low-cell adhesion surface via an underlying magnet which would 
provide the necessary force the cells need to attach and spread - the cells could then easily be 
detached by removal of the magnet after they form confluent sheets37.  
Ito et al. were able to generate well defined layers of hepatocytes and feeder NIH3T3 cells (Fig. 5.5) 
 
Figure 5.5: NIH3T3 and hepatocytes tagged with magnetic particles sequentially layered onto a 
magnetic surface, creating an ordered stack of cells that can clearly be observed via confocal 
microscopy (modified and reprinted with permission by Ito et al.)37  
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with this method, and showed that hepatocytes would secrete more albumin when co-cultured with 
the fibroblasts37.  This represents another scaffold-less technique for creating cell sheets – but yet 
again the sheets themselves are thin (and can even be seen to crumple in their figures after being 
manipulated with forceps).  Matsusaki et al. created 3D co-cultures of cell sheets in a microwell plate 
via inkjet printing, printing each cell one at a time38.  This ‘bottom-up’ approach is commonly 
advocated for by other biomedical scientists, and allows for precise construction of all sorts of 
complicated cell arrangements in a layer-by-layer fashion – all with no pre-constructed scaffold 
required39.   Matsusaki et al. would first print a bottom layer of cells, then a layer of fibronectin and 
gelatin, then another layer of cells – slowly building up a de novo tissue for use in assays that require 
more physiologically relevant models than 2D cell culture38.  Using this technique, Matsusaki et al. 
generated multiple layers of C2C12 cells, and hepatocytes layered with HUVECs38. 
Cell sheets have also been generated with scaffolds before, particularly in the work of Jennifer Lewis 
at Harvard University.  Lewis et al. created a grid-like silk fibroin scaffold by 3D direct ink writing 40.  
Through extrusion (rather than electrospinning), the scaffolds were generated layer-by-layer through 
a programmable movable nozzle, and then cultured with hMSCs that were differentiated into 
chondrocyte-like cells (Fig. 5.6) 40.  These cells seem to form sheets (Fig. 5.6-C) that span across the 
grid, though they are relatively small squares (~100 µm sides).  This suggests that similar sheets of 




Sun et al. later used the same technique to generate silk/hydroxyapatite grid scaffolds – as 
hydroxyapatite is the mineral found in bone, it was felt that these could potentially be ideal for 
osteogenic tissue engineering41.  Shepherd et al. created poly(2-hydroxyethyl methacrylate) hydrogel 
grid scaffolds through a direct-writing method to grow networks of hippocampal neurons42.  In all 
three examples, cells grew on grid scaffolds and could span across the squares, though only Sun et al. 

















Figure 5.6:  (a)  SEM of extruded silk fibroin scaffold; (b) close up of the scaffold with 
differentiating hMSCs, and (c) actin immunofluorescence of differentiating hMSCs, showcasing the 
formed cell sheets (modified with permission by Ghosh et al.)51  
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Rationale, Project Goals, and Hypotheses 
 
The work of Okano, Matsusaki, and Lewis has all advanced the field of cell sheet engineering 
significantly.  However, each has disadvantages which need to be addressed.  The sheets created by 
Okano have little to support them beyond the extracellular matrix created by the sheets themselves, 
likely making them difficult to handle with a pair of forceps – gelatin stamps, PVDF donut 
membranes, and complex cell cartridges with polycarbonate membranes appear to be how they 
solved this problem, but all are somewhat complicated to use (for example, the gelatin stamps are 
custom built)28, 31.  Also, it would be difficult to shape the sheets Okano develops into higher 
architectures (such as tubes or spheres) – the most complicated structures generated are co-cultures 
of different cell sheets stacked onto one another31.    Unlike Okano, Matsusaki can precisely place 
individual cells into any sort of pattern desired, even cells of a different lineage38.  However, his 
methodology is not designed for easily removing the sheets after their generation (they are pulled off 
mechanically) – given that his goal is to create more physiologically relevant in vitro assays (rather 
than engineered tissues for clinical use), this is not surprising38.  Finally, while Lewis et al. have 
created grid scaffolds that cell sheets have been grown on, their use of silk fibroin limits their ability 
to be functionalized40.  Her scaffolds are created through simple extrusion40, and thus could not be 
made multicompartmental like those scaffolds that can be generated via EHD co-jetting. 
 
As discussed above, Jordahl recently developed a method for EHD co-jetting that uses a 
programmable x-y stage to create scaffolds from multiple layers of stacked or weaved PLGA in 
precise patterns.  A ring electrode added to stabilize the jet was a breakthrough essential for getting 
the fibers to stack on each other; the viscosity and solvent choice were also critical.   Unlike any 
other grids previously made, the fibers could be multicompartmental, allowing potentially for cell-
selectivity or enhancement of differentiation by the attachment of growth factors (Fig. 5.7).  The 
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scaffolds themselves are strong, yet flexible and easy to manipulate into multiple shapes (Fig 5.7-c), 
and can be made on the order of centimeters.  They provide a 3D culture environment for the cells 
to grow on (as opposed to the 2D platforms used by Okano).  Furthermore, unlike the work of 
Brown et al.21, these were made with EHD co-jetting rather than melt electrospinning, thus avoiding 
the disadvantages associated with that technique (such as the required high temperatures).  PLGA is 
a biocompadable and degradable material, and ideal for tissue engineering10.  Cell sheets generated 
through rotary culture on these scaffolds could be used to create complex 3D cultures in vitro for 
assay development a la Matsusaki, or potentially even used in for clinical applications. 
 
We proposed using these scaffolds to create cell sheets.  Unlike the sheets created by Okano (which 
purposefully avoid the use of scaffolding), we believe that cells grown on these scaffolds could be 
subsequently bent and shaped into a complicated 3D conformation, then potentially placed in a gel 
of collagen or Matrigel to form a complex 3D cell culture.  Furthermore, like Okano’s sheets, the 
cell sheets generated with these scaffolds can also be stacked, but unlike Okano et al. do not require 
a complicated gelatin stamping mechanism.  We also have the added benefit of making our scaffolds 
multicompartmental, though for this initial study we do not take advantage of this feature as we first 
 
Figure 5.7: (a) Confocal and SEM of biphasic PLGA grid deposited using an x-y movable platform 
and EHD co-jetting (confocal scale bar: 20 µm, SEM scale bar:  50 µm; figure by Jacob Jordahl). (b)  
Macroscopic photo of a grid scaffold, and (c) demonstration of their flexibility (scale bar – 1 cm) 
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would like to characterize and optimize the production of cell sheets on unmodified single-phase 
PLGA.  Nevertheless, it is a built in advantage that other methods lack.   
 
The general protocol for generating sheets was largely adapted from the bioactuator project 
discussed in Chapter 4 (Fig. 5.8).  We adsorbed fibronectin onto the scaffolds in order to enhance 
cell attachment (necessary for cell sheet formation), then incubated the scaffolds with a variety of 
cell lines on a rotator.  The time of incubation, cell concentration, and grid spacing were optimized 
for NIH3T3 fibroblasts, which were used as a model cell line for cell sheet formation given their 
robustness and fibroblastic morphology.  We used confocal and scanning electron microscopy to 
look at both cell/sheet morphology and the expression of various extracellular matrix proteins, as 
we believed these were important for the formation of stable and confluent cell sheets given their 
role as supportive scaffolding for other cell sheets (such as those created by Okano).  We 
hypothesized the following:  fibroblasts grown on scaffolds will form denser sheets at longer incubation times, and 
the deposition of fibronectin can be correlated to sheet formation.  We tested this hypothesis by culturing 
NIH3T3 fibroblasts with the scaffolds, then fixing them at various time points and staining for 
fibronectin via immunofluorescence. 
 
 
Figure 5.8:  General protocol for create cell sheets with stacked grid PLGA scaffolds 
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Next, we hypothesized that there is an optimal grid size, and grid sizes which are too large will fail to generate 
cell sheets.  Scaffolds of different grid spacing were created to test this hypothesis.  We also 
hypothesized that keratinocyte epithelial cells will have a difficult time forming sheets in comparison to fibroblasts 
due to their morphology.  However, they will form sheets on top of a pre-formed sheet of fibroblasts grown on the 
scaffold.  We tested this by growing NIH3T3 cells first on a scaffold, then we incubated the resulting 
sheet with keratinocytes and characterized the resulting sheet after various incubation times.  
Throughout this project, we demonstrate that we can reliably and continuously create sheets of cells 
that span across our scaffold, paving the way for a multitude of projects ranging from the creation 
of bone-like scaffolds after differentiation of hMSC sheets to other complex co-cultures such as 





























Parts of this experimental section were paraphrased from original unpublished text by collaborator 
Jacob Jordahl. 
 
Electrohydrodynamic Co-Jetting  
A jetting solution composed of 30 w/v% PLGA dissolved in 93:7 v/v% chloroform:N,N-
dimethylformamide and a polymeric fluorescent probe at a concentration of <0.01 w/v% was 
loaded into two side-by-side syringes.   Next, the solution was pumped through two side-by-side 26 
gauge needles via a syringe pump (Fischer Scientific Model 78-0100I).  An electrostatic lens 
composed of a copper cylindrical ring (5 cm in diameter and 2.5 cm tall) stabilized the jet and 
allowed it to be stacked.  A positive potential was applied using a DC power supply (Gamma High-
Voltage Research ES30P-10W), while a nominal potential of16 kV and 9kV was applied to the 
needle and the band respectively (with a needle to ground electrode distance of 5 cm). The resulting 
fibers were collected on a grounded stainless steel plate attached to an x-y moving axis (Velmex Inc.). 
The motion of the x-y axis was controlled via a proprietary programming language. After collection, 
the structures were put in a vacuum for solvent removal, and then subsequently cut via razor blade. 
 
NIH3T3 Fibroblast and hMSC Culture on Scaffolds 
The scaffolds were sterilized overnight using UV irradiation.  After this process, the scaffolds 
contained in 1.5 ml Eppendorf tubes were incubated in 100 µg/ml human fibronectin (Sigma 
Aldrich) for 1 hr at room temperature on a rotator.  These were then washed three times at five 
minute intervals with DPBS (Life Technologies, Inc).  NIH3T3 fibroblasts (ATCC) were thawed 
from liquid nitrogen and diluted to a concentration of 6 x 105 cells/ml in DMEM (ATCC) + 10% 
calf bovine serum (ATCC) at passage 6.  hMSCs (a kind gift from Dr. Paul Krebsbach) were also 
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thawed from liquid nitrogen and diluted to a concentration of 3 x 105 cells/ml. Cells were then 
seeded onto the scaffolds (1 ml/scaffold) and rotated in the incubator at 37°C and 5% CO2.  These 
were fed at 24 hr, and then every 48 hr thereafter if needed.  The scaffolds were fixed at various time 
points in 2.5% gluteraldehyde for 20 minutes, then immunostained for fibronectin with a primary 
antibody (monoclonal anti-fibronectin antibody produced in mouse, Sigma Aldrich) diluted 1:400 
and secondary antibody (Alexa Fluor® 488 Goat Anti-Mouse IgG (H+L) Antibody, Life 
Technologies) diluted to 1:400.  Collagen I was also sometimes stained for, with a primary antibody 
(Anti-collagen I antibody, rabbit polyclonal, Abcam) diluted 1:100 and secondary antibody (Marina 
Blue® Goat Anti-Rabbit IgG (H+L) Antibody, Life Technologies) diluted to 1:100.  Phalloidin 555 
(Life Technologies) was also added at a concentration of 40 µl/ml to stain actin, and TO-PRO®-3 
Iodide (642/661) at a dilution of 1:400 for nuclear staining.  Scaffolds were then imaged using a 
confocal microscope – some were then further prepped for scanning electron microscopy (SEM).  
Scaffolds were submerged in 10%, 30%, 50%, and 70% solutions of ethanol/water for 7 minutes 
each sequentially.  Then they were submerged in a 90% solution of ethanol/water for two 7 minute 
incubations, then 100% ethanol for another two 7 minute incubations.  Finally, the scaffolds were 
incubated three times at 7 minute increments with pure hexamethyldisilazane (HMDS) and allowed 
to dry overnight.  The scaffolds were then mounted on an SEM stand, sputtered, and then imaged 
using an AMRAY 1910 Field Emission Scanning Electron Microscope (FEG-SEM). 
 
Co-Culture of NIH3T3/GFP Fibroblasts and Keratinocytes 
The scaffolds were sterilized overnight using UV irradiation.  After this process, the scaffolds 
contained in 1.5 ml Eppendorf tubes were incubated in 100 µg/ml human fibronectin (Sigma 
Aldrich) for 1 hr at room temperature on a rotator.  These were then washed three times for five 
minute intervals with DPBS (Life Technologies, Inc).  NIH3T3 fibroblasts stably transfected with 
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green fluorescent protein (GFP) (Cell Biolabs, Inc) were thawed from liquid nitrogen and diluted to 
a concentration of 6 x 105 cells/ml in DMEM + 10% fetal bovine serum (FBS) + 1% L-Glutamine 
(L-Glut) + 1% Non-essential amino acids (NEAA) + 1% penicillin/streptomycin (P/S) (media and 
all from supplements Life Technologies, Inc)  at passage 2.  1 ml of the cell-media mixture was 
incubated with each scaffold, and the scaffolds were placed on a rotator in an incubator at 37 °C and 
5% CO2.  The media was replaced at 24 hr.  After 72 hr, normal human epithelial keratinocytes 
(NHEKs) (Lonza) were thawed from liquid nitrogen and diluted to a concentration of 3 x 105 
cells/ml in KGM-Gold complete media (Lonza) + 10% FBS + 1% NEAA + 1% L-Glut (Life 
Technologies, Inc.).  The cell-media mixture then replaced the media with the scaffolds, and media 
was replaced after 24 hr and then after every 48 hr.  As a control, NHEKs were also incubated with 
freshly prepared scaffolds (UV-irradiated and coated in fibronectin by methods described earlier) 
that were not previously incubated with NIH3T3/GFP cells.  At various time points, the scaffold-
cell constructs were fixed with 2.5% gluteraldehyde (Sigma Aldrich), then stained via 
immunofluorescence with a pan-keratin antibody (Pan-Keratin (C11) mouse mAb #4545) at a 




















Characterization of the scaffolds by SEM and fluorescence microscopy was first performed in order 
to demonstrate the high fidelity stacked PLGA grids generated via EHD jetting (data not shown).  
Biphasic grids were generated with co-jetting, adding a functional alkyne group to one side. 
Furthermore, other patterns were generated via changes in the MATLAB code which controls the 
movable platform.  However, for the cell experiments the grid pattern was almost exclusively used, 
and the fibers were not biphasic. 
 
We initially worked with fibroblasts to create cell sheets as they were easy to grow, robust, and 
relatively inexpensive.  A fibroblastic morphology and behavior also seemed desirable with regards 
to generating sheets, as fibroblasts tend to show a great deal of motility in culture and spread out on 
most amenable surfaces (as opposed to epithelial cells, which mostly display a ‘cobble stone’ 
morphology with less motility).  This cell motility was felt to be important for generating cell sheets.  
The scaffolds were first cultured with NIH3T3 fibroblasts for 18 hr, then stained with Cell Tracker 
(Life Technologies Inc) and Hoescht probe (Fig. 5.9).  As can be seen from microscopy, sheets 
formed over the majority of the scaffold, though there are gaps in coverage.   Scaffolds not 
incubated beforehand in fibronectin did not form sheets and had few fibroblasts attached to them 
(data not shown).  From the walls, via SEM we could observe the fibroblasts actively beginning to 




In Fig. 5.9-c, we see fibroblasts attached to both the wall of the scaffold and while also reaching out 
towards the space between the grids.  Further out, cells which are not directly attached to the 
scaffold are attached to cells which are, suggesting several possible mechanisms by which the sheets 
are generated.  First, it is possible that cells initially attached to the scaffolds will begin to protrude 
across the void, then while undergoing cell division will generate attached cells which jut out farther.  
It is also possible that cells which jut out serve as initial platforms for other cells on the scaffold to 
move across, adding another cell ‘further’ out (like a self-building bridge) until they eventually reach 
the other side.  ‘Bridges’ of cells can be seen in other images, adding weight to this hypothesis (Fig. 
5.10).  Cells were ubiquitous on the walls of the scaffolding themselves (Fig. 5.10-b).  It has been 
hypothesized that while incubating the scaffolds with fibronectin, a small sheet of it formed in 
between the grids as well as adsorbing onto them, providing some initial base to which the 
fibroblasts could reach out to and form the sheets.  However, no evidence of this sheet has ever 
 
Figure 5.9: (a) Fluorescent CLSM image overlaid with a differential interference contrast image 
showing NIH3T3 cells forming sheets on a PLGA scaffold (scale bar:  500 µm) (b)  SEM of cell 
sheet (same conditions as a, scale bar: 100 µm) (c)  Early formation of a cell sheet (scale bar: 10 µm) 
(figure by Jacob Jordahl)  
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been observed in either confocal microscopy or the SEM, even when staining for fibronectin via 
immunofluoresence.   
 
In order to delve further into this hypothesis, we next cultured NIH3T3 fibroblasts with the 
scaffolds at three different time points:  6 hr, 18 hr, and 72 hr.  Cells were stained with TO-PRO (a 
far-red stain for nuclei false colored blue in Fig. 5.11, found to work much better for z-stacks than 
DAPI or Hoescth probe, which tended to ‘smear’ in the image) and phalloidin (red).  ECM proteins 
likely play a major role in giving the cells needed support while they make sheets, so we also stained 
 
Figure 5.10: (a) Fibroblast ‘bridge’ that spans across the gridding of a scaffold (b) Even when 
not forming sheets, fibroblasts will cover the scaffold completely (c and d) Cell sheets at 
various stages of completion 
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via immunofluorescence for fibronectin (green).  After fluorescence imaging, we also imaged the 
same scaffolds via SEM. 
 
After six hours of incubation, the fibroblasts do not form any sheets, and are relatively small and not 
spread out.  In both the confocal (Fig. 5.11-c) and SEM (Fig. 5.11-d) images, clumps of the 
fibroblasts can be seen sticking to each other and the scaffold, forming grape-like clusters which are 
ubiquitous.  The fibronectin is patchy (Fig. 5.11-c) and only present on some cells, which implies 
that the extracellular matrix is still under development at this time point.  There does seem to be a 
leading edge of fibronectin on the surfaces of some fibroblasts, which can be seen via confocal z-
 
Figure 5.11: (a) Confocal micrograph of a scaffold seeded with NIH3T3 and incubated for 6 hours, 
then immuostained for fibronectin (green) along with phalloidin (red) and TO-PRO (blue) ; (b)  
Confocal of zoomed in area from (a); (c) z-stack of (b); and (d) SEM of region from (b) and (c).    
(e) Confocal micrograph of a scaffold seeded with NIH3T3 and incubated for 18 hours; (f)  
Confocal of zoomed in area from (e); (g) z-stack of (f); and (h) SEM of region from (f) and (g).    (i) 
Confocal micrograph of a scaffold seeded with NIH3T3 and incubated for 72 hours (j)  Confocal 




stack (Fig. 5.12).   We can however observe a few cells beginning to branch out towards the space 
between the grids, hinting at an eventual cell sheet. 
At 18 hours, the fibroblasts are now beginning to form sheets.  In some areas the sheets cover nearly 
half of the grid space, while in other areas we only see rope-like ‘bridges’ of cells spanning from one 
end of the grid to the other.  We took a z-stack of one of these cell bridges, and discovered that the 
fibronectin essentially wrapped around the bridge like an encasing sheath (Fig. 5.11-f and Fig 5.13). 
As Fig. 5.13 shows, the fibronectin (green) almost circles around the cells in the middle as they 
bridge out (red).  A z-stack (Fig. 5.11-f) shows that the top of the cell bridge is completely covered 
 
 
Figure 5.13: z-stack analysis of the fibroblast bridge after an 18 hour incubation 
 
Figure 5.12: z-stack analysis of the fibroblasts on the scaffold after 6 hours of incubation 
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in fibronectin.   This is strong evidence that the fibronectin (and by extension the extracellular 
matrix) plays an early key role in supporting the cells as they form nascent sheets.  This is different 
from what Hitani et al. observed when they created cell sheets of corneal epithelial cells – after 
immunostaining they saw that fibronectin was weakly present on the surface of the sheet, but 
strongly present  in between cells 43.  However, their sheets were cultured for a week on a flat surface 
before being removed – perhaps fibronectin is stronger on the surfaces of the forming cell sheet at 
earlier times.  As shown in the SEM and confocal images (Fig. 5.11-h), fibroblast morphology at 18 
hours is not as rounded like those at 6 hours, but more flattened out. 
Finally, after 72 hours of incubation the fibroblasts formed thick sheets across the entire scaffold, 
with almost no gaps in coverage present.  The cell bridges observed at 18 hr are mostly gone, 
replaced by the sheets which are now nearly ubiquitous.  The sheets are roughly 2-3 cells thick, and 
the fibronectin is now found coating one side as a sort of support (Fig. 5.14).  Fibronectin was also 
present somewhat in the intercellular region, but was not strong as observed by Hitani et al 43.  
However, we do observe that the fibronectin (and by extension the ECM) tends to form mainly on 
one side (it is difficult to delineate one side as ‘apical’ or the other ‘basolateral’ as they did not form 
on a solid structure) – this can be seen especially well with z-stack confocal microscopy (Fig 5.14-c).  
In the SEM, the cell morphology was observed to be extremely flat and spread out (Fig 5.11-l).   
Thus, it seems that 72 hr is an ideal time point for generating a confluent cell sheet layer with 
fibroblasts.  Given the results obtained from all three time points, we can correlate sheet formation 
with fibronectin deposition.   Initially, cells attach in clumps and only just begin to spread out after 6 
hours of incubation.  No sheets are present as we believe there is no underlying extracellular matrix 
yet.  The ECM is still being constructed, as evidenced by the ‘patchiness’ of the fibronectin.  At 18 
hr, we begin to see sheets at various stages of development.  The fullest sheets take up the entire 
grid, but we also find plenty of examples of half sheets and earlier cell bridges, where a fiber of cells 
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(just a few cells thick at the center) spans across the grid to attach one side to the other.  How these 
bridges form remains an open question, but one must keep in mind that theses scaffolds are kept 
rotating at all times.  It is possible that cells remaining in suspension continue to hit and attach to 
cells that are slowly probing out towards the grid space, slowly building the bridge piece by piece.  
However, we rarely find these bridges at a ‘half-way’ point (it’s possible that the ones we do see are a 
result of breakage during handling for microscopy) – they always are found already spanning the grid, 
suggesting that this action occurs quickly and likely involves cells from both sides of the spanned 
area.    
At 18 hr, the fibronectin covers the entire thickness of the cell bridges as they thrust across the grid, 
providing essential support for the cells as they span with no solid substrate underneath.  We 
hypothesize that the half sheets and full sheets are likely then generated by cell proliferation; this 
 
 
Figure 5.14:  NIH3T3 fibroblast sheets immunostained for fibronectin (green) after 72 hr of 
growth (a).  Side-slice of the confocal image in (b); (c) side slice of the confocal image in (d) 
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could be confirmed with live-cell confocal microscopy and NIH3T3/GFP cells, though the 
scaffolds would need to be removed from rotation after a set period of time so for the remainder 
they could be dynamically observed.  It is clear that cell proliferation plays a role given the extent of 
cell sheet coverage present at 72 hr – the media is changed at 24 hr, so any non-anchored cells from 
the initial seeding would be removed by then.  Thus, the other cells most likely come from cell 
division.  Finally, at 72 hr the fibronectin appears to primarily coat one side of the cell sheet, though 
it is present intercellularly and on the other side too.  This polarity is only evident with fully-formed 
sheets.  Now fully formed, the fibroblasts seem to show the usual polarity cells display when 
arranged as sheets.  The ECM serves as a base to support the sheets as they continue to proliferate.  
We can see that the sheets are as two or even three cells thick in some areas (Fig. 5.14), though other 
areas of the sheet are only one cell thick.  Thus, as the fibronectin changes where it is deposited over 
time, the cells go from clumps adhered to a scaffold, to small bridges which span across a grid, to 
full sheets that are confluent across the entire scaffold.  Furthermore, we measured the number of 
fibroblasts after 72 hr of confluent growth to be 7.4 x 104 cells/scaffold (with the dimensions of the 
scaffolds as 3 mm x 3 mm).  
 
We also incubated fibroblasts with the scaffolds for 15 days as a long-term culture, in order to see if 
the cells would survive and continue to thrive as sheets.  We wanted to know if the cell sheets would 
become any thicker than those observed after 72 hr of culture.  We used an NIH3T3 line that was 
stably transfected with green fluorescent protein (GFP) (Cell Biolabs, Inc) which will be titled 
NIH3T3/GFP for the rest of this thesis.  Cells were incubated with the scaffolds for a full fifteen 
days, with the media first changed post 24 hr after seeding, and then regular media changes every 48 
hr. The cells formed confluent sheets that were not any thicker than those observed with 72 hr of 
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culture (Fig. 5.15).  The scaffolds also remained very intact with only minor warping, showing the 
robustness of their construction despite over two weeks of submersion in media at 37°C. 
The role of the scaffold size in cell sheet formation was also tested.  In addition to the 750 µm grid 
sized scaffolds previously used to generate NIH3T3 sheets, we also tested scaffolds with a 500 µm 
and 1500 µm sized grid.  Based on previous work, we looked at scaffold development at both 18 hr 
and 72 hr.  The 500 µm sized grid scaffolds had multiple sheets in formation at 18 hr just like the 
750 µm grids, and were completely confluent by 72 hr (Fig. 5.16).  In contrast, at 18 hr the 1500 µm 
sized grid scaffolds showed no cell sheet formation at all.  By 72 hr, they had sufficiently warped 
enough in culture to allow some sheets to form – nevertheless they were nowhere near confluent 
like those seen on the 750 µm and 500 µm scaffolds.  Thus, it seems that the geometry of the 
scaffolds plays an important role in cell sheet establishment.  Also, the larger 1500 µm grid sized 
scaffolds tended to more easily deform in culture than the 750 µm.  Deformation to some extent 
occurs with all scaffolds due to continual shearing by the media under rotation and the forces the 
cell sheets exert as they grow.  However, the 1500 µm scaffolds were observed to undergo far worse 
deformation than the other sizes, showing the importance of mechanical rigidity in design. 
 
 
Figure 5.15:  NIH3T3/GFP fibroblast sheets on a scaffold after 15 days of continuous rotation 




Given the success of generating fibroblast cell sheets, we decided to branch out to other cell types 
that are more physiologically interesting than NIH3T3.  We first cultured hMSCs on the scaffolds 
for 72 hr to generate fully confluent sheets.  As the importance of fibronectin became apparent, we 
also examined collagen I expression via immunofluorescence.   Collagen provides tensile strength to 
extracellular matrices (while fibronectin provides a cell attachment anchor), so we thought it would 
be interesting to see if we could view its formation on hMSC sheets. 
 
After 72 hr, the hMSCs form confluent sheets of across the scaffold.  A confocal z-stack shows that 
while the cells are very flat one side of the sheet, the other side shows an almost chaotic frenzy of 
 
 
Figure 5.16:  NIH3T3 fibroblast sheets on a 500 µm grid-sized scaffolds for (a) 18 hr and (b) 72 hr.  
1500 µm grid-sized scaffolds were also tested at (c) 18 hr and (d) 72 hr (figure by Jacob Jordahl) 
142 
 
hMSCs reaching into the space above them as if to branch out further.  This was not observed with 
the fibroblasts.   
 
The collagen is easy to distinguish as long fibers that appear almost cagelike around the cells (dark 
blue, Fig. 5.17-b, d, e).  This is precisely what we hypothesized collagen would look like on cell 
sheets.  The fibronectin can also be seen as almost fiberlike (especially in Fig. 5.17-b) on the hMSCs.  
The relative ease with which hMSCs form sheets on scaffolds was not particularly surprising, given 
their fibroblastic morphology and the success we had with NIH3T3 cells earlier.  Nevertheless, it is 
an important first step in potentially creating scaffolds of bone-like or cartilage-like cells. 
We next attempted to create sheets of keratinocytes, as skin tissue engineering is a major area of 
biotechnology44.  Products such as Apligraf and Permaderm are already on the market for use in 
 
Figure 5.17:  (a) hMSCs grown on a scaffold into a confluent sheet after a 72 hr incubation (b, d, e) 
Immunofluoresence of collagen (dark blue) and fibronectin (green), (c, f) z-stacks of two sides of 
the same hMSC sheet 
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chronic skin wounds and burns, respectively 44.  As our scaffolds are sheetlike (like skin), we thought 
it was a natural area to explore.  We first attempted to grow NHEKSs (normal human epithelial 
keratinocytes, a primary cell line) by themselves on scaffolds for 72 hr, as that time point had 
previously given us confluent sheets of fibroblasts.  Like the fibroblasts, we immunostained the 
NHEK cells for fibronectin, and counter stained with phalloidin and TO-PRO. 
 
Unfortunately, the NHEKs did not form anything like a confluent sheet, and most of the spaces 
between the grids were devoid of cells, though the keratinocytes readily attached to the scaffolding 
itself (Fig. 5.18-a).  However, there were a few isolated areas where sheets were present, and with z-
stacking we saw that the keratinocytes retained their epithelial morphology (‘cobblestone’) (Fig. 5.18-
b).  The sheets formed were no thicker than those formed by fibroblasts, and the fibronectin 
appeared to be on the surfaces of the cells as seen earlier (Fig. 5.18-b).  Encouraged, we next tried a 
 
Figure 5.18:  (a) Scaffold incubated with NHEKs for 72 hr (b) z-stack showing the top and (c) side 
of NHEK sheet 
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different strategy.  Previous work suggested that NHEKs co-cultured with fibroblasts could be 
beneficial45, 46.  Rheinwald et al. documented one of the first instances of keratinocyte/fibroblast co-
culture in 1975, by mixing irradiated NIH3T3 cells (the irradiation prevents further proliferation of 
the fibroblasts while allowing them to maintain their supportive role) with keratinocytes from 
foreskin47.  They were subsequently able to culture human keratinocytes, a feat previously found to 
be extremely challenging47.  Wang et al. found that keratinocytes co-cultured with fibroblasts would 
proliferate quicker than those without fibroblasts45.  In fact, feeder layers of fibroblasts for clinical 
keratinocyte expansion remain part of the standard protocol for rapid proliferation (though the 
NHEKs grown for the experiments in this thesis did not require them)46.  As fibroblasts form 
excellent sheets on scaffolds and have been shown in previous literature to support keratinocyte 
culture, we hypothesized that a co-culture of NHEKs on a pre-formed fibroblast sheet would lead 
to keratinocyte sheets47.  Another strategy could be to grow hMSCs into sheets as we have already 
demonstrated, then differentiate them into keratinocyte-like cells – previous studies have been able 
to differentiate hMSCs towards an epidermal-like cell line48, 49.  In order to distinguish between 
fibroblasts and NHEKs, we used NIH3T3 cells that have been stably transfected with green 
fluorescent protein.  Keratinocytes were identified by immunostaining for keratin with an anti-pan-
keratin antibody (a marker for epithelial cells), followed by a red fluorescent secondary antibody48.  
Thus, the fibroblasts would fluoresce with a green light, and the keratinocytes with a red light.  
Fibroblasts were cultured first for 72 hr to form sheets – then keratinocytes were co-cultured for 3 
days, 5 days, and 7 days in an optimized co-culture media (described in the Experimental Section).  
We then imaged them using confocal microscopy and took z-stacks to observe how the two cell 





NIH3T3/GFP fibroblasts formed fully confluent sheets by 72 hr post-seeding as expected (Fig. 
5.19-a).  After 3 days of co-culture, sheets of keratinocytes co-existed with that of fibroblasts (Fig. 
5.19-b); however, they did not two distinct layers.  z-stacks indicate that they actually became mixed 
together in the same plane, with some areas having a heavy number of fibroblasts and some areas 
only the keratinocytes (Fig. 5.20-b).  After 5 days of co-culture however, the fibroblasts are almost 
completely gone and replaced by a confluent NHEK sheet (Fig. 5.19-c).  Only a few fibroblasts 
could be spotted on top of the sheet that now existed.  This largely held true for 7 days of co-culture 
as well, although there were now more fibroblasts (Fig. 5.19-d).  They seemed to have been relegated 
to a sort of supportive role, with one or two fibroblasts clinging to a dense sheet of NHEK cells 
 
Figure 5.19:  (a) NIH3T3/GFP cells cultured for 72 hr prior to keratinocyte seeding.  
Keratinocytes were then seeded with NIH3T3/GFP-confluent sheets on scaffolds for (b) three, (c) 
five, and (d) seven days.  (e) NHEK cells cultured on scaffolds for 7 days without fibroblasts  
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(Fig. 5.20-c,d).  Nevertheless, our hypothesis of NHEK sheet formation via fibroblast co-culture 
was supported by the formation of the keratinocyte sheets.  Even after 7 days of culture, NHEKs 
seeded onto scaffolds with no prior fibroblasts failed to form any sheets of significant size (Fig. 
5.19-e). 
 
What leads to this massive loss of fibroblasts between 3 and 5 days is not clear.  Irradiated 
fibroblasts (which cannot proliferate) used in co-culture eventually detach and die after extended 
culture with keratinocytes46.  Using non-irradiated human fibroblasts, Jubin et al. observed that in a 
6:1 ratio of keratinocytes to fibroblasts the resulting co-culture was composed of over 90% 
 
Figure 5.20:  (a) z-stack of NHEK-NIH3T3/GFP co-culture incubated for 3 days (b) cross-
sectional images of z-stack shown in (a); z-stack of NHEK-NIH3T3/GFP co-culture incubated for 
(c) 5 days and (d) 7 days 
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keratinocytes after 15 days, while lower ratios of keratinocytes to fibroblasts led to fibroblast 
dominance instead46.  Given that there are approximately 60,000-80,000 fibroblasts per scaffold at 
the end of 72 hr, maybe subsequently seeding over 300,000 keratinocytes onto them (a ratio of 
approximately 4-5:1, not too far from what Jubin et al. used) allows the keratinocytes to overwhelm 
the fibroblasts by sheer numbers and subsequent proliferation rates46.  Of course Jubin et al. did 
their culture on flat 2D substrates while we did ours on 3D scaffolds, and we know that not all 
300,000 keratinocytes attach to the scaffold.  Still, there are a lot more keratinocytes present in the 
culture than fibroblasts initially.  One way of testing this hypothesis would be to try seeding different 
concentrations of NHEKs with the scaffolds after generated confluent fibroblast layers.  To test if it 
is the co-culture medium (which is not used until the NHEKs are seeded), we could simply continue 
to grow the NIH3T3/GFP cells in it without NHEKs to see if it is toxic. 
 
We also noticed that the keratinocytes after co-culture looked different from those that were 
cultured without fibroblasts.  While the keratinocytes grown by themselves had the classic 
cobblestone morphology as observed by confocal microscopy (Fig. 5.18), keratinocytes grown in co-
culture appeared more fibroblastic and spindle-shaped, almost even balled up (Fig. 5.20-c).  In order 
to investigate this further, we performed SEM with keratinocytes grown without fibroblasts (which 
will form a few small sheets one can examine), and keratinocytes that had been co-cultured with 




While we do see a marked difference in morphology, we believe that this is just a confinement effect.  
Thus, we are unconcerned about this difference, though it is striking (Fig. 5.21). These cultures were 
grown in a hypoxic environment – hypoxia induces the downregulation of e-cadherins in 
keratinocytes 50.  Perhaps we are observing the effects of this downregulation, as the keratinocytes 












Figure 5.21:  (a) SEM of NHEK cells grown in co-culture for 5 days in co-culture with 
NIH3T3/GFP cells (b) SEM of NHEK cells grown without NIH3T3/GFP cells 
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Conclusions and Future Work 
By using a ring electrode to stabilize our jetted polymer and a controllable collecting stage, we are 
able to generate high fidelity scaffolds with precise geometric spacing.  While many different types of 
scaffolds were created, we initially focused on using a simple square grid pattern for generating our 
cell sheets.  We characterized the deposition of fibrocetin by NIH3T3 fibroblasts over time, and 
correlated its appearance and distribution to the formation of cell sheets.  SEM also further 
elucidated how cells beginning to form sheets do so by anchoring part of their cell body to the 
scaffold wall while another part reaches out into the space between the grid walls, allowing for other 
cells to attach at these ends and further ‘bridge’ out until they form a span across.  Multiple cell 
sheets have been formed with our scaffolds, including mesenchymal stem cells and keratinocytes 
with a co-culture of fibroblasts. 
Many tissues can be thought of as being organized into sheets, and future work will involve growing 
more cell types to create sheets, including hepatocytes, endothelial cells, and eventually neurons.  As 
of the writing of this thesis however, we are actively working on differentiating our sheets of 
mesenchymal stem cells towards osteogenic fates.  While one obvious application would be to use 
the scaffolds and cell sheets as a platform for creating bone-like sheets that could be used in a 
clinical setting, another use would be as a model in vitro osteogenic platform for studying the 
interactions of tumor cells with bone.  The scaffolds are flexible, yet provide a strong platform for 
generating sheets that does not tear or break easily.  Thus, we plan to expand our co-culture strategy 
towards growing two or more types of cells on individual scaffolds (such as osteogenic cells and 
chrondrogeneic cells, or liver cells and endothelial cells) and then stacking the individual scaffolds on 
top of one another.  As tissues are composed of multiple cell types and our scaffolds are flexible 
enough to be contorted into various possible shapes (including three- dimensional ones such as 
tubes or spheres), we potentially have a technology platform that allows us to recapitulate very 
150 
 
complicated tissue architectures in vitro.  This is an advantage over other cell sheet methods reviewed.  
For example, we could grow a sheet of hepatocytes and a sheet of endothelial cells on separate 
scaffolds, then fold the endothelial cell sheet into a tube, and then wrap that tube with the 
hepatocyte sheet.  We also plan to exploit the fact that these scaffolds can be jetted to contain 
multiple phases featuring reactive functional groups.  We could jet a PLGA scaffold containing a 
cyclooctyne (much like what was done for Chapter 4), click on an ATRP bromo-initiator, then 
create zwitterionic polymer brushes of PMEDSAH.  This would potentially then allow us to grow 
hESCs or iPSCs onto our scaffolds, which can then be exploited to differentiate into a wide array of 
cell lines.  We could even create multimodal fibers with one or more biomolecules immobilized via 
bio-orthogonal chemistries to illicit synergistic effects on the cells we culture, or to influence 
differentiation of stem cells down a certain path.  For example, we could tether an azido-TGF-β to 
our scaffolds to induce hMSC sheets to differentiate down an chondrogenic pathway – McCall et al. 
did precisely this and demonstrated that immobilized TGF-β induced encapsulated hMSCs to 
differentiate into chondrocyte-like cells51.   EGF on the other hand has been shown to stimulate 
hMSCs into differentiating down an osteogenic pathway52.  If one could selectively tether TGF-β to 
one side of a scaffold while tethering EGF to the other side, it is possible that one could make 
alternating grids of osteocytes and chondrocytes.  This could then be a useful in vitro model for 
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Conclusions and Future Work 
General Conclusions 
In this work, we have characterized the behaviors of mammalian cells after they are cultured with a 
variety of microenvironments, ranging from two-dimensional surfaces tethered with multiple 
biomolecules, to three-dimensional scaffolds that could host entire sheets of cells.  In Chapter 2, we 
successfully demonstrated that we could modify a substrate by immobilizing two biomolecules 
independently (or ‘orthogonally’) of each other.  We then showed that these biomolecules could still 
interact as expected with the model cell lines HUVEC and A431.  Chapter 3 dealt with the 
development of a microenvironment for feeder-free culture of hESCs, and characterizing how 
hMSCs behaved on it.  By designing an anisotropic microenvironment featuring spatially distributed 
areas of cell-selective and cell-resistant domains, we successfully built and characterized a 
bioactuator powered by rat neonatal cardiomyocytes in Chapter 4.  Finally, in Chapter 5 we used a 
novel grid PLGA scaffold generated from EHD-cojetting and a movable/programmable x-y stage 
to create sheets of various cell lines (including hMSCs and keratinocytes). 
The advances generated by this work add to the overall body of scientific knowledge and ‘toolboxes’ 
available to biomedical engineers.  The ability to create microenvironments is a powerful tool 
because these niches do so much in vivo to guide and support cells in performing their physiological 
roles, especially stem cells1.  They can also play a pathological role, as it is well known that the 
microenvironment of cancer cells is critical to their development 2.  By developing methods for 
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bioorthogonal surface reactions, we have pushed the field forward towards better techniques for the 
precise immobilization of biomolecules.   We also now have a much clearer idea of how hMSCs 
behave on PMEDSAH, and how the method of coating PMEDSAH can play a major role in their 
proliferation.  Stem cells will continue to play an increasingly important role in medicine and in 
studies of fundamental cell physiology, so coatings like PMEDSAH that result in feeder-free 
conditions will be more and more prevalent – being able to differentiate hESCs into hMSCs and 
continue to culture them on the same substrate will represent another step towards a ‘universal’ 
substrate that can be used for all the steps of stem cell culture, from growth to maintenance to 
differentiation.  Even though hMSCs can be grown and maintained on TCPS, other groups have 
moved towards developing xeno-free conditions for their expansion, including a using surface with 
an immobilized peptide (PQVTRGDVFTMP) – their growth rate on these modified substrates was 
significantly higher in comparison to TCPS 3.  Thus, it is important that we continue to characterize 
hMSC proliferation on substrates intended for xeno-free culture, and that’s precisely what Chapter 3 
explored.   
In the burgeoning field of bioactuators, we created free-floating actuators which are much smaller 
than many others that have been developed, and found that they are able to host a large number of 
cardiomyocytes which together exert a calculated force nearly an order of magnitude larger than 
many of those previously created (detailed in Chapter 2).  We also advanced the field of cell 
microcarriers by developing a spatially selective magnetic microcylinder that could host both 
fibroblasts and cardiomyocytes.  Finally, the field of cell sheet engineering now has a new method 




In Chapter 1, we discuss the historical context and modern scientific relevance of biomaterials to 
medicine and engineering, and emphasize that the field of biomaterials is rapidly moving from 
simple and basic materials like metals and unmodified polymers to complex substrates that in many 
cases directly incorporate biomolecules such as proteins or nucleic acids in order to better integrate 
with a patient after transplantation, or to influence the behavior of cells in some way.  Even the 
topology of the surfaces can play a role in dictating cell behavior (e.g., rough vs. smooth surfaces, or 
stiff vs. flexible substrates) and can be modified to induce some specific biological outcome, as 
reviewed by Ross et al4.  Biomaterials should be thought of as creating microenvironments just as we 
currently think of niches in the body where cells reside as microenvironments.   In this dissertation, 
we leverage this paradigm to characterize the biological outcomes of a variety of biomaterials, and 
we continue to build on our knowledge of this fascinating field. 
Future Work 
As discussed earlier, our successful dual immobilization strategy for biomolecules should be 
exploited to attempt more intriguing biological phenomenon.  For example, by microcontact 
printing different growth factors or small molecules to our surface sequentially, we could create 
patterns of factors that would differentiate mesenchymal stem cells towards different lineages.  
Other groups have demonstrated the feasibility of this approach5.  Other possible ways forward 
include attempting to create gradients of biomolecules on our surface, rather than just a 
homogeneous density6.  This would allow us to induce behaviors such as neural guidance7.  This 
could also potentially allow us to create surfaces or substrates that can induce morphogenesis with 
cell lines, along the French Flag model espoused by Wolpert 8.  With opposing gradients of our co-
polymer, we could even create a system where one population of cells undergoes morphogenesis in 
one direction, while another does so in the opposite.  Gradients of biomolecules can be created in 
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CVD by coating a gradient of the co-polymer (this is done by not rotating the sample stage), creating 
a thin polymer film with a spatially increasing amount of reactive functional groups (and thus after 
immobilization a gradient of tethered molecules such as proteins)6.  Opposing co-culture gradients 
can be generated with two-source CVD.  One of the chief difficulties with this way forward is non-
specific adsorption of the proteins (negating the advantages of the polymer gradient).    
There is still much work to be done with the hMSCs grown on PMEDSAH.  It is not clear whether 
the differences in the number of hMCSs after 1 week of culture on UV-grafted and ATRP 
PMEDSAH are solely due to proliferation, or if initial attachment rates also play a role.  Several 
experiments designed to measure initial cell attachment were not successful – however, we believe 
these technical issues can be overcome.  We also must continue to investigate why hMSCs show 
such a radical difference when cultured on UV-grafted PMEDSAH over ATRP PMEDSAH.  We 
also still need to confirm that hMSCs grown on PMEDSAH still differentiate down their key 
lineages.  We plan to exploit the EDTA effect we observed during this work to generate patterned 
PMEDSAH surfaces that can resist cell adhesion. 
We hope to continue our work with the bioactuators and the culture of cardiomyocytes on 
substrates for tissue engineering (particularly our scaffolds discussed in Chapter 5).  We would like 
to further optimize our protocols in order to get only a few cardiomyocytes on our cylinders (and 
avoid the giant balls of cells that currently accumulate on them) – in order for these to then bend we 
likely will need to make our cylinders even less stiff than they currently are (perhaps by making them 
smaller in diameter).  We also would like to explore the possibility of using our cylinders as spatially 
selective cell microcarriers.  Their magnetic properties could potentially allow for self-assembly, or 
for them to act as ‘cell trains’ that carry cells from location to location based on magnetic fields. 
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Finally, we are very excited about the results we have obtained from our PLGA grid scaffolds.  We 
are currently working on differentiating hMSCs down an osteogenic lineage on our scaffolds, and 
hope to place them in an in vivo model such as a mouse both to demonstrate their safety and 
potential for use in tissue engineering.  We have plans to create sheets of cells from a wide variety of 
sources, including the liver, endothelial cells, cardiomyocytes, and gastric cells.  We would like to 
move beyond simple sheets and attempt to create more complicated structures by post-incubation 
manipulation.  The scaffolds will hopefully provided the necessary structural support needed to do 
this, without breaking the cell sheets.  These can then be arranged by stacks or overlaying structures 
of various gross geometric conformation (such as tubes) to create complicated 3D cell co-cultures.  
Furthermore, we can take advantage of our library of functionalized PLGAs and our ability to jet 
multicompartmental fibers to create scaffolds which can be enhanced with tethered biomolecules 
and other functional groups – these could be picked to enhance proliferation, or induce 
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